https://biotechmorning.com 2026-10-27T08:46:51.005Z daily 1 https://biotechmorning.com/issues 2026-10-27T08:46:51.005Z daily 0.8 https://biotechmorning.com/news 2026-10-27T08:46:51.005Z daily 0.9 https://biotechmorning.com/news/argenx-sjogrens-trial-failure 2026-10-20T14:12:55.140Z never 0.8 https://biotechmorning.com/news/lilly-metis-ai-lnp-delivery-deal 2026-10-20T14:12:09.297Z never 0.8 https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-biggest-deal 2026-10-20T14:11:21.289Z never 0.8 https://biotechmorning.com/news/china-biopharma-technology-export-restrictions 2026-10-20T14:10:32.870Z never 0.8 https://biotechmorning.com/news/tezepelumab-crossing-eoe-phase-3-results 2026-10-20T14:09:51.923Z never 0.8 https://biotechmorning.com/news/eyepoint-wet-amd-double-failure-layoffs 2026-10-20T14:09:03.827Z never 0.8 https://biotechmorning.com/news/dostarlimab-rectal-cancer-fda-approval 2026-10-20T14:08:18.776Z never 0.8 https://biotechmorning.com/news/merck-kgaa-silence-therapeutics-acquisition 2026-10-20T14:07:34.760Z never 0.8 https://biotechmorning.com/news/shionogi-intrabio-2-billion-rare-disease-acquisition-2 2026-10-19T14:12:44.375Z never 0.8 https://biotechmorning.com/news/bitopertin-apollo-epp-trial-results 2026-10-19T14:11:57.932Z never 0.8 https://biotechmorning.com/news/roche-hansoh-second-adc-deal 2026-10-19T14:11:08.813Z never 0.8 https://biotechmorning.com/news/nouscom-135-million-cancer-vaccine 2026-10-19T14:10:20.120Z never 0.8 https://biotechmorning.com/news/viatris-pacira-acquisition-non-opioid-pain 2026-10-19T14:09:37.435Z never 0.8 https://biotechmorning.com/news/gilead-crashes-ibd-party-ulcerative-colitis 2026-10-19T14:08:50.559Z never 0.8 https://biotechmorning.com/news/abbvie-abbv-466-beats-skyrizi-crohns-disease 2026-10-19T14:08:07.412Z never 0.8 https://biotechmorning.com/news/teva-weltruza-schizophrenia-monthly-injection-fda-approval 2026-10-18T14:17:59.021Z never 0.8 https://biotechmorning.com/news/roche-billion-dollar-dualitas-bispecific-screening-deal 2026-10-18T14:17:07.996Z never 0.8 https://biotechmorning.com/news/verastem-kras-g12d-pancreatic-cancer-data 2026-10-18T14:16:20.593Z never 0.8 https://biotechmorning.com/news/undruggable-kras-conquers-europe-pancreatic-cancer 2026-10-18T14:15:30.957Z never 0.8 https://biotechmorning.com/news/intellia-crispr-phase-3-hereditary-angioedema 2026-10-18T14:14:45.731Z never 0.8 https://biotechmorning.com/news/astrazeneca-absci-ai-antibody-deal 2026-10-18T14:13:58.883Z never 0.8 https://biotechmorning.com/news/biontech-mRNA-cancer-vaccine-bnt113-fails-phase-3 2026-10-18T14:13:13.006Z never 0.8 https://biotechmorning.com/news/once-weekly-achondroplasia-therapy-europe 2026-10-18T14:12:28.383Z never 0.8 https://biotechmorning.com/news/novartis-fabhalta-lupus-nephritis-trial-halted 2026-10-18T14:11:44.020Z never 0.8 https://biotechmorning.com/news/bms-orbital-therapeutics-1-5-billion-acquisition 2026-10-18T14:10:55.404Z never 0.8 https://biotechmorning.com/news/adc-that-couldnt-clear-the-bar 2026-10-18T14:10:12.303Z never 0.8 https://biotechmorning.com/news/novartis-kills-fabhalta-kidney-trial-strategic-reasons 2026-10-17T14:14:57.801Z never 0.8 https://biotechmorning.com/news/fda-approves-enspryng-thyroid-eye-disease-mixed-data 2026-10-17T14:14:11.282Z never 0.8 https://biotechmorning.com/news/caribou-biosciences-shutdown-crispr-doudna 2026-10-17T14:13:24.112Z never 0.8 https://biotechmorning.com/news/astrazeneca-2-billion-summit-therapeutics-cancer-deal 2026-10-17T14:12:41.086Z never 0.8 https://biotechmorning.com/news/estuary-biotherapeutics-adpkd-gene-therapy-launch 2026-10-17T14:11:54.032Z never 0.8 https://biotechmorning.com/news/biotech-ipo-drought-over-2026 2026-10-17T14:11:06.404Z never 0.8 https://biotechmorning.com/news/novo-nordisk-orbis-medicines-oral-cardiometabolic-deal 2026-10-17T14:10:19.788Z never 0.8 https://biotechmorning.com/news/hhs-ai-clinical-trials-initiative 2026-10-17T14:09:33.969Z never 0.8 https://biotechmorning.com/news/shkreli-violates-lifetime-pharma-ban 2026-10-16T14:14:58.969Z never 0.8 https://biotechmorning.com/news/pennsylvania-big-pharma-investment-merck-gsk 2026-10-16T14:14:18.386Z never 0.8 https://biotechmorning.com/news/lilly-obesity-pill-european-hurdle 2026-10-16T14:13:29.749Z never 0.8 https://biotechmorning.com/news/biotech-seed-funding-drops-2026 2026-10-16T14:12:39.526Z never 0.8 https://biotechmorning.com/news/china-biotech-export-controls-window-open 2026-10-16T14:11:59.404Z never 0.8 https://biotechmorning.com/news/rnai-biggest-problem-200-million-bet-city-therapeutics 2026-10-16T14:11:16.955Z never 0.8 https://biotechmorning.com/news/revita-device-glp1-weight-regain-remain1-results 2026-10-16T14:10:24.285Z never 0.8 https://biotechmorning.com/news/iambic-therapeutics-ipo-150-million 2026-10-15T14:14:43.430Z never 0.8 https://biotechmorning.com/news/ipf-claims-another-victim-syndax-stock 2026-10-15T14:13:56.057Z never 0.8 https://biotechmorning.com/news/astrazeneca-insitro-ai-mash-deal 2026-10-15T14:13:10.858Z never 0.8 https://biotechmorning.com/news/vertex-10-billion-crinetics-acquisition-5 2026-10-15T14:12:19.049Z never 0.8 https://biotechmorning.com/news/agilent-proscia-240m-digital-pathology-acquisition 2026-10-15T14:11:39.314Z never 0.8 https://biotechmorning.com/news/fda-rare-disease-framework-overhaul 2026-10-15T14:10:50.550Z never 0.8 https://biotechmorning.com/news/mit-in-vivo-nk-cell-reprogramming-nanoparticles 2026-10-15T14:10:02.844Z never 0.8 https://biotechmorning.com/news/arrowhead-aro-mapt-tau-rna-alzheimers 2026-10-15T14:09:21.035Z never 0.8 https://biotechmorning.com/news/omass-therapeutics-310-million-series-c 2026-10-15T14:08:32.038Z never 0.8 https://biotechmorning.com/news/anktiva-bladder-cancer-label-expansion 2026-10-15T14:07:44.787Z never 0.8 https://biotechmorning.com/news/legend-biotech-in-vivo-car-t-lb2501 2026-10-15T14:07:03.420Z never 0.8 https://biotechmorning.com/news/sanofi-caught-trash-talking-rival-vaccine 2026-10-14T14:18:32.342Z never 0.8 https://biotechmorning.com/news/glp1-graveyard-getting-crowded 2026-10-14T14:17:46.324Z never 0.8 https://biotechmorning.com/news/zealand-generate-ai-obesity-protein-deal 2026-10-14T14:17:01.234Z never 0.8 https://biotechmorning.com/news/gsk-billion-dollar-idrx-gist-acquisition 2026-10-14T14:16:15.974Z never 0.8 https://biotechmorning.com/news/pfizer-enodia-protein-degradation-deal 2026-10-14T14:15:28.194Z never 0.8 https://biotechmorning.com/news/syndax-walks-away-ipf-lung-disease 2026-10-14T14:14:38.349Z never 0.8 https://biotechmorning.com/news/otsuka-rexulti-ptsd-fda-adcom-skepticism 2026-10-14T14:13:51.027Z never 0.8 https://biotechmorning.com/news/keytruda-first-biosimilar-fda-review 2026-10-14T14:13:06.633Z never 0.8 https://biotechmorning.com/news/novartis-abogen-rna-deal 2026-10-14T14:12:26.585Z never 0.8 https://biotechmorning.com/news/gilead-vir-biotechnology-masked-tce-deal 2026-10-14T14:11:42.330Z never 0.8 https://biotechmorning.com/news/vykat-xr-withdrawal-call-prader-willi 2026-10-13T14:17:40.455Z never 0.8 https://biotechmorning.com/news/roche-rona-rni-obesity-deal 2026-10-13T14:16:53.480Z never 0.8 https://biotechmorning.com/news/novo-nordisk-300m-hengrui-oral-glp1-deal 2026-10-13T14:16:03.595Z never 0.8 https://biotechmorning.com/news/bms-ryz101-action-1-gep-nets-radiopharmaceutical-win 2026-10-13T14:15:18.364Z never 0.8 https://biotechmorning.com/news/sanofi-regeneron-8-billion-immunology-expansion 2026-10-13T14:14:35.759Z never 0.8 https://biotechmorning.com/news/daiichi-sankyo-merck-adc-bla-withdrawal-sclc 2026-10-13T14:13:49.973Z never 0.8 https://biotechmorning.com/news/bms-admilparant-ipf-mixed-results 2026-10-13T14:13:04.826Z never 0.8 https://biotechmorning.com/news/biontech-mrna-cancer-vaccine-phase-3-miss 2026-10-13T14:12:19.134Z never 0.8 https://biotechmorning.com/news/europe-pharma-rd-decline-competitiveness-crisis 2026-10-12T14:17:42.830Z never 0.8 https://biotechmorning.com/news/merck-400m-scibrunch-kras-preclinical-deal 2026-10-12T14:17:00.177Z never 0.8 https://biotechmorning.com/news/scholar-rock-myostatin-fda-approval-sma 2026-10-12T14:16:10.099Z never 0.8 https://biotechmorning.com/news/genmab-8-billion-merus-acquisition-2 2026-10-12T14:15:24.727Z never 0.8 https://biotechmorning.com/news/acoramidis-beats-tafamidis-real-world-attr-cardiomyopathy 2026-10-12T14:14:34.617Z never 0.8 https://biotechmorning.com/news/trex-bio-ipo-treg-immune-therapy 2026-10-12T14:13:45.809Z never 0.8 https://biotechmorning.com/news/gsk-mrna-flu-vaccine-phase-3-3 2026-10-12T14:12:57.307Z never 0.8 https://biotechmorning.com/news/uniqure-huntington-gene-therapy-four-year-setback 2026-10-12T14:12:16.355Z never 0.8 https://biotechmorning.com/news/iovance-amtagvi-revenue-guidance-raise-2026 2026-10-11T14:16:06.685Z never 0.8 https://biotechmorning.com/news/first-new-herpes-antiviral-mechanism-fda-approval-pritelivir 2026-10-11T14:15:23.785Z never 0.8 https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-3 2026-10-11T14:14:40.769Z never 0.8 https://biotechmorning.com/news/lilly-taltz-zepbound-psoriasis-obesity-combination 2026-10-11T14:13:58.855Z never 0.8 https://biotechmorning.com/news/bayer-2-2-billion-bet-american-soil 2026-10-11T14:13:18.842Z never 0.8 https://biotechmorning.com/news/foghorn-lilly-partnership-collapse-layoffs 2026-10-11T14:12:32.461Z never 0.8 https://biotechmorning.com/news/merck-10-billion-verona-pharma-lung-drug 2026-10-11T14:11:47.058Z never 0.8 https://biotechmorning.com/news/fda-rna-editing-accelerated-approval-wave-life-sciences 2026-10-10T14:14:47.630Z never 0.8 https://biotechmorning.com/news/cancer-vaccine-warp-speed-initiative 2026-10-10T14:14:01.947Z never 0.8 https://biotechmorning.com/news/crispr-ctx310-aha-late-breaker-gene-editing-cardiovascular 2026-10-10T14:13:16.976Z never 0.8 https://biotechmorning.com/news/iambic-ai-model-abbvie-deal-ipo-filing 2026-10-10T14:12:28.922Z never 0.8 https://biotechmorning.com/news/schizophrenia-shot-skips-scariest-side-effect 2026-10-10T14:11:41.880Z never 0.8 https://biotechmorning.com/news/chai-discovery-six-pharma-partners-nine-months 2026-10-10T14:10:52.482Z never 0.8 https://biotechmorning.com/news/revolution-medicines-zealand-pharma-bad-week 2026-10-10T14:10:04.189Z never 0.8 https://biotechmorning.com/news/life-biosciences-cellular-reprogramming-glaucoma-human-trial 2026-10-10T14:09:11.466Z never 0.8 https://biotechmorning.com/news/novo-nordisk-nanexa-pharmashell-deal-2 2026-10-09T14:17:53.830Z never 0.8 https://biotechmorning.com/news/thermo-fisher-clario-acquisition-8-9-billion 2026-10-09T14:17:05.152Z never 0.8 https://biotechmorning.com/news/argenx-sjogrens-failure-celiac-success 2026-10-09T14:16:24.475Z never 0.8 https://biotechmorning.com/news/small-biotechs-crushed-by-trump-drug-tariffs 2026-10-09T14:15:39.459Z never 0.8 https://biotechmorning.com/news/bytedance-anew-labs-ai-drug-discovery 2026-10-09T14:14:54.255Z never 0.8 https://biotechmorning.com/news/four-deaths-evenamide-schizophrenia-fda-hold 2026-10-09T14:14:08.838Z never 0.8 https://biotechmorning.com/news/tecentriq-adjuvant-colon-cancer-fda-approval 2026-10-09T14:13:23.038Z never 0.8 https://biotechmorning.com/news/roche-defand-molecular-glue-china-deal 2026-10-09T14:12:35.653Z never 0.8 https://biotechmorning.com/news/viatris-pacira-acquisition-branded-pain 2026-10-09T14:11:49.939Z never 0.8 https://biotechmorning.com/news/endeavor-ipf-hedgehog-inhibitor-reversal 2026-10-09T14:11:10.225Z never 0.8 https://biotechmorning.com/news/pfizer-seagen-tucatinib-maintenance-approval 2026-10-08T14:15:39.682Z never 0.8 https://biotechmorning.com/news/halozyme-patent-fight-keytruda-subcutaneous 2026-10-08T14:14:51.827Z never 0.8 https://biotechmorning.com/news/caribou-biosciences-crispr-shutdown 2026-10-08T14:14:03.639Z never 0.8 https://biotechmorning.com/news/editas-crispr-cholesterol-gene-editing-trial 2026-10-08T14:13:20.473Z never 0.8 https://biotechmorning.com/news/argenx-celiac-disease-phase-2-win 2026-10-08T14:12:33.587Z never 0.8 https://biotechmorning.com/news/phrma-sues-trump-medicare-drug-pricing 2026-10-08T14:11:50.189Z never 0.8 https://biotechmorning.com/news/ai-room-temperature-mrna-vaccines-mit 2026-10-08T14:11:07.270Z never 0.8 https://biotechmorning.com/news/zymeworks-theravance-929-million-acquisition 2026-10-08T14:10:18.219Z never 0.8 https://biotechmorning.com/news/telix-itm-isotope-acquisition-radiopharmaceutical 2026-10-08T14:09:32.836Z never 0.8 https://biotechmorning.com/news/cerevance-solengepras-parkinsons-phase-3-win 2026-10-08T14:08:44.357Z never 0.8 https://biotechmorning.com/news/csl-amazon-aws-ai-drug-pipeline 2026-10-07T14:18:09.361Z never 0.8 https://biotechmorning.com/news/astrazeneca-billion-dollar-kendall-square-rd-hub 2026-10-07T14:17:23.194Z never 0.8 https://biotechmorning.com/news/arrivent-lung-cancer-trial-failure 2026-10-07T14:16:46.644Z never 0.8 https://biotechmorning.com/news/caribou-biosciences-shuts-down-crispr-car-t 2026-10-07T14:16:00.927Z never 0.8 https://biotechmorning.com/news/trex-bio-ipo-lilly-backed 2026-10-07T14:15:15.515Z never 0.8 https://biotechmorning.com/news/boehringer-leo-pharma-spevigo-il36-deal 2026-10-07T14:14:30.369Z never 0.8 https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-gene-therapy-crisis-2 2026-10-07T14:13:46.028Z never 0.8 https://biotechmorning.com/news/nobel-prize-mirror-image-molecules-drug-development 2026-10-07T14:12:59.360Z never 0.8 https://biotechmorning.com/news/fayuvi-gene-therapy-3-95-million-price 2026-10-07T14:12:16.210Z never 0.8 https://biotechmorning.com/news/eli-lilly-beat-its-own-zepbound-obesity-drug 2026-10-07T14:11:31.297Z never 0.8 https://biotechmorning.com/news/oral-infigratinib-achondroplasia-fda-priority-review 2026-10-06T14:16:21.452Z never 0.8 https://biotechmorning.com/news/csl-alentis-claudin-1-deal 2026-10-06T14:15:39.360Z never 0.8 https://biotechmorning.com/news/sarepta-elevidys-gene-therapy-fda-investigation-deaths 2026-10-06T14:14:54.967Z never 0.8 https://biotechmorning.com/news/novartis-abogen-mRNA-deal 2026-10-06T14:14:11.982Z never 0.8 https://biotechmorning.com/news/nobel-prize-optogenetics-brain-light 2026-10-06T14:13:24.868Z never 0.8 https://biotechmorning.com/news/fda-public-input-ibogaine-trial-design 2026-10-06T14:12:36.150Z never 0.8 https://biotechmorning.com/news/forbion-2-3-billion-european-biotech-fund 2026-10-06T14:11:52.090Z never 0.8 https://biotechmorning.com/news/fda-clears-app-treat-schizophrenia-negative-symptoms 2026-10-06T14:11:11.262Z never 0.8 https://biotechmorning.com/news/shionogi-intrabio-2-billion-rare-disease-acquisition 2026-10-06T14:10:21.153Z never 0.8 https://biotechmorning.com/news/epcoritamab-frontline-dlbcl-phase-3-results 2026-10-06T14:09:35.397Z never 0.8 https://biotechmorning.com/news/astrazeneca-2-billion-summit-therapeutics-ivonescimab-2 2026-10-06T14:08:51.885Z never 0.8 https://biotechmorning.com/news/thymus-tolerance-bio-tanabe-560-million-deal 2026-10-05T14:16:04.014Z never 0.8 https://biotechmorning.com/news/ge-healthcare-sofie-biosciences-acquisition-cyclotrons 2026-10-05T14:15:21.103Z never 0.8 https://biotechmorning.com/news/sanofi-regeneron-8-billion-immunology-deal 2026-10-05T14:14:34.948Z never 0.8 https://biotechmorning.com/news/vaxcyte-vax-31-picks-fight-with-pfizer-vaccine 2026-10-05T14:13:52.589Z never 0.8 https://biotechmorning.com/news/genentech-alector-al050-brain-delivery-deal 2026-10-05T14:13:04.516Z never 0.8 https://biotechmorning.com/news/enveda-311m-series-e-natural-product-ai 2026-10-05T14:12:18.167Z never 0.8 https://biotechmorning.com/news/novo-nordisk-denecimig-fda-delay-manufacturing 2026-10-05T14:11:29.070Z never 0.8 https://biotechmorning.com/news/bridgebio-bbp-418-cardiac-data-lgmd 2026-10-05T14:10:43.595Z never 0.8 https://biotechmorning.com/news/europe-pharma-ceos-joint-letter-biotech-competitiveness 2026-10-05T14:09:54.741Z never 0.8 https://biotechmorning.com/news/daiichi-sankyo-merck-adc-fda-withdrawal 2026-10-05T14:09:13.561Z never 0.8 https://biotechmorning.com/news/rna-drug-sefaxersen-iga-nephropathy-phase-3 2026-10-05T14:08:27.482Z never 0.8 https://biotechmorning.com/news/genmab-ovarian-cancer-adc-wont-quit 2026-10-04T14:12:52.114Z never 0.8 https://biotechmorning.com/news/zepbound-cheaper-vials-pricing 2026-10-04T14:12:06.387Z never 0.8 https://biotechmorning.com/news/cutaneous-lupus-litifilimab-52-week-data 2026-10-04T14:11:22.794Z never 0.8 https://biotechmorning.com/news/gsk-hutchmed-kras-deal 2026-10-04T14:10:41.415Z never 0.8 https://biotechmorning.com/news/lilly-ajax-therapeutics-jak-inhibitor-acquisition 2026-10-04T14:09:56.578Z never 0.8 https://biotechmorning.com/news/genmab-8-billion-merus-acquisition 2026-10-04T14:09:10.715Z never 0.8 https://biotechmorning.com/news/shanghai-biotech-city-courting-western-pharma 2026-10-04T14:08:24.300Z never 0.8 https://biotechmorning.com/news/china-crashed-obesity-drug-party 2026-10-04T14:07:40.520Z never 0.8 https://biotechmorning.com/news/fda-cder-office-china-clinical-trial-race 2026-10-04T14:06:52.606Z never 0.8 https://biotechmorning.com/news/pirtobrutinib-frontline-cll-approval 2026-10-03T14:15:15.837Z never 0.8 https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-2 2026-10-03T14:14:29.658Z never 0.8 https://biotechmorning.com/news/xaira-ai-antibody-design-platform 2026-10-03T14:13:46.744Z never 0.8 https://biotechmorning.com/news/florida-sues-pfizer-covid-vaccine 2026-10-03T14:13:03.682Z never 0.8 https://biotechmorning.com/news/heart-valve-grows-with-kid 2026-10-03T14:12:22.707Z never 0.8 https://biotechmorning.com/news/rna-activation-ractigen-dmd-first-in-human 2026-10-03T14:11:41.665Z never 0.8 https://biotechmorning.com/news/bayer-2-2-billion-ohio-pharma-manufacturing 2026-10-03T14:10:50.717Z never 0.8 https://biotechmorning.com/news/generate-biomedicines-400-million-ipo 2026-10-03T14:10:06.769Z never 0.8 https://biotechmorning.com/news/adarx-446-million-ipo-rna-therapeutics 2026-10-03T14:09:24.156Z never 0.8 https://biotechmorning.com/news/regeneron-trevogrumab-muscle-loss-semaglutide 2026-10-03T14:08:34.592Z never 0.8 https://biotechmorning.com/news/wave-life-sciences-single-trial-rna-editing-aatd 2026-10-02T14:15:39.514Z never 0.8 https://biotechmorning.com/news/regeneron-muscle-mass-wegovy-trevogrumab 2026-10-02T14:14:53.759Z never 0.8 https://biotechmorning.com/news/foghorn-lilly-breakup-layoffs 2026-10-02T14:14:04.978Z never 0.8 https://biotechmorning.com/news/novartis-abogen-mrna-t-cell-engager-deal 2026-10-02T14:13:20.562Z never 0.8 https://biotechmorning.com/news/adecto-biotech-shutdown-funding-crisis 2026-10-02T14:12:26.856Z never 0.8 https://biotechmorning.com/news/daiichi-astrazeneca-summit-adc-bispecific-combo-trial 2026-10-02T14:11:42.354Z never 0.8 https://biotechmorning.com/news/fresenius-kabi-mabxience-full-acquisition 2026-10-02T14:10:54.981Z never 0.8 https://biotechmorning.com/news/camzyos-first-pediatric-ohcm-approval 2026-10-02T14:10:14.712Z never 0.8 https://biotechmorning.com/news/amgen-horizon-sjogrens-phase-3-win 2026-10-02T14:09:28.052Z never 0.8 https://biotechmorning.com/news/novartis-alteogen-3-2-billion-drug-delivery-deal 2026-10-02T14:08:44.085Z never 0.8 https://biotechmorning.com/news/varda-251-million-space-drug-manufacturing 2026-10-01T14:17:56.377Z never 0.8 https://biotechmorning.com/news/sanofi-regeneron-billion-dollar-early-stage-deal 2026-10-01T14:17:10.806Z never 0.8 https://biotechmorning.com/news/bms-admilparant-liver-safety-death-fibrosis 2026-10-01T14:16:25.694Z never 0.8 https://biotechmorning.com/news/tarlatamab-durvalumab-first-line-sclc-survival 2026-10-01T14:15:42.919Z never 0.8 https://biotechmorning.com/news/lilly-amylin-zepbound-combo-record-weight-loss 2026-10-01T14:14:53.230Z never 0.8 https://biotechmorning.com/news/merck-tl1a-hidradenitis-suppurativa-phase-2-win 2026-10-01T14:14:05.350Z never 0.8 https://biotechmorning.com/news/viking-obesity-drug-monthly-dosing 2026-10-01T14:13:22.423Z never 0.8 https://biotechmorning.com/news/giredestrant-oral-serd-breast-cancer-evera 2026-10-01T14:12:40.350Z never 0.8 https://biotechmorning.com/news/fenebrutinib-ms-pill-fda-priority-review 2026-10-01T14:11:54.514Z never 0.8 https://biotechmorning.com/news/hhs-ai-clinical-trial-overhaul 2026-10-01T14:11:08.159Z never 0.8 https://biotechmorning.com/news/roche-obesity-drug-party 2026-09-30T14:18:39.354Z never 0.8 https://biotechmorning.com/news/uniqure-huntington-gene-therapy-durability-loss 2026-09-30T14:17:52.619Z never 0.8 https://biotechmorning.com/news/oral-il-17a-inhibitor-psoriasis-ascletis 2026-09-30T14:16:59.112Z never 0.8 https://biotechmorning.com/news/roche-autonomous-ai-labs 2026-09-30T14:16:12.453Z never 0.8 https://biotechmorning.com/news/peanut-patch-seven-years-fda-door 2026-09-30T14:15:29.583Z never 0.8 https://biotechmorning.com/news/phrma-eric-cantor-ceo-former-congressman 2026-09-30T14:14:42.872Z never 0.8 https://biotechmorning.com/news/amgen-lupus-graveyard-phase-2-win 2026-09-30T14:13:58.871Z never 0.8 https://biotechmorning.com/news/beam-therapeutics-trade-secret-lawsuit-yoltech-serapha 2026-09-30T14:13:13.693Z never 0.8 https://biotechmorning.com/news/obesity-drug-petrelintide-lower-dose-twist 2026-09-30T14:12:32.127Z never 0.8 https://biotechmorning.com/news/lilly-retatrutide-phase-3-obesity-data 2026-09-30T14:11:43.321Z never 0.8 https://biotechmorning.com/news/mrna-vaccine-no-freezer-ai-lipid-nanoparticles 2026-09-29T14:18:49.465Z never 0.8 https://biotechmorning.com/news/novo-nordisk-2-6-billion-hengrui-preclinical-glp1 2026-09-29T14:18:05.315Z never 0.8 https://biotechmorning.com/news/astrazeneca-2-billion-summit-therapeutics-ivonescimab 2026-09-29T14:17:18.467Z never 0.8 https://biotechmorning.com/news/novartis-avidity-12-billion-bet 2026-09-29T14:16:27.291Z never 0.8 https://biotechmorning.com/news/roche-obesity-antibody-emugrobart-discontinued 2026-09-29T14:15:41.675Z never 0.8 https://biotechmorning.com/news/telix-itm-radiopharmaceutical-acquisition 2026-09-29T14:14:56.464Z never 0.8 https://biotechmorning.com/news/merck-discontinues-recarbrio-antibiotic-superbug-crisis 2026-09-29T14:14:13.725Z never 0.8 https://biotechmorning.com/news/genetics-heart-drugs-pelacarsen-ziltivekimab-fail 2026-09-29T14:13:29.654Z never 0.8 https://biotechmorning.com/news/novartis-remibrutinib-ms-trial-results 2026-09-29T14:12:42.735Z never 0.8 https://biotechmorning.com/news/merck-scibrunch-kras-g12d-deal 2026-09-29T14:11:57.811Z never 0.8 https://biotechmorning.com/news/kodiak-sciences-daybreak-eye-drug-comeback 2026-09-29T14:11:09.284Z never 0.8 https://biotechmorning.com/news/gene-editing-child-deaths-china-oversight 2026-09-28T14:14:05.410Z never 0.8 https://biotechmorning.com/news/telix-itm-isotope-acquisition-radiopharmaceutical-supply 2026-09-28T14:13:28.924Z never 0.8 https://biotechmorning.com/news/prime-medicine-prime-editing-aatd-ind-clearance 2026-09-28T14:12:40.217Z never 0.8 https://biotechmorning.com/news/gotistobart-nearly-doubles-survival-squamous-nsclc 2026-09-28T14:11:46.856Z never 0.8 https://biotechmorning.com/news/roche-simcere-zaiming-trispecific-antibody-deal 2026-09-28T14:11:03.790Z never 0.8 https://biotechmorning.com/news/brelovitug-hepatitis-delta-phase-3-azure 2026-09-28T14:10:16.187Z never 0.8 https://biotechmorning.com/news/eli-lilly-once-weekly-insulin-approval 2026-09-28T14:09:31.960Z never 0.8 https://biotechmorning.com/news/cancer-therapy-curing-lupus-adicet-car-t 2026-09-28T14:08:52.264Z never 0.8 https://biotechmorning.com/news/astrazeneca-wainua-attr-cm-phase-3-failure 2026-09-28T14:08:05.079Z never 0.8 https://biotechmorning.com/news/trump-rescission-billion-biotech-pipeline 2026-09-27T14:18:05.603Z never 0.8 https://biotechmorning.com/news/in-vivo-car-t-iaso-bio-first-human-data 2026-09-27T14:17:25.796Z never 0.8 https://biotechmorning.com/news/lilly-innocare-3-billion-china-licensing-deal 2026-09-27T14:16:34.525Z never 0.8 https://biotechmorning.com/news/sarepta-elevidys-black-box-warning-deaths 2026-09-27T14:15:37.077Z never 0.8 https://biotechmorning.com/news/lundbeck-ditches-midwest-for-boston 2026-09-27T14:14:48.677Z never 0.8 https://biotechmorning.com/news/roche-magl-inhibitor-progressive-ms 2026-09-27T14:14:03.685Z never 0.8 https://biotechmorning.com/news/lilly-breast-cancer-combo-approval 2026-09-27T14:13:19.176Z never 0.8 https://biotechmorning.com/news/revolution-medicines-ras-pancreatic-cancer-drug 2026-09-27T14:12:32.459Z never 0.8 https://biotechmorning.com/news/novo-nordisk-orbis-macrocycle-oral-deal 2026-09-27T14:11:45.970Z never 0.8 https://biotechmorning.com/news/lilly-2-9-billion-merida-biosciences-acquisition-2 2026-09-27T14:11:00.379Z never 0.8 https://biotechmorning.com/news/nutshell-therapeutics-nts231-triple-mechanism-degrader 2026-09-26T14:17:54.686Z never 0.8 https://biotechmorning.com/news/eli-lilly-90m-nektar-unwritten-rule 2026-09-26T14:17:07.638Z never 0.8 https://biotechmorning.com/news/child-died-china-gene-editing-trial-transparency 2026-09-26T14:16:21.615Z never 0.8 https://biotechmorning.com/news/fop-zilurgisertib-fda-approval-mirum 2026-09-26T14:15:36.012Z never 0.8 https://biotechmorning.com/news/merck-daiichi-sankyo-second-fda-withdrawal 2026-09-26T14:14:54.377Z never 0.8 https://biotechmorning.com/news/abbvie-iambic-ai-drug-discovery-deal 2026-09-26T14:14:08.523Z never 0.8 https://biotechmorning.com/news/china-newco-consultant-double-dealing-lawsuit 2026-09-26T14:13:25.245Z never 0.8 https://biotechmorning.com/news/boehringer-billion-dollar-rna-splicing-envisagenics 2026-09-26T14:12:36.035Z never 0.8 https://biotechmorning.com/news/novo-nordisk-nanexa-pharmashell-deal 2026-09-26T14:11:45.844Z never 0.8 https://biotechmorning.com/news/parkinsons-first-new-dopamine-drug-type-decades 2026-09-26T14:10:59.502Z never 0.8 https://biotechmorning.com/news/gene-therapy-sanfilippo-syndrome-fda-approval 2026-09-26T14:10:14.400Z never 0.8 https://biotechmorning.com/news/first-drug-cerebral-adrenoleukodystrophy-nezglyal 2026-09-25T14:14:59.089Z never 0.8 https://biotechmorning.com/news/adarx-half-billion-dollar-ipo-bet-silencing-genes 2026-09-25T14:14:16.835Z never 0.8 https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-picks-shovels-biotech 2026-09-25T14:13:33.673Z never 0.8 https://biotechmorning.com/news/end-of-daily-insulin-shots-finally-here 2026-09-25T14:12:51.736Z never 0.8 https://biotechmorning.com/news/acadia-alzheimers-drug-phase-2-miss-phase-3-anyway 2026-09-25T14:12:09.821Z never 0.8 https://biotechmorning.com/news/biogen-fda-breakthrough-designation-crl-sma 2026-09-25T14:11:21.571Z never 0.8 https://biotechmorning.com/news/genentech-earendil-bispecific-antibody-deal 2026-09-25T14:10:33.929Z never 0.8 https://biotechmorning.com/news/one-shot-cholesterol-epigenetic-pcsk9-silencing 2026-09-25T14:09:47.093Z never 0.8 https://biotechmorning.com/news/merck-belzutifan-lenvatinib-kidney-cancer-fda-approval 2026-09-25T14:08:57.956Z never 0.8 https://biotechmorning.com/news/carvykti-five-year-remission-multiple-myeloma 2026-09-25T14:08:13.673Z never 0.8 https://biotechmorning.com/news/lilly-100m-innocare-beijing-deal 2026-09-24T14:20:23.640Z never 0.8 https://biotechmorning.com/news/europe-pharma-ceos-sos-biotech-decline 2026-09-24T14:19:41.622Z never 0.8 https://biotechmorning.com/news/sefaxersen-igan-phase-3-crowded-market 2026-09-24T14:18:59.875Z never 0.8 https://biotechmorning.com/news/roche-2-billion-atavistik-bio-cvrm-deal 2026-09-24T14:18:13.450Z never 0.8 https://biotechmorning.com/news/merck-remigromig-brunello-trial-dme 2026-09-24T14:17:24.399Z never 0.8 https://biotechmorning.com/news/galleri-blood-test-fda-panel-vote 2026-09-24T14:16:40.024Z never 0.8 https://biotechmorning.com/news/eu-gene-edited-crops-regulation-shift 2026-09-24T14:15:53.766Z never 0.8 https://biotechmorning.com/news/flagship-pioneering-pentagon-biodefense-contract 2026-09-24T14:15:12.133Z never 0.8 https://biotechmorning.com/news/enveda-311m-series-e-plant-ai-drug-discovery 2026-09-24T14:14:29.658Z never 0.8 https://biotechmorning.com/news/kyverna-car-t-miv-cel-autoimmune-one-year-data 2026-09-24T14:13:40.399Z never 0.8 https://biotechmorning.com/news/fda-nominee-heidi-overton-senate-confirmation-hearing 2026-09-24T14:12:53.404Z never 0.8 https://biotechmorning.com/news/merck-winrevair-hyperion-pah-label-update 2026-09-23T14:17:08.169Z never 0.8 https://biotechmorning.com/news/sjogrens-disease-amgen-dazodalibep-phase-3-win 2026-09-23T14:16:21.741Z never 0.8 https://biotechmorning.com/news/celldex-barzolvolimab-phase-3-chronic-hives-safety-concerns 2026-09-23T14:15:35.770Z never 0.8 https://biotechmorning.com/news/ulefnersen-fus-als-phase-3-survival-results 2026-09-23T14:14:49.656Z never 0.8 https://biotechmorning.com/news/immunovant-lupus-bet-goes-bust 2026-09-23T14:14:06.689Z never 0.8 https://biotechmorning.com/news/hhs-reduce-animal-testing-drug-development 2026-09-23T14:13:22.622Z never 0.8 https://biotechmorning.com/news/novartis-boomray-900m-preclinical-radioligand-deal 2026-09-23T14:12:38.338Z never 0.8 https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-duchenne-3 2026-09-23T14:11:52.901Z never 0.8 https://biotechmorning.com/news/novartis-avidity-second-trial-failure 2026-09-23T14:11:05.916Z never 0.8 https://biotechmorning.com/news/white-house-veto-power-nih-grants 2026-09-22T14:18:18.490Z never 0.8 https://biotechmorning.com/news/alteogen-novartis-3-billion-subcutaneous-delivery-deal 2026-09-22T14:17:37.730Z never 0.8 https://biotechmorning.com/news/novo-nordisk-cagrisema-beats-tirzepatide-weight-loss 2026-09-22T14:16:49.520Z never 0.8 https://biotechmorning.com/news/roche-obesity-drug-data-lilly-novo-competition 2026-09-22T14:16:05.616Z never 0.8 https://biotechmorning.com/news/grail-galleri-fda-staff-review-no-major-concerns 2026-09-22T14:15:22.411Z never 0.8 https://biotechmorning.com/news/nvidia-backed-iambic-therapeutics-ipo-filing 2026-09-22T14:14:39.480Z never 0.8 https://biotechmorning.com/news/china-25-percent-first-in-class-drug-target-2030 2026-09-22T14:13:56.382Z never 0.8 https://biotechmorning.com/news/adhd-drug-nothing-to-do-with-stimulants 2026-09-22T14:13:08.202Z never 0.8 https://biotechmorning.com/news/sarepta-worst-week-gene-therapy-playbook 2026-09-22T14:12:21.397Z never 0.8 https://biotechmorning.com/news/viking-therapeutics-obesity-data-spooks-lilly-novo 2026-09-22T14:11:38.243Z never 0.8 https://biotechmorning.com/news/novo-nordisk-strategy-reset-job-cuts 2026-09-22T14:10:45.746Z never 0.8 https://biotechmorning.com/news/scholar-rock-apitegromab-sma-muscle-therapy-fda-approval 2026-09-21T14:18:08.632Z never 0.8 https://biotechmorning.com/news/thyroid-trick-bipolar-depression-elunetirom 2026-09-21T14:17:24.444Z never 0.8 https://biotechmorning.com/news/bms-nvidia-ai-supercomputer-drug-discovery 2026-09-21T14:16:40.436Z never 0.8 https://biotechmorning.com/news/ionis-zilganersen-zanvastro-fda-approval-alexander-disease 2026-09-21T14:15:51.081Z never 0.8 https://biotechmorning.com/news/sleep-drug-aces-adhd-test-alkermes-orexin 2026-09-21T14:15:05.707Z never 0.8 https://biotechmorning.com/news/beacon-therapeutics-laru-zova-xlrp-pivotal-win 2026-09-21T14:14:18.750Z never 0.8 https://biotechmorning.com/news/telix-itm-acquisition-radiopharmaceutical-novartis 2026-09-21T14:13:38.333Z never 0.8 https://biotechmorning.com/news/keytruda-trodelvy-tnbc-first-line-fda-approval 2026-09-21T14:12:43.752Z never 0.8 https://biotechmorning.com/news/novo-nordisk-kallyope-non-incretin-obesity-deal 2026-09-21T14:11:55.409Z never 0.8 https://biotechmorning.com/news/transgene-tg4050-perfect-three-year-survival 2026-09-20T14:15:14.975Z never 0.8 https://biotechmorning.com/news/menarini-innovent-bofanglutide-europe-obesity-deal 2026-09-20T14:14:32.289Z never 0.8 https://biotechmorning.com/news/novo-nordisk-drops-nordisk-rebrand 2026-09-20T14:13:43.724Z never 0.8 https://biotechmorning.com/news/zealand-pharma-zeydovio-chmp-positive-opinion-europe 2026-09-20T14:13:00.663Z never 0.8 https://biotechmorning.com/news/fda-expedited-ind-pilot-program-phase-1-trials 2026-09-20T14:12:15.779Z never 0.8 https://biotechmorning.com/news/gsk-hutchmed-hmpl-a830-adc-deal 2026-09-20T14:11:26.441Z never 0.8 https://biotechmorning.com/news/roche-simcere-trispecific-deal 2026-09-20T14:10:38.629Z never 0.8 https://biotechmorning.com/news/skyhawk-sky-0515-huntington-pill 2026-09-20T14:09:49.833Z never 0.8 https://biotechmorning.com/news/astrazeneca-camizestrant-serena4-trial-miss 2026-09-20T14:09:04.127Z never 0.8 https://biotechmorning.com/news/astrazeneca-summit-15-billion-ivonescimab-deal 2026-09-20T14:08:24.104Z never 0.8 https://biotechmorning.com/news/lilly-zepbound-single-dose-vials-price-war 2026-09-19T14:14:44.868Z never 0.8 https://biotechmorning.com/news/anthropic-wet-biology-lab 2026-09-19T14:13:57.222Z never 0.8 https://biotechmorning.com/news/esr1-mutation-breast-cancer-fda-approval-imlunestrant 2026-09-19T14:13:10.581Z never 0.8 https://biotechmorning.com/news/intellia-crispr-hae-one-shot-phase-3 2026-09-19T14:12:24.431Z never 0.8 https://biotechmorning.com/news/uk-250-million-life-sciences-investment 2026-09-19T14:11:37.702Z never 0.8 https://biotechmorning.com/news/cannabis-compound-doubled-semaglutide-weight-loss 2026-09-19T14:10:53.158Z never 0.8 https://biotechmorning.com/news/us-china-pharma-licensing-deal-restrictions-easing 2026-09-19T14:10:05.182Z never 0.8 https://biotechmorning.com/news/curium-lantheus-8-billion-radiopharmaceutical-deal-2 2026-09-19T14:09:19.500Z never 0.8 https://biotechmorning.com/news/electra-therapeutics-350m-ipo-sirp-antibody 2026-09-18T14:19:38.796Z never 0.8 https://biotechmorning.com/news/xenon-depression-drug-psychosis-pause 2026-09-18T14:18:48.614Z never 0.8 https://biotechmorning.com/news/fayuvi-gene-therapy-sanfilippo-syndrome-approval 2026-09-18T14:18:04.725Z never 0.8 https://biotechmorning.com/news/genentech-190m-hanmi-preclinical-obesity-deal 2026-09-18T14:17:18.806Z never 0.8 https://biotechmorning.com/news/novo-nordisk-orbis-medicines-oral-macrocycle-deal 2026-09-18T14:16:30.813Z never 0.8 https://biotechmorning.com/news/enhertu-nhs-england-approval-breast-cancer 2026-09-18T14:15:39.760Z never 0.8 https://biotechmorning.com/news/315m-preclinical-parkinsons-deal-sk-biopharmaceuticals 2026-09-18T14:14:57.234Z never 0.8 https://biotechmorning.com/news/novartis-als-trial-failure-lifonebart 2026-09-18T14:14:06.673Z never 0.8 https://biotechmorning.com/news/bms-orum-dac-phase-1-termination 2026-09-18T14:13:18.205Z never 0.8 https://biotechmorning.com/news/trutakna-origin-3-kidney-disease-zero-progression 2026-09-18T14:12:34.668Z never 0.8 https://biotechmorning.com/news/kerendia-type-1-diabetes-ckd-approval 2026-09-17T14:17:19.125Z never 0.8 https://biotechmorning.com/news/pd1-agonist-rheumatoid-arthritis-jak-like-efficacy 2026-09-17T14:16:38.728Z never 0.8 https://biotechmorning.com/news/novartis-sironax-brain-delivery-platform-deal 2026-09-17T14:15:55.266Z never 0.8 https://biotechmorning.com/news/pfizer-10-billion-metsera-obesity-acquisition 2026-09-17T14:15:02.691Z never 0.8 https://biotechmorning.com/news/lilly-twist-bioscience-tunelab-ai-antibody-discovery 2026-09-17T14:14:16.972Z never 0.8 https://biotechmorning.com/news/acelot-oral-tdp43-als-drug-first-dosing 2026-09-17T14:13:33.890Z never 0.8 https://biotechmorning.com/news/skyhawk-huntingtons-rna-splicing-therapy-15-month-data 2026-09-17T14:12:43.138Z never 0.8 https://biotechmorning.com/news/oral-pill-thyroid-eye-disease-sling-therapeutics 2026-09-17T14:12:00.482Z never 0.8 https://biotechmorning.com/news/roche-dualitas-bispecific-antibody-screening-deal 2026-09-17T14:11:16.044Z never 0.8 https://biotechmorning.com/news/novo-nordisk-anthropic-claude-ai-drug-development 2026-09-17T14:10:22.354Z never 0.8 https://biotechmorning.com/news/ge-healthcare-sofie-biosciences-acquisition 2026-09-16T14:17:28.103Z never 0.8 https://biotechmorning.com/news/fda-operation-trialblazer-accelerate-phase-1-trials 2026-09-16T14:16:42.969Z never 0.8 https://biotechmorning.com/news/astrazeneca-15-billion-ivonescimab-summit-deal 2026-09-16T14:15:56.704Z never 0.8 https://biotechmorning.com/news/roche-hanmi-obesity-muscle-preservation-deal 2026-09-16T14:15:12.036Z never 0.8 https://biotechmorning.com/news/sionna-therapeutics-cystic-fibrosis-layoffs 2026-09-16T14:14:26.213Z never 0.8 https://biotechmorning.com/news/ai-drug-rentosertib-phase-3-pulmonary-fibrosis 2026-09-16T14:13:43.367Z never 0.8 https://biotechmorning.com/news/lilly-2-9-billion-merida-biosciences-acquisition 2026-09-16T14:12:55.471Z never 0.8 https://biotechmorning.com/news/lutathera-first-generic-radioligand-copycat 2026-09-16T14:12:14.110Z never 0.8 https://biotechmorning.com/news/merck-kgaa-bio-techne-11-billion-acquisition-2 2026-09-16T14:11:29.063Z never 0.8 https://biotechmorning.com/news/gsk-chimagen-750m-myeloma-deal 2026-09-15T14:15:17.511Z never 0.8 https://biotechmorning.com/news/moderna-mflusiva-mrna-flu-vaccine-fda-approval-2 2026-09-15T14:14:31.058Z never 0.8 https://biotechmorning.com/news/lilly-kills-obesity-drug-smart-move 2026-09-15T14:13:44.081Z never 0.8 https://biotechmorning.com/news/corbus-obesity-drug-cb1-novo-nordisk 2026-09-15T14:12:58.955Z never 0.8 https://biotechmorning.com/news/biontech-gotistobart-doubles-survival-squamous-lung-cancer 2026-09-15T14:12:07.603Z never 0.8 https://biotechmorning.com/news/fda-psychedelic-therapy-approval-hearing 2026-09-15T14:11:23.375Z never 0.8 https://biotechmorning.com/news/novo-nordisk-walks-away-285m-ascendis-glp1-deal 2026-09-15T14:10:35.135Z never 0.8 https://biotechmorning.com/news/jnj-contineum-depression-drug-phase-2-failure 2026-09-15T14:09:46.674Z never 0.8 https://biotechmorning.com/news/zipalertinib-egfr-exon20-lung-cancer-challenge 2026-09-14T14:19:03.003Z never 0.8 https://biotechmorning.com/news/electra-therapeutics-billion-dollar-ipo-sirp 2026-09-14T14:18:15.600Z never 0.8 https://biotechmorning.com/news/cellectis-abandons-allogeneic-car-t-pivots-in-vivo 2026-09-14T14:17:34.200Z never 0.8 https://biotechmorning.com/news/jj-amivantamab-papillon-os-catch 2026-09-14T14:16:45.332Z never 0.8 https://biotechmorning.com/news/lsd-pill-three-phase-3-wins-psychedelic-medicine 2026-09-14T14:15:53.507Z never 0.8 https://biotechmorning.com/news/brain-cancer-first-real-map-pixclara-fda 2026-09-14T14:15:08.366Z never 0.8 https://biotechmorning.com/news/vyriad-in-vivo-car-t-first-patient 2026-09-14T14:14:24.602Z never 0.8 https://biotechmorning.com/news/gilead-trodelvy-lung-cancer-trial-failure 2026-09-14T14:13:38.286Z never 0.8 https://biotechmorning.com/news/lenacapavir-purpose-2-hiv-prevention-results 2026-09-14T14:12:42.202Z never 0.8 https://biotechmorning.com/news/stealth-bio-barth-syndrome-fda-approval 2026-09-14T14:11:57.684Z never 0.8 https://biotechmorning.com/news/gsk-survival-bomb-lung-cancer 2026-09-13T14:19:17.279Z never 0.8 https://biotechmorning.com/news/fda-approves-camizestrant-after-negative-advisory-vote 2026-09-13T14:18:30.486Z never 0.8 https://biotechmorning.com/news/alexander-disease-first-drug-zanvastro-ionis 2026-09-13T14:17:41.814Z never 0.8 https://biotechmorning.com/news/car-t-autoimmune-safety-crisis 2026-09-13T14:16:53.934Z never 0.8 https://biotechmorning.com/news/gsk-mrna-flu-vaccine-phase-3-2 2026-09-13T14:16:05.241Z never 0.8 https://biotechmorning.com/news/car-t-after-car-t-failure-pepromene 2026-09-13T14:15:20.832Z never 0.8 https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-gene-therapy-crisis 2026-09-13T14:14:40.540Z never 0.8 https://biotechmorning.com/news/first-drug-fixes-narcolepsy-orexin-agonist 2026-09-13T14:13:54.055Z never 0.8 https://biotechmorning.com/news/tam-peli-sclc-phase-3-death-risk 2026-09-13T14:13:09.416Z never 0.8 https://biotechmorning.com/news/ivonescimab-beats-keytruda-lung-cancer 2026-09-13T14:12:19.210Z never 0.8 https://biotechmorning.com/news/fda-new-cancer-boss-ai-staffing-plan 2026-09-12T14:15:31.806Z never 0.8 https://biotechmorning.com/news/solstice-oncology-225m-bet-cold-tumors 2026-09-12T14:14:50.075Z never 0.8 https://biotechmorning.com/news/astrazeneca-camizestrant-serena-4-failure 2026-09-12T14:14:05.500Z never 0.8 https://biotechmorning.com/news/sma-muscle-targeted-therapy-apitegromab-approval 2026-09-12T14:13:23.074Z never 0.8 https://biotechmorning.com/news/exelixis-fda-delay-colorectal-cancer 2026-09-12T14:12:35.657Z never 0.8 https://biotechmorning.com/news/fda-commissioner-tried-to-kill-kalvista-drug-approval 2026-09-12T14:11:54.689Z never 0.8 https://biotechmorning.com/news/jj-spravato-patent-victory-2035 2026-09-12T14:11:05.463Z never 0.8 https://biotechmorning.com/news/personalized-mrna-cancer-vaccine-phase-3-win 2026-09-12T14:10:23.900Z never 0.8 https://biotechmorning.com/news/gene-therapy-worst-week-sarepta-crisis 2026-09-12T14:09:36.240Z never 0.8 https://biotechmorning.com/news/biotech-reverse-mergers-shell-company-shortage 2026-09-11T14:19:24.075Z never 0.8 https://biotechmorning.com/news/kailera-obesity-pill-side-effects 2026-09-11T14:18:38.657Z never 0.8 https://biotechmorning.com/news/car-t-prevention-multiple-myeloma 2026-09-11T14:17:56.491Z never 0.8 https://biotechmorning.com/news/biohaven-fda-hold-after-350m-deal 2026-09-11T14:17:07.572Z never 0.8 https://biotechmorning.com/news/kura-oncology-diabetes-spinout-caspian-therapeutics 2026-09-11T14:16:21.503Z never 0.8 https://biotechmorning.com/news/abbvie-menstrual-migraine-atogepant-phase-3 2026-09-11T14:15:32.787Z never 0.8 https://biotechmorning.com/news/andy-plump-takeda-rd-retirement 2026-09-11T14:14:46.530Z never 0.8 https://biotechmorning.com/news/frazier-life-sciences-1-1-billion-fund-close 2026-09-11T14:14:03.723Z never 0.8 https://biotechmorning.com/news/novartis-shareholder-activist-board-overhaul 2026-09-11T14:13:22.790Z never 0.8 https://biotechmorning.com/news/bridgebio-abandons-first-line-kras-lung-cancer 2026-09-11T14:12:39.015Z never 0.8 https://biotechmorning.com/news/bms-arlo-cel-car-t-withheld-data 2026-09-11T14:11:50.793Z never 0.8 https://biotechmorning.com/news/evommune-mrgprx2-eczema-drug-second-phase-2-failure 2026-09-10T14:18:52.154Z never 0.8 https://biotechmorning.com/news/novartis-alteogen-subcutaneous-delivery-deal 2026-09-10T14:18:05.170Z never 0.8 https://biotechmorning.com/news/first-ai-designed-drug-phase-3-trial 2026-09-10T14:17:17.229Z never 0.8 https://biotechmorning.com/news/bayer-sevabertinib-her2-lung-cancer-approval 2026-09-10T14:16:33.127Z never 0.8 https://biotechmorning.com/news/samsung-biologics-polypeptide-takeover-peptide-cdmo 2026-09-10T14:15:47.110Z never 0.8 https://biotechmorning.com/news/mogad-first-approved-treatment-roche-enspryng 2026-09-10T14:15:04.709Z never 0.8 https://biotechmorning.com/news/roche-simcere-sim0660-preclinical-deal 2026-09-10T14:14:18.952Z never 0.8 https://biotechmorning.com/news/arpa-h-ai-heart-failure-advocate 2026-09-10T14:13:28.896Z never 0.8 https://biotechmorning.com/news/lasker-award-orexin-sleep-scientists-nobel-track 2026-09-10T14:12:42.650Z never 0.8 https://biotechmorning.com/news/novartis-del-desiran-rna-drug-phase-3-failure 2026-09-10T14:11:59.487Z never 0.8 https://biotechmorning.com/news/novartis-tourmaline-bio-il6-cardiovascular-deal 2026-09-10T14:11:14.954Z never 0.8 https://biotechmorning.com/news/bbo-8520-kras-g12c-resistant-lung-cancer 2026-09-09T14:18:03.247Z never 0.8 https://biotechmorning.com/news/pharvaris-oral-hae-pill-phase-3-win 2026-09-09T14:17:15.203Z never 0.8 https://biotechmorning.com/news/intellia-crispr-lonvo-z-fda-priority-review 2026-09-09T14:16:29.920Z never 0.8 https://biotechmorning.com/news/astrazeneca-tozorakimab-copd-biologic 2026-09-09T14:15:39.719Z never 0.8 https://biotechmorning.com/news/novartis-del-desiran-harbor-trial-failure 2026-09-09T14:14:54.862Z never 0.8 https://biotechmorning.com/news/ox40-agonist-inhibrx-comeback 2026-09-09T14:14:08.322Z never 0.8 https://biotechmorning.com/news/roivant-mosliciguat-pulmonary-hypertension-10-billion 2026-09-09T14:13:22.517Z never 0.8 https://biotechmorning.com/news/blood-test-catches-breast-cancer-fighting-back 2026-09-09T14:12:37.870Z never 0.8 https://biotechmorning.com/news/sclc-imdelltra-imfinzi-survival-win 2026-09-09T14:11:48.903Z never 0.8 https://biotechmorning.com/news/novartis-avidity-12-billion-bet-lost 2026-09-08T14:17:14.894Z never 0.8 https://biotechmorning.com/news/sclc-bispecific-immunotherapy-survival-benefit 2026-09-08T14:16:26.308Z never 0.8 https://biotechmorning.com/news/merck-10-billion-verona-pharma-copd-bet 2026-09-08T14:15:41.387Z never 0.8 https://biotechmorning.com/news/moderna-2-6-billion-oncology-bet 2026-09-08T14:14:55.816Z never 0.8 https://biotechmorning.com/news/lilly-merida-biosciences-autoimmune-acquisition 2026-09-08T14:14:07.623Z never 0.8 https://biotechmorning.com/news/base-editing-sickle-cell-thalassemia-remission 2026-09-08T14:13:19.209Z never 0.8 https://biotechmorning.com/news/semaglutide-step-young-children-obesity-results 2026-09-08T14:12:29.777Z never 0.8 https://biotechmorning.com/news/covid-vaccine-xfg-variant-fall-2026 2026-09-07T14:13:24.279Z never 0.8 https://biotechmorning.com/news/pfizer-seagen-adc-medicus-pharma-deal 2026-09-07T14:12:39.604Z never 0.8 https://biotechmorning.com/news/abbvie-etentamig-myeloma-results 2026-09-07T14:11:52.774Z never 0.8 https://biotechmorning.com/news/rusfertide-fda-approval-polycythemia-vera 2026-09-07T14:11:08.514Z never 0.8 https://biotechmorning.com/news/novo-nordisk-kidney-program-cancelled 2026-09-07T14:10:27.923Z never 0.8 https://biotechmorning.com/news/novo-nordisk-ziltivekimab-cardiovascular-trials-scrapped 2026-09-07T14:09:43.236Z never 0.8 https://biotechmorning.com/news/pelacarsen-lpa-horizon-trial-failure 2026-09-06T14:14:34.575Z never 0.8 https://biotechmorning.com/news/teva-celiac-disease-phase-2-first-drug 2026-09-06T14:13:45.229Z never 0.8 https://biotechmorning.com/news/invivyd-board-chair-ceo-clinical-readout 2026-09-06T14:12:57.386Z never 0.8 https://biotechmorning.com/news/novartis-kleinbasel-biologics-site-closure 2026-09-06T14:12:11.048Z never 0.8 https://biotechmorning.com/news/treprostinil-ipf-teton-phase-3-results 2026-09-06T14:11:30.475Z never 0.8 https://biotechmorning.com/news/lilly-zepbound-cheaper-vials-higher-doses 2026-09-06T14:10:49.227Z never 0.8 https://biotechmorning.com/news/sangamo-gene-therapy-fire-sale-ptc-lilly 2026-09-05T14:14:42.926Z never 0.8 https://biotechmorning.com/news/autoimmune-car-t-safety-problem 2026-09-05T14:13:57.273Z never 0.8 https://biotechmorning.com/news/pelacarsen-lp-a-horizon-trial-failure 2026-09-05T14:13:12.027Z never 0.8 https://biotechmorning.com/news/pfizer-penicillin-recall-syphilis-crisis-2 2026-09-05T14:12:21.405Z never 0.8 https://biotechmorning.com/news/menarini-gan-lee-glp1-licensing-deal-europe 2026-09-05T14:11:40.922Z never 0.8 https://biotechmorning.com/news/sarepta-black-box-layoffs-stock-rally 2026-09-05T14:10:52.720Z never 0.8 https://biotechmorning.com/news/blood-test-changed-breast-cancer-treatment 2026-09-05T14:10:06.062Z never 0.8 https://biotechmorning.com/news/zorevunersen-dravet-syndrome-4-year-data 2026-09-04T14:18:33.667Z never 0.8 https://biotechmorning.com/news/pfizer-sells-seagen-adc-12-million-medicus 2026-09-04T14:17:44.697Z never 0.8 https://biotechmorning.com/news/fda-tempo-pilot-ai-devices-before-authorization 2026-09-04T14:17:00.054Z never 0.8 https://biotechmorning.com/news/ivonescimab-beats-keytruda-overall-survival-lung-cancer 2026-09-04T14:16:11.246Z never 0.8 https://biotechmorning.com/news/alexander-disease-first-treatment-zanvastro 2026-09-04T14:15:22.452Z never 0.8 https://biotechmorning.com/news/abbvie-crashes-myeloma-party-etentamig-phase-3 2026-09-04T14:14:40.845Z never 0.8 https://biotechmorning.com/news/roche-ucn2-muscle-sparing-weight-loss 2026-09-04T14:13:52.866Z never 0.8 https://biotechmorning.com/news/keytruda-biosimilar-cipla-qilu-deal 2026-09-04T14:13:06.001Z never 0.8 https://biotechmorning.com/news/psilocybin-prevents-chemo-nerve-pain-mice 2026-09-04T14:12:18.108Z never 0.8 https://biotechmorning.com/news/kardigan-myokardia-400m-ipo-comeback 2026-09-04T14:11:27.337Z never 0.8 https://biotechmorning.com/news/novartis-autoimmune-car-t-deaths-pause 2026-09-04T14:10:39.781Z never 0.8 https://biotechmorning.com/news/fda-reversal-uniqure-huntingtons-gene-therapy 2026-09-03T14:19:17.216Z never 0.8 https://biotechmorning.com/news/gsk-hutchmed-kras-egfr-deal 2026-09-03T14:18:26.949Z never 0.8 https://biotechmorning.com/news/novartis-argo-5-billion-cardiovascular-deal 2026-09-03T14:17:41.347Z never 0.8 https://biotechmorning.com/news/ivonescimab-beats-keytruda-overall-survival-nsclc 2026-09-03T14:16:55.323Z never 0.8 https://biotechmorning.com/news/arpa-h-benchtop-mrna-manufacturing-waterfall-scientific 2026-09-03T14:16:10.330Z never 0.8 https://biotechmorning.com/news/fda-china-clinical-trial-scrutiny 2026-09-03T14:15:27.751Z never 0.8 https://biotechmorning.com/news/crispr-deaths-china-viral-vector-delivery-debate 2026-09-03T14:14:46.992Z never 0.8 https://biotechmorning.com/news/teva-celiac-disease-anti-il15-phase-2-win 2026-09-03T14:13:56.450Z never 0.8 https://biotechmorning.com/news/tg4050-cancer-vaccine-zero-relapses-three-years 2026-09-03T14:13:09.055Z never 0.8 https://biotechmorning.com/news/ultragenyx-angelman-syndrome-phase-3-failure 2026-09-03T14:12:25.348Z never 0.8 https://biotechmorning.com/news/lilly-deal-spree-venture-capital-recycling 2026-09-02T14:22:02.625Z never 0.8 https://biotechmorning.com/news/lupus-humbled-tyk2-drug-alumis 2026-09-02T14:21:16.288Z never 0.8 https://biotechmorning.com/news/roche-simcere-trispecific-antibody-deal 2026-09-02T14:20:27.774Z never 0.8 https://biotechmorning.com/news/novartis-3-2b-alteogen-subcutaneous-delivery-deal 2026-09-02T14:19:40.451Z never 0.8 https://biotechmorning.com/news/novartis-remibrutinib-ms-cheat-code 2026-09-02T14:18:55.008Z never 0.8 https://biotechmorning.com/news/arpa-h-125m-rna-manufacturing 2026-09-02T14:18:08.228Z never 0.8 https://biotechmorning.com/news/biomx-tessera-defense-phage-therapy-pivot 2026-09-02T14:17:16.895Z never 0.8 https://biotechmorning.com/news/regeneron-fop-bone-disease-approval 2026-09-02T14:16:28.845Z never 0.8 https://biotechmorning.com/news/novo-oral-wegovy-germany-launch 2026-09-02T14:15:47.939Z never 0.8 https://biotechmorning.com/news/arsenal-bio-torches-playbook-pivots-in-vivo-car-t 2026-09-02T14:15:02.000Z never 0.8 https://biotechmorning.com/news/mrna-cancer-vaccine-hits-wall 2026-09-02T14:14:14.918Z never 0.8 https://biotechmorning.com/news/parse-biosciences-patent-verdict-single-cell-sequencing 2026-09-01T14:15:18.981Z never 0.8 https://biotechmorning.com/news/oral-relaxin-heart-failure-comeback 2026-09-01T14:14:30.850Z never 0.8 https://biotechmorning.com/news/car-t-autoimmune-safety-crisis-novartis-bms 2026-09-01T14:13:38.927Z never 0.8 https://biotechmorning.com/news/fda-commissioner-kalvista-drug-rejection-staff-pushback 2026-09-01T14:12:57.183Z never 0.8 https://biotechmorning.com/news/sanofi-backed-electra-nasdaq-ipo-filing 2026-09-01T14:12:12.622Z never 0.8 https://biotechmorning.com/news/drug-pricing-squeeze-midsize-biotech 2026-09-01T14:11:30.571Z never 0.8 https://biotechmorning.com/news/samsung-biologics-polypeptide-group-takeover 2026-09-01T14:10:47.062Z never 0.8 https://biotechmorning.com/news/gsk-mrna-flu-vaccine-phase-3 2026-09-01T14:10:01.140Z never 0.8 https://biotechmorning.com/news/tagrisso-orpathys-egfr-lung-cancer-combo 2026-09-01T14:09:17.376Z never 0.8 https://biotechmorning.com/news/perfuze-stroke-catheter-marrs-trial-results 2026-08-31T14:14:20.863Z never 0.8 https://biotechmorning.com/news/genentech-hanmi-hm17321-obesity-deal 2026-08-31T14:13:38.932Z never 0.8 https://biotechmorning.com/news/sarepta-gene-therapy-black-box-warning-layoffs 2026-08-31T14:12:50.666Z never 0.8 https://biotechmorning.com/news/claude-ai-designed-protein-binders-validated 2026-08-31T14:12:06.689Z never 0.8 https://biotechmorning.com/news/lilly-merida-autoantibody-degradation-deal 2026-08-31T14:11:19.720Z never 0.8 https://biotechmorning.com/news/first-new-et-treatment-30-years-besremi 2026-08-31T14:10:31.378Z never 0.8 https://biotechmorning.com/news/ascendis-biomarin-yuviwel-patent-settlement 2026-08-31T14:09:48.857Z never 0.8 https://biotechmorning.com/news/tenax-tnx-103-level-trial-subgroup-esc-2026 2026-08-30T14:13:24.989Z never 0.8 https://biotechmorning.com/news/gene-therapy-biggest-swing-heart-failure 2026-08-30T14:12:40.558Z never 0.8 https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-elevidys-3 2026-08-30T14:11:51.086Z never 0.8 https://biotechmorning.com/news/ausperbio-120m-series-c-hepatitis-b-cure 2026-08-30T14:11:03.552Z never 0.8 https://biotechmorning.com/news/teva-bioxcel-bankruptcy-cns-deal 2026-08-30T14:10:16.664Z never 0.8 https://biotechmorning.com/news/roivant-first-pill-dermatomyositis-fda-approval 2026-08-30T14:09:29.511Z never 0.8 https://biotechmorning.com/news/camzyos-five-year-data-esc-2026 2026-08-30T14:08:46.549Z never 0.8 https://biotechmorning.com/news/bayer-evuzamitide-cardiac-amyloidosis-pet-diagnostic 2026-08-30T14:07:59.784Z never 0.8 https://biotechmorning.com/news/stargardt-disease-first-treatment-tinlarebant-2 2026-08-30T14:07:10.252Z never 0.8 https://biotechmorning.com/news/teva-bioxcel-igalmi-bankruptcy-bid 2026-08-29T14:19:05.606Z never 0.8 https://biotechmorning.com/news/mounjaro-cardiovascular-approval-glp1-race 2026-08-29T14:18:19.420Z never 0.8 https://biotechmorning.com/news/astrazeneca-cardio-ttransform-rna-silencer-flop 2026-08-29T14:17:32.504Z never 0.8 https://biotechmorning.com/news/mimrylo-rusfertide-fda-approval-polycythemia-vera 2026-08-29T14:16:43.336Z never 0.8 https://biotechmorning.com/news/cancer-vaccine-that-made-things-worse 2026-08-29T14:16:02.275Z never 0.8 https://biotechmorning.com/news/shingrix-cardiovascular-benefit-oxford-study 2026-08-29T14:14:59.743Z never 0.8 https://biotechmorning.com/news/aficamten-non-obstructive-hcm-acacia-trial 2026-08-29T14:14:14.055Z never 0.8 https://biotechmorning.com/news/one-shot-rewrite-cholesterol-forever 2026-08-29T14:13:29.025Z never 0.8 https://biotechmorning.com/news/moderna-2-6-billion-bet-mrna-cancer 2026-08-29T14:12:46.410Z never 0.8 https://biotechmorning.com/news/covid-vaccines-annual-update-cycle-2026 2026-08-28T14:20:22.093Z never 0.8 https://biotechmorning.com/news/tezspire-eosinophilic-esophagitis-phase-3-crossing-results 2026-08-28T14:19:36.937Z never 0.8 https://biotechmorning.com/news/genentech-dualitybio-adc-resistance-billion-dollar-deal 2026-08-28T14:18:51.998Z never 0.8 https://biotechmorning.com/news/gilead-bixlenvo-lenacapavir-oral-hiv-pill 2026-08-28T14:18:04.935Z never 0.8 https://biotechmorning.com/news/rasonque-pancreatic-cancer-fda-approval 2026-08-28T14:17:19.770Z never 0.8 https://biotechmorning.com/news/alnylam-heart-drug-wall-street-trust-crisis 2026-08-28T14:16:34.693Z never 0.8 https://biotechmorning.com/news/white-house-midsize-biotech-drug-pricing-deals 2026-08-28T14:15:47.278Z never 0.8 https://biotechmorning.com/news/sk-biohaven-kv7-epilepsy-deal 2026-08-28T14:15:04.884Z never 0.8 https://biotechmorning.com/news/hbv-cccdna-elimination-first-clinical-evidence 2026-08-28T14:14:20.221Z never 0.8 https://biotechmorning.com/news/metsera-founders-launch-sentivera-inflammation-deal 2026-08-28T14:13:31.515Z never 0.8 https://biotechmorning.com/news/first-pill-dermatomyositis-lisraya-fda-approval 2026-08-28T14:12:44.035Z never 0.8 https://biotechmorning.com/news/tl1a-spyre-ra-phase-2-disappointment 2026-08-26T14:17:18.650Z never 0.8 https://biotechmorning.com/news/astrazeneca-cspc-sirna-kidney-deal 2026-08-26T14:16:34.730Z never 0.8 https://biotechmorning.com/news/mckesson-precision-medicine-group-acquisition 2026-08-26T14:15:46.882Z never 0.8 https://biotechmorning.com/news/ziihera-dethrones-trastuzumab-gastric-cancer 2026-08-26T14:15:04.769Z never 0.8 https://biotechmorning.com/news/vertex-10-billion-crinetics-acquisition-4 2026-08-26T14:14:19.439Z never 0.8 https://biotechmorning.com/news/ipsen-kartos-myelofibrosis-acquisition 2026-08-26T14:13:36.819Z never 0.8 https://biotechmorning.com/news/ra-capital-avilar-trade-secret-verdict-yale 2026-08-26T14:12:47.802Z never 0.8 https://biotechmorning.com/news/ivonescimab-beats-durvalumab-biliary-tract-cancer 2026-08-26T14:12:05.229Z never 0.8 https://biotechmorning.com/news/abbott-libre-duo-dual-glucose-ketone-sensor-fda 2026-08-26T14:11:19.699Z never 0.8 https://biotechmorning.com/news/first-fda-approved-drug-warm-autoimmune-hemolytic-anemia 2026-08-26T14:10:28.710Z never 0.8 https://biotechmorning.com/news/lady-gaga-biotech-startup-outer-biosciences 2026-08-25T14:15:54.484Z never 0.8 https://biotechmorning.com/news/robot-blood-draw-fda-vitestro-aletta 2026-08-25T14:15:07.170Z never 0.8 https://biotechmorning.com/news/first-drug-cure-hepatitis-b-japan-approval 2026-08-25T14:14:24.981Z never 0.8 https://biotechmorning.com/news/first-ever-waiha-treatment-fda-approval 2026-08-25T14:13:42.496Z never 0.8 https://biotechmorning.com/news/boston-biotech-paradox-more-money-fewer-people 2026-08-25T14:12:57.957Z never 0.8 https://biotechmorning.com/news/first-drug-fixes-narcolepsy-japan 2026-08-25T14:12:13.562Z never 0.8 https://biotechmorning.com/news/roche-alzheimers-blood-test-fda-clearance 2026-08-25T14:11:25.304Z never 0.8 https://biotechmorning.com/news/regenxbio-brain-tumor-problem-gene-therapy-hold 2026-08-24T14:16:24.421Z never 0.8 https://biotechmorning.com/news/leqembi-subcutaneous-approval-alzheimers 2026-08-24T14:15:42.920Z never 0.8 https://biotechmorning.com/news/lilly-foundayo-oral-weight-loss-pill-uk-launch 2026-08-24T14:14:57.805Z never 0.8 https://biotechmorning.com/news/roche-hanmi-ucn2-muscle-preserving-obesity-deal 2026-08-24T14:14:10.031Z never 0.8 https://biotechmorning.com/news/jj-sail-in-vivo-car-t-deal 2026-08-24T14:13:23.973Z never 0.8 https://biotechmorning.com/news/personalized-mrna-cancer-vaccine-melanoma 2026-08-24T14:12:37.909Z never 0.8 https://biotechmorning.com/news/uk-335-million-life-sciences-bet 2026-08-24T14:11:53.914Z never 0.8 https://biotechmorning.com/news/tempus-ecg-ph-ai-pulmonary-hypertension-fda-clearance 2026-08-24T14:11:10.609Z never 0.8 https://biotechmorning.com/news/braveheart-bio-ipo-382-million-cardiac-drug 2026-08-24T14:10:22.412Z never 0.8 https://biotechmorning.com/news/ultragenyx-gene-therapy-replace-midnight-snack-gsdia 2026-08-24T14:09:37.388Z never 0.8 https://biotechmorning.com/news/repligen-biolife-solutions-acquisition-bioprocessing 2026-08-23T14:17:58.556Z never 0.8 https://biotechmorning.com/news/fda-commissioner-kalvista-rare-disease-drug-rejection 2026-08-23T14:17:11.441Z never 0.8 https://biotechmorning.com/news/lilly-ataibeckley-psychedelic-acquisition 2026-08-23T14:16:29.142Z never 0.8 https://biotechmorning.com/news/moderna-merck-mrna-cancer-vaccine-melanoma-phase-3 2026-08-23T14:15:42.324Z never 0.8 https://biotechmorning.com/news/australia-first-h5n1-mammal-seal 2026-08-23T14:14:55.330Z never 0.8 https://biotechmorning.com/news/taiho-cullinan-lung-cancer-challenge-jj 2026-08-23T14:14:12.909Z never 0.8 https://biotechmorning.com/news/ptc-therapeutics-fabry-disease-gene-therapy-bankruptcy 2026-08-23T14:13:27.563Z never 0.8 https://biotechmorning.com/news/eli-lilly-750m-resilience-kwikpen-manufacturing 2026-08-23T14:12:42.464Z never 0.8 https://biotechmorning.com/news/kennedy-hhs-vaccine-policy-document-details 2026-08-22T14:18:26.359Z never 0.8 https://biotechmorning.com/news/polish-company-matched-ozempic-novo-nordisk 2026-08-22T14:17:43.868Z never 0.8 https://biotechmorning.com/news/capricor-duchenne-fda-rejection-activist-investor 2026-08-22T14:17:02.271Z never 0.8 https://biotechmorning.com/news/supernus-indivior-cns-merger-2 2026-08-22T14:16:08.960Z never 0.8 https://biotechmorning.com/news/sarepta-elevidys-black-box-warning-job-cuts 2026-08-22T14:15:24.796Z never 0.8 https://biotechmorning.com/news/sentynl-mereo-475m-rare-lung-disease-deal 2026-08-22T14:14:37.008Z never 0.8 https://biotechmorning.com/news/werewolf-therapeutics-ambros-reverse-merger-painkiller 2026-08-22T14:13:48.599Z never 0.8 https://biotechmorning.com/news/sandoz-henlius-322-million-biosimilar-deal 2026-08-22T14:13:00.699Z never 0.8 https://biotechmorning.com/news/4-1bb-first-drug-filing-leads-biolabs 2026-08-22T14:12:17.970Z never 0.8 https://biotechmorning.com/news/resilience-cdmo-bankruptcy-six-sites-closing 2026-08-22T14:11:28.453Z never 0.8 https://biotechmorning.com/news/blood-test-alzheimers-replaces-pet-scan 2026-08-21T14:14:34.724Z never 0.8 https://biotechmorning.com/news/boehringer-mystery-safety-scare-japan 2026-08-21T14:13:41.460Z never 0.8 https://biotechmorning.com/news/roche-750-million-oregon-biologics-manufacturing 2026-08-21T14:12:55.392Z never 0.8 https://biotechmorning.com/news/teva-appeals-court-ira-drug-pricing-challenge 2026-08-21T14:12:11.706Z never 0.8 https://biotechmorning.com/news/149-pill-blow-up-glp1-war 2026-08-21T14:11:25.731Z never 0.8 https://biotechmorning.com/news/ultragenyx-gsd-ia-gene-therapy-fda-approval 2026-08-21T14:10:38.875Z never 0.8 https://biotechmorning.com/news/biontech-two-drug-cocktail-lung-cancer 2026-08-21T14:09:53.889Z never 0.8 https://biotechmorning.com/news/bms-chai-discovery-ai-antibody-deal 2026-08-21T14:09:06.644Z never 0.8 https://biotechmorning.com/news/amgen-walks-away-tscan-tcr-therapy-deal 2026-08-21T14:08:19.139Z never 0.8 https://biotechmorning.com/news/fda-downclassifies-oncology-diagnostics 2026-08-20T14:18:41.209Z never 0.8 https://biotechmorning.com/news/mini-brains-five-years-alive-nature-study 2026-08-20T14:17:53.186Z never 0.8 https://biotechmorning.com/news/biomarin-alesta-oral-therapy-hypophosphatasia 2026-08-20T14:17:08.054Z never 0.8 https://biotechmorning.com/news/jazz-actio-kcnt1-epilepsy-acquisition 2026-08-20T14:16:22.498Z never 0.8 https://biotechmorning.com/news/fop-first-treatment-fda-approval-pasatru 2026-08-20T14:15:36.218Z never 0.8 https://biotechmorning.com/news/thymus-biotech-tolerance-bio-neoimmune-deal 2026-08-20T14:14:50.816Z never 0.8 https://biotechmorning.com/news/lsd-pill-aces-late-stage-anxiety-trial 2026-08-20T14:14:01.155Z never 0.8 https://biotechmorning.com/news/jj-returns-car-t-rights-abelzeta-fda-ind 2026-08-20T14:13:15.543Z never 0.8 https://biotechmorning.com/news/huidagene-patient-death-disclosure-delay 2026-08-20T14:12:26.654Z never 0.8 https://biotechmorning.com/news/fda-next-boss-heidi-overton-nomination 2026-08-20T14:11:43.860Z never 0.8 https://biotechmorning.com/news/fda-generative-ai-medical-devices-public-input 2026-08-19T14:17:52.222Z never 0.8 https://biotechmorning.com/news/sandoz-henlius-biosimilar-licensing-deal 2026-08-19T14:17:07.560Z never 0.8 https://biotechmorning.com/news/pfizer-penicillin-recall-syphilis-pregnancy 2026-08-19T14:16:22.484Z never 0.8 https://biotechmorning.com/news/eikon-therapeutics-ipo-381-million-wall-street-shrugged 2026-08-19T14:15:43.259Z never 0.8 https://biotechmorning.com/news/enveda-exercise-pill-lac-phe-obesity-maintenance 2026-08-19T14:14:56.560Z never 0.8 https://biotechmorning.com/news/tagrisso-combo-bet-lung-cancer-resistance 2026-08-19T14:14:08.269Z never 0.8 https://biotechmorning.com/news/genbio-ai-aido-cell-virtual-cell 2026-08-19T14:13:17.174Z never 0.8 https://biotechmorning.com/news/csl-best-day-25-years-plasma-earnings 2026-08-19T14:12:24.738Z never 0.8 https://biotechmorning.com/news/argenx-forte-biosciences-acquisition-2-2-billion 2026-08-19T14:11:37.810Z never 0.8 https://biotechmorning.com/news/lilly-orna-therapeutics-circular-rna-acquisition 2026-08-19T14:10:48.062Z never 0.8 https://biotechmorning.com/news/personalized-mrna-cancer-vaccine-phase-3-melanoma 2026-08-19T14:10:05.110Z never 0.8 https://biotechmorning.com/news/fda-approves-cancer-killing-virus-melanoma 2026-08-18T14:17:37.589Z never 0.8 https://biotechmorning.com/news/pathos-ai-alphamab-jskn016-2-billion-deal 2026-08-18T14:16:53.383Z never 0.8 https://biotechmorning.com/news/regeneron-eye-trial-halted-safety-review 2026-08-18T14:15:56.760Z never 0.8 https://biotechmorning.com/news/leo-pharma-dersimelagon-deal-435-million 2026-08-18T14:15:16.400Z never 0.8 https://biotechmorning.com/news/amylyx-avexitide-post-bariatric-hypoglycemia-comeback 2026-08-18T14:14:32.092Z never 0.8 https://biotechmorning.com/news/argenx-vyvgart-myositis-phase-3-win 2026-08-18T14:13:42.031Z never 0.8 https://biotechmorning.com/news/fulcrum-slate-medicines-reverse-merger-nasdaq 2026-08-18T14:12:56.717Z never 0.8 https://biotechmorning.com/news/evaxion-kills-tumor-vaccine-bets-on-brain-cancer 2026-08-18T14:12:14.076Z never 0.8 https://biotechmorning.com/news/sanofi-blueprint-medicines-layoffs-post-acquisition 2026-08-18T14:11:25.480Z never 0.8 https://biotechmorning.com/news/moonlake-sonelokimab-izar-1-trial-results-wall-street 2026-08-17T14:17:08.457Z never 0.8 https://biotechmorning.com/news/oncosil-fda-approval-bile-duct-cancer-device 2026-08-17T14:16:20.663Z never 0.8 https://biotechmorning.com/news/eyepoint-duravyu-lugano-phase-3-wet-amd-mixed-results 2026-08-17T14:15:38.434Z never 0.8 https://biotechmorning.com/news/biotech-vc-funding-gap-widens-h1-2026 2026-08-17T14:14:46.884Z never 0.8 https://biotechmorning.com/news/sandoz-henlius-biosimilar-deal-china 2026-08-17T14:14:03.033Z never 0.8 https://biotechmorning.com/news/lilly-370m-ion-channel-omniab-deal 2026-08-17T14:13:14.925Z never 0.8 https://biotechmorning.com/news/astrazeneca-bispecific-antibody-trial-flop 2026-08-17T14:12:26.062Z never 0.8 https://biotechmorning.com/news/ribox-circular-rna-in-vivo-car-therapy-fda-clearance 2026-08-17T14:11:37.768Z never 0.8 https://biotechmorning.com/news/charles-river-labs-bellwether-biotech-recovery 2026-08-16T14:16:41.421Z never 0.8 https://biotechmorning.com/news/biomarin-270-million-phase-3-failure 2026-08-16T14:15:56.795Z never 0.8 https://biotechmorning.com/news/capricor-stock-surge-after-fda-adcom-rejection-duchenne 2026-08-16T14:15:16.510Z never 0.8 https://biotechmorning.com/news/fda-commissioner-kalvista-drug-rejection 2026-08-16T14:14:27.738Z never 0.8 https://biotechmorning.com/news/bms-15-billion-hengrui-china-deal-2 2026-08-16T14:13:46.528Z never 0.8 https://biotechmorning.com/news/tavneos-eu-withdrawal-gcp-violations 2026-08-16T14:13:00.012Z never 0.8 https://biotechmorning.com/news/cytokinetics-sues-bristol-myers-squibb-patent-dispute 2026-08-16T14:12:18.040Z never 0.8 https://biotechmorning.com/news/cancer-drug-worked-still-rejected-itm-fda 2026-08-16T14:11:33.918Z never 0.8 https://biotechmorning.com/news/biocryst-kills-internal-drug-discovery 2026-08-15T14:18:45.457Z never 0.8 https://biotechmorning.com/news/fibrx-therapeutics-skye-redx-merger-fibrosis 2026-08-15T14:17:59.537Z never 0.8 https://biotechmorning.com/news/epicrispr-epigenetic-editing-fshd-milestone 2026-08-15T14:17:12.926Z never 0.8 https://biotechmorning.com/news/ai-designed-parkinsons-drug-clinical-trials 2026-08-15T14:16:25.296Z never 0.8 https://biotechmorning.com/news/zymeworks-theravance-acquisition-strategy 2026-08-15T14:15:39.811Z never 0.8 https://biotechmorning.com/news/lilly-750m-resilience-kwikpen-glp1-manufacturing 2026-08-15T14:14:51.707Z never 0.8 https://biotechmorning.com/news/cdc-director-erica-schwartz-confirmed 2026-08-15T14:14:05.052Z never 0.8 https://biotechmorning.com/news/first-orexin-drug-narcolepsy-fda-approval 2026-08-15T14:13:25.826Z never 0.8 https://biotechmorning.com/news/moderna-mflusiva-mrna-flu-vaccine-fda-approval 2026-08-15T14:12:40.319Z never 0.8 https://biotechmorning.com/news/zipalertinib-second-phase-3-win-egfr-lung-cancer 2026-08-14T14:17:52.041Z never 0.8 https://biotechmorning.com/news/ptc-sangamo-fabry-gene-therapy-bankruptcy-auction 2026-08-14T14:17:06.196Z never 0.8 https://biotechmorning.com/news/sarepta-gene-therapy-nightmare 2026-08-14T14:16:14.513Z never 0.8 https://biotechmorning.com/news/first-celmod-therapy-fda-approval-iberdomide 2026-08-14T14:15:28.901Z never 0.8 https://biotechmorning.com/news/uk-250-million-life-sciences-rd-site 2026-08-14T14:14:39.043Z never 0.8 https://biotechmorning.com/news/lantheus-mk-6240-tau-pet-alzheimers-fda-decision 2026-08-14T14:13:59.836Z never 0.8 https://biotechmorning.com/news/lilly-449-gambit-zepbound-black-market 2026-08-14T14:13:19.009Z never 0.8 https://biotechmorning.com/news/lyme-disease-vaccine-back-from-dead 2026-08-14T14:12:31.438Z never 0.8 https://biotechmorning.com/news/vertex-10-billion-crinetics-acquisition-3 2026-08-13T14:20:07.880Z never 0.8 https://biotechmorning.com/news/gilead-ouro-medicines-acquisition 2026-08-13T14:19:23.428Z never 0.8 https://biotechmorning.com/news/zipalertinib-rezilient3-egfr-exon20-lung-cancer 2026-08-13T14:18:37.773Z never 0.8 https://biotechmorning.com/news/crispr-problem-cells-not-scissors 2026-08-13T14:17:50.432Z never 0.8 https://biotechmorning.com/news/biotech-1-2-billion-ipo-day-braveheart-kardigan-eikon 2026-08-13T14:17:04.898Z never 0.8 https://biotechmorning.com/news/china-us-clinical-trial-regulatory-divergence 2026-08-13T14:16:14.398Z never 0.8 https://biotechmorning.com/news/novo-nordisk-amazon-drug-discovery-hub 2026-08-13T14:15:35.192Z never 0.8 https://biotechmorning.com/news/lilly-retatrutide-black-market-lawsuits 2026-08-13T14:14:49.358Z never 0.8 https://biotechmorning.com/news/vykat-prader-willi-safety-concerns 2026-08-13T14:14:06.683Z never 0.8 https://biotechmorning.com/news/novartis-myricx-bio-adc-acquisition-3 2026-08-13T14:13:24.623Z never 0.8 https://biotechmorning.com/news/jj-sail-biomedicines-acquisition-option-immunology 2026-08-13T14:12:39.044Z never 0.8 https://biotechmorning.com/news/moonlake-immunotherapeutics-data-transparency-concerns 2026-08-12T14:20:33.438Z never 0.8 https://biotechmorning.com/news/ivonescimab-china-squamous-nsclc-approval 2026-08-12T14:19:52.392Z never 0.8 https://biotechmorning.com/news/zydus-sentynl-mereo-alvelestat-rare-lung-disease-deal 2026-08-12T14:19:04.726Z never 0.8 https://biotechmorning.com/news/pharma-us-manufacturing-tariff-wave 2026-08-12T14:18:19.558Z never 0.8 https://biotechmorning.com/news/definium-lsd-anxiety-second-phase-3-win 2026-08-12T14:17:37.174Z never 0.8 https://biotechmorning.com/news/itm-11-fda-rejection-manufacturing 2026-08-12T14:16:51.253Z never 0.8 https://biotechmorning.com/news/vertex-cf-fortress-sionna-trial-failure 2026-08-12T14:16:08.443Z never 0.8 https://biotechmorning.com/news/curium-lantheus-8-billion-radiopharmaceutical-deal 2026-08-12T14:15:42.091Z never 0.8 https://biotechmorning.com/news/trump-executive-order-childhood-vaccine-schedule-cut 2026-08-12T14:14:53.524Z never 0.8 https://biotechmorning.com/news/jazz-actio-biosciences-kcnt1-epilepsy-deal 2026-08-12T14:14:09.900Z never 0.8 https://biotechmorning.com/news/fda-bespoke-gene-therapy-framework-3 2026-08-12T14:13:21.877Z never 0.8 https://biotechmorning.com/news/harrow-tyrvaya-nasal-spray-dry-eye-acquisition 2026-08-10T14:15:53.313Z never 0.8 https://biotechmorning.com/news/actimed-recovers-cachexia-rights-faraday-collapse 2026-08-10T14:15:08.533Z never 0.8 https://biotechmorning.com/news/ensoma-running-out-of-lifelines 2026-08-10T14:14:23.027Z never 0.8 https://biotechmorning.com/news/biotech-ipo-window-blossomhill-2026 2026-08-10T14:13:40.988Z never 0.8 https://biotechmorning.com/news/latigo-biotherapeutics-ipo-346-million 2026-08-10T14:12:59.450Z never 0.8 https://biotechmorning.com/news/icon-anthropic-claude-ai-clinical-trials 2026-08-10T14:12:13.208Z never 0.8 https://biotechmorning.com/news/repligen-biolife-solutions-acquisition-cell-therapy-2 2026-08-10T14:11:31.912Z never 0.8 https://biotechmorning.com/news/supernus-indivior-merger-cns-powerhouse 2026-08-10T14:10:49.269Z never 0.8 https://biotechmorning.com/news/eli-lilly-3-8-billion-psychedelics-atai-beckley 2026-08-10T14:09:57.237Z never 0.8 https://biotechmorning.com/news/fda-approves-bemotrizinol-first-new-sunscreen-ingredient-20-years-2 2026-08-10T14:09:13.414Z never 0.8 https://biotechmorning.com/news/pathos-ai-alphamab-astrazeneca-deals 2026-08-09T14:14:22.556Z never 0.8 https://biotechmorning.com/news/tarsus-alkeus-800-million-stargardt-disease-deal 2026-08-09T14:13:36.321Z never 0.8 https://biotechmorning.com/news/circular-rna-in-vivo-car-t-ribox-fda-clearance 2026-08-09T14:12:52.925Z never 0.8 https://biotechmorning.com/news/fda-casgevy-pediatric-sickle-cell-gene-therapy 2026-08-09T14:12:04.985Z never 0.8 https://biotechmorning.com/news/intellia-crispr-liver-toxicity-root-cause 2026-08-09T14:11:19.467Z never 0.8 https://biotechmorning.com/news/lilly-ajax-jak-inhibitor-acquisition 2026-08-09T14:10:30.223Z never 0.8 https://biotechmorning.com/news/argenx-forte-biosciences-acquisition-2-billion 2026-08-09T14:09:47.195Z never 0.8 https://biotechmorning.com/news/lilly-kelonia-in-vivo-car-t-acquisition-2 2026-08-09T14:09:00.311Z never 0.8 https://biotechmorning.com/news/itc-investigation-china-biotech-subsidies 2026-08-09T14:08:13.451Z never 0.8 https://biotechmorning.com/news/car-t-prevent-multiple-myeloma 2026-08-08T14:14:08.483Z never 0.8 https://biotechmorning.com/news/gene-editor-delete-hepatitis-b 2026-08-08T14:13:23.426Z never 0.8 https://biotechmorning.com/news/nih-visa-researchers-funding-blocked 2026-08-08T14:12:34.073Z never 0.8 https://biotechmorning.com/news/biomarin-bmn-401-phase-3-failure-270-million 2026-08-08T14:11:50.029Z never 0.8 https://biotechmorning.com/news/merck-tulisokibart-split-phase-2-results 2026-08-08T14:11:07.709Z never 0.8 https://biotechmorning.com/news/fda-moderna-flu-vaccine-rejection-vaccine-industry-impact 2026-08-08T14:10:21.709Z never 0.8 https://biotechmorning.com/news/melanoma-drug-fda-rejected-twice-approved 2026-08-08T14:09:37.527Z never 0.8 https://biotechmorning.com/news/crispr-worst-nightmare-intellia-clinical-hold 2026-08-08T14:08:43.813Z never 0.8 https://biotechmorning.com/news/cdc-buried-covid-vaccine-effectiveness-report 2026-08-07T14:18:24.512Z never 0.8 https://biotechmorning.com/news/dexcom-stelo-otc-cgm-pediatric-approval 2026-08-07T14:17:43.937Z never 0.8 https://biotechmorning.com/news/epicrispr-gene-therapy-growing-muscle-fshd 2026-08-07T14:16:59.747Z never 0.8 https://biotechmorning.com/news/servier-edgewise-muscular-dystrophy-acquisition 2026-08-07T14:16:19.883Z never 0.8 https://biotechmorning.com/news/gilead-tubulis-5-billion-adc-acquisition-5 2026-08-07T14:15:35.638Z never 0.8 https://biotechmorning.com/news/biogen-apellis-acquisition-ophthalmology-2 2026-08-07T14:14:51.475Z never 0.8 https://biotechmorning.com/news/narcolepsy-orexin-agonist-orzeyful-fda-approval 2026-08-07T14:14:04.676Z never 0.8 https://biotechmorning.com/news/mrna-flu-vaccine-fda-approval-moderna 2026-08-07T14:13:12.928Z never 0.8 https://biotechmorning.com/news/100-percent-tariff-brand-name-drugs 2026-08-07T14:12:22.406Z never 0.8 https://biotechmorning.com/news/fda-resumes-publishing-drug-rejection-letters 2026-08-06T14:29:02.038Z never 0.8 https://biotechmorning.com/news/incyte-vega-therapeutics-acquisition-von-willebrand 2026-08-06T14:28:07.442Z never 0.8 https://biotechmorning.com/news/first-new-adhd-drug-class-decades-fda-approval 2026-08-06T14:27:11.385Z never 0.8 https://biotechmorning.com/news/gsk-nuvalent-10-billion-acquisition-lung-cancer 2026-08-06T14:26:24.350Z never 0.8 https://biotechmorning.com/news/novo-nordisk-clinical-trial-data-breach 2026-08-06T14:25:27.571Z never 0.8 https://biotechmorning.com/news/roche-recursion-ai-drug-target-neurodegeneration 2026-08-06T14:24:36.017Z never 0.8 https://biotechmorning.com/news/roche-acquires-pathai-digital-pathology-ai 2026-08-06T14:23:40.815Z never 0.8 https://biotechmorning.com/news/moderna-mrna-flu-vaccine-fda-decision-2 2026-08-06T14:22:48.195Z never 0.8 https://biotechmorning.com/news/ai-designed-psoriasis-drug-zasocitinib-beats-sotyktu 2026-08-06T14:21:52.143Z never 0.8 https://biotechmorning.com/news/charles-river-guidance-raise-biotech-recovery 2026-08-05T14:24:11.235Z never 0.8 https://biotechmorning.com/news/vertex-10-billion-crinetics-acquisition-2 2026-08-05T14:23:20.649Z never 0.8 https://biotechmorning.com/news/fda-operation-trailblazer-clinical-trial-modernization 2026-08-05T14:22:28.959Z never 0.8 https://biotechmorning.com/news/scribe-therapeutics-ipo-cholesterol-gene-editing 2026-08-05T14:21:29.758Z never 0.8 https://biotechmorning.com/news/genentech-490m-deal-and-layoffs 2026-08-05T14:20:31.636Z never 0.8 https://biotechmorning.com/news/immvira-oncolytic-virus-bladder-cancer-100-percent-response 2026-08-05T14:19:37.718Z never 0.8 https://biotechmorning.com/news/prime-medicine-beam-therapeutics-ip-dispute-ruling 2026-08-05T14:18:43.686Z never 0.8 https://biotechmorning.com/news/gilead-wins-duty-to-innovate-case 2026-08-05T14:17:49.614Z never 0.8 https://biotechmorning.com/news/osteosarcoma-hansoh-b7h3-adc-phase-3-win 2026-08-04T14:26:37.098Z never 0.8 https://biotechmorning.com/news/gsk-alector-neurodegeneration-deal-collapse 2026-08-04T14:25:49.717Z never 0.8 https://biotechmorning.com/news/curium-lantheus-8-billion-radiopharmaceutical-megadeal 2026-08-04T14:24:58.777Z never 0.8 https://biotechmorning.com/news/biontech-sahin-steps-down-oelkers-ceo 2026-08-04T14:24:06.943Z never 0.8 https://biotechmorning.com/news/haya-lncrna-heart-drug-fda-fast-track 2026-08-04T14:23:13.564Z never 0.8 https://biotechmorning.com/news/wave-life-sciences-wve-007-obesity-fat-spares-muscle 2026-08-04T14:22:24.564Z never 0.8 https://biotechmorning.com/news/amgen-corlanor-recall-million-bottles 2026-08-04T14:21:20.502Z never 0.8 https://biotechmorning.com/news/sandoz-450-million-generic-drug-price-fixing-settlement 2026-08-04T14:20:28.697Z never 0.8 https://biotechmorning.com/news/nih-budget-cut-biotech-pipeline-threat 2026-08-04T14:19:42.036Z never 0.8 https://biotechmorning.com/news/supernus-indivior-cns-merger 2026-08-04T14:18:48.794Z never 0.8 https://biotechmorning.com/news/wainua-attr-cardiomyopathy-phase-3-failure 2026-08-04T14:17:51.850Z never 0.8 https://biotechmorning.com/news/astrazeneca-ionis-attr-cm-phase-3-failure 2026-08-03T14:24:07.244Z never 0.8 https://biotechmorning.com/news/jj-sail-biomedicines-in-vivo-car-t-deal 2026-08-03T14:23:10.235Z never 0.8 https://biotechmorning.com/news/astrazeneca-bms-megamerger-talks 2026-08-03T14:22:16.211Z never 0.8 https://biotechmorning.com/news/weight-loss-drug-aced-alcohol-addiction-trial 2026-08-03T14:21:24.289Z never 0.8 https://biotechmorning.com/news/moderna-mrna-flu-vaccine-fda-decision 2026-08-03T14:20:33.247Z never 0.8 https://biotechmorning.com/news/arpa-h-160-million-gene-editing-thrive-program 2026-08-03T14:19:40.505Z never 0.8 https://biotechmorning.com/news/replimune-rp1-fda-rejection-melanoma-stock-crash 2026-08-03T14:18:50.013Z never 0.8 https://biotechmorning.com/news/elevidys-gene-therapy-liver-failure-deaths-fda-investigation 2026-08-03T14:17:55.195Z never 0.8 https://biotechmorning.com/news/fda-oncology-trial-eligibility-guidances-2026 2026-08-02T14:22:47.501Z never 0.8 https://biotechmorning.com/news/tepezza-lost-monopoly-viridian-lumvoa-approval 2026-08-02T14:22:02.546Z never 0.8 https://biotechmorning.com/news/one-dose-lsd-beat-every-antidepressant 2026-08-02T14:21:05.985Z never 0.8 https://biotechmorning.com/news/lilly-abbisko-china-oncology-deal 2026-08-02T14:20:14.082Z never 0.8 https://biotechmorning.com/news/lantheus-cancer-imaging-fda-manufacturing-rejection 2026-08-02T14:19:20.907Z never 0.8 https://biotechmorning.com/news/ebola-bundibugyo-strain-vaccine-race 2026-08-02T14:18:40.616Z never 0.8 https://biotechmorning.com/news/fda-shaved-year-off-drug-timeline 2026-08-02T14:17:52.796Z never 0.8 https://biotechmorning.com/news/fda-real-time-clinical-trial-monitoring-pilot 2026-08-02T14:16:57.406Z never 0.8 https://biotechmorning.com/news/oruka-one-shot-psoriasis-beats-skyrizi 2026-08-02T14:16:05.237Z never 0.8 https://biotechmorning.com/news/intellia-crispr-phase-3-fda-filing 2026-08-02T14:15:13.846Z never 0.8 https://biotechmorning.com/news/ipsen-two-acquisitions-one-week-rare-disease 2026-08-01T14:23:47.679Z never 0.8 https://biotechmorning.com/news/astrazeneca-cspc-kidney-disease-sirna-deal 2026-08-01T14:22:54.586Z never 0.8 https://biotechmorning.com/news/novo-inflammation-drug-trial-failure 2026-08-01T14:22:03.104Z never 0.8 https://biotechmorning.com/news/lilly-2-3-billion-ajax-jak-inhibitor-deal 2026-08-01T14:21:14.900Z never 0.8 https://biotechmorning.com/news/legend-biotech-in-vivo-car-t-perfect-response-rate 2026-08-01T14:20:20.688Z never 0.8 https://biotechmorning.com/news/bms-15-billion-hengrui-china-deal 2026-08-01T14:19:27.039Z never 0.8 https://biotechmorning.com/news/fda-precheck-manufacturing-pilot-fast-lane 2026-08-01T14:18:33.255Z never 0.8 https://biotechmorning.com/news/pfizer-ritlecitinib-vitiligo-phase-3-results 2026-08-01T14:17:45.287Z never 0.8 https://biotechmorning.com/news/first-toddlers-eligible-crispr-gene-therapy 2026-08-01T14:16:54.868Z never 0.8 https://biotechmorning.com/news/novartis-myricx-adc-acquisition 2026-08-01T14:16:00.968Z never 0.8 https://biotechmorning.com/news/lilly-zepbound-vial-pricing-trick 2026-07-31T14:28:19.367Z never 0.8 https://biotechmorning.com/news/ipsen-kartos-navtemadlin-myelofibrosis-deal 2026-07-31T14:27:26.719Z never 0.8 https://biotechmorning.com/news/fda-real-time-clinical-trials-operation-trailblazer 2026-07-31T14:26:38.435Z never 0.8 https://biotechmorning.com/news/first-base-edited-human-embryo 2026-07-31T14:25:47.026Z never 0.8 https://biotechmorning.com/news/biomarin-inozyme-phase-3-failure 2026-07-31T14:24:54.411Z never 0.8 https://biotechmorning.com/news/pharma-2-trillion-forecast-asterisk 2026-07-31T14:24:00.677Z never 0.8 https://biotechmorning.com/news/vera-therapeutics-trutakna-fda-approval-igan 2026-07-31T14:23:05.473Z never 0.8 https://biotechmorning.com/news/astrazeneca-2-billion-copd-merck-ohtuvayre-challenger 2026-07-31T14:22:13.040Z never 0.8 https://biotechmorning.com/news/bms-printing-money-clock-ticking 2026-07-31T14:21:26.425Z never 0.8 https://biotechmorning.com/news/non-viral-car-t-tcx-001-first-in-human-trial 2026-07-31T14:20:30.483Z never 0.8 https://biotechmorning.com/news/spudcell-synthetic-cell-built-from-scratch 2026-07-31T14:19:41.761Z never 0.8 https://biotechmorning.com/news/rfk-jr-covid-vaccine-injury-table 2026-07-30T14:21:27.473Z never 0.8 https://biotechmorning.com/news/fate-therapeutics-car-t-systemic-sclerosis 2026-07-30T14:20:38.416Z never 0.8 https://biotechmorning.com/news/deramiocel-adcom-vote-duchenne-cardiomyopathy 2026-07-30T14:19:44.809Z never 0.8 https://biotechmorning.com/news/lytenava-fda-approval-three-rejections 2026-07-30T14:18:57.056Z never 0.8 https://biotechmorning.com/news/setanaxib-nox-inhibitor-pbc-liver-disease-transform-trial 2026-07-30T14:18:04.084Z never 0.8 https://biotechmorning.com/news/dna-predict-car-t-therapy-toxicity 2026-07-29T14:21:56.296Z never 0.8 https://biotechmorning.com/news/roche-walks-away-huntington-disease-twice 2026-07-29T14:21:05.933Z never 0.8 https://biotechmorning.com/news/fda-cder-staff-exodus-drug-review-crisis 2026-07-29T14:20:12.465Z never 0.8 https://biotechmorning.com/news/eli-lilly-ataibeckley-psychedelic-depression-deal 2026-07-29T14:19:18.261Z never 0.8 https://biotechmorning.com/news/fda-adcom-capricor-deramiocel-dmd-heart-drug 2026-07-29T14:18:21.358Z never 0.8 https://biotechmorning.com/news/sanofi-kills-dupixent-successor-amlitelimab 2026-07-29T14:17:30.800Z never 0.8 https://biotechmorning.com/news/pfizer-penicillin-recall-syphilis-crisis 2026-07-29T14:16:39.121Z never 0.8 https://biotechmorning.com/news/gsk-2-5-billion-restructuring-q2-2026 2026-07-29T14:15:47.276Z never 0.8 https://biotechmorning.com/news/kailera-obesity-pill-side-effects-problem 2026-07-28T14:25:58.612Z never 0.8 https://biotechmorning.com/news/pancreatic-cancer-ras-inhibitor-daraxonrasib-fda 2026-07-28T14:25:08.395Z never 0.8 https://biotechmorning.com/news/fda-goes-dark-drug-rejections 2026-07-28T14:24:15.628Z never 0.8 https://biotechmorning.com/news/vertex-10-billion-crinetics-acquisition 2026-07-28T14:23:27.165Z never 0.8 https://biotechmorning.com/news/zymeworks-acquires-theravance-929m-royalty-bet 2026-07-28T14:22:33.571Z never 0.8 https://biotechmorning.com/news/awiqli-once-weekly-insulin-india-launch 2026-07-28T14:21:33.359Z never 0.8 https://biotechmorning.com/news/moderna-bird-flu-vaccine-phase-3-trial-2 2026-07-28T14:20:31.950Z never 0.8 https://biotechmorning.com/news/roche-walks-away-huntingtons-disease 2026-07-28T14:19:38.587Z never 0.8 https://biotechmorning.com/news/glp1-gold-rush-pothole-dr-reddys-semaglutide-delay 2026-07-27T14:26:55.531Z never 0.8 https://biotechmorning.com/news/prime-medicine-beam-arbitration-gene-editing 2026-07-27T14:26:00.355Z never 0.8 https://biotechmorning.com/news/allogene-allo-316-car-t-solid-tumors-breakthrough 2026-07-27T14:25:08.546Z never 0.8 https://biotechmorning.com/news/715-million-48-hours-two-bets-reshaping-biotech 2026-07-27T14:23:30.923Z never 0.8 https://biotechmorning.com/news/gsk-alector-neuroscience-collaboration-terminated 2026-07-27T14:22:35.305Z never 0.8 https://biotechmorning.com/news/europe-flu-covid-combo-vaccine-moderna 2026-07-27T14:21:43.638Z never 0.8 https://biotechmorning.com/news/astrazeneca-sino-biopharmaceutical-copd-drug-deal 2026-07-26T14:23:14.611Z never 0.8 https://biotechmorning.com/news/gilead-tubulis-5-billion-adc-acquisition-4 2026-07-26T14:22:23.832Z never 0.8 https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition 2026-07-26T14:21:29.471Z never 0.8 https://biotechmorning.com/news/congress-merck-abbvie-china-military-hospital-trials 2026-07-26T14:20:37.240Z never 0.8 https://biotechmorning.com/news/gene-editing-breaks-two-year-ipo-drought 2026-07-26T14:19:50.401Z never 0.8 https://biotechmorning.com/news/lab-grown-eggs-sperm-ivg-breakthrough-2026 2026-07-26T14:18:53.123Z never 0.8 https://biotechmorning.com/news/ema-revokes-amgen-tavneos-data-integrity-2 2026-07-26T14:17:59.175Z never 0.8 https://biotechmorning.com/news/centanafadine-adhd-fda-decision-otsuka 2026-07-25T14:14:30.781Z never 0.8 https://biotechmorning.com/news/genentech-490-million-deal-layoffs 2026-07-25T14:13:40.691Z never 0.8 https://biotechmorning.com/news/car-t-prevent-myeloma-before-it-starts 2026-07-25T14:12:42.595Z never 0.8 https://biotechmorning.com/news/fda-bespoke-gene-therapy-framework-2 2026-07-24T14:28:25.309Z never 0.8 https://biotechmorning.com/news/eplontersen-attr-cardiomyopathy-trial-failure 2026-07-24T14:27:32.461Z never 0.8 https://biotechmorning.com/news/lilly-retatrutide-obesity-cardiovascular-miss 2026-07-24T14:26:39.264Z never 0.8 https://biotechmorning.com/news/sclc-ris-rez-survival-benefit 2026-07-24T14:25:43.947Z never 0.8 https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-elevidys-2 2026-07-24T14:24:53.667Z never 0.8 https://biotechmorning.com/news/car-t-solid-tumor-breakthrough-china-approval 2026-07-24T14:23:59.896Z never 0.8 https://biotechmorning.com/news/novartis-myricx-billion-dollar-adc-deal 2026-07-24T14:23:12.061Z never 0.8 https://biotechmorning.com/news/crispr-casgevy-approved-toddlers-sickle-cell 2026-07-24T14:22:14.185Z never 0.8 https://biotechmorning.com/news/pfizer-seagen-sigvotatug-vedotin-nsclc-failure 2026-07-24T14:21:19.827Z never 0.8 https://biotechmorning.com/news/abbvie-apogee-therapeutics-acquisition-10-billion-2 2026-07-24T14:20:29.867Z never 0.8 https://biotechmorning.com/news/nih-5-billion-ai-chronic-disease-initiative 2026-07-23T14:24:42.427Z never 0.8 https://biotechmorning.com/news/congress-fda-animal-testing-modernization-act 2026-07-23T14:23:53.330Z never 0.8 https://biotechmorning.com/news/cancer-weapon-switched-sides-oblenio-bio 2026-07-23T14:23:03.115Z never 0.8 https://biotechmorning.com/news/ai-built-proteins-molecular-sensors 2026-07-23T14:22:02.682Z never 0.8 https://biotechmorning.com/news/pfizer-talzenna-xtandi-priority-review-prostate-cancer 2026-07-23T14:21:04.211Z never 0.8 https://biotechmorning.com/news/zepbound-cheaper-single-dose-vials-2 2026-07-23T14:20:16.130Z never 0.8 https://biotechmorning.com/news/roche-kills-lupus-tce-doubles-down-autoimmune 2026-07-23T14:19:26.053Z never 0.8 https://biotechmorning.com/news/senate-bill-biologic-patent-thickets 2026-07-23T14:18:34.571Z never 0.8 https://biotechmorning.com/news/fifth-ros1-lung-cancer-drug-fda-approval-zidesamtinib 2026-07-23T14:17:41.114Z never 0.8 https://biotechmorning.com/news/battery-less-brain-implant-ability-neurotech 2026-07-22T14:26:53.075Z never 0.8 https://biotechmorning.com/news/repligen-biolife-solutions-acquisition-cell-therapy 2026-07-22T14:26:00.092Z never 0.8 https://biotechmorning.com/news/fda-lost-3000-now-hiring-them-back 2026-07-22T14:25:07.995Z never 0.8 https://biotechmorning.com/news/novo-nordisk-sues-eli-lilly-glp1-advertising 2026-07-22T14:24:16.792Z never 0.8 https://biotechmorning.com/news/allo-316-allogeneic-car-t-solid-tumor-remissions 2026-07-22T14:23:24.640Z never 0.8 https://biotechmorning.com/news/crystalys-gout-drug-dotinurad-series-b 2026-07-22T14:22:28.971Z never 0.8 https://biotechmorning.com/news/arpa-h-160m-genetic-medicine-platforms 2026-07-22T14:21:40.632Z never 0.8 https://biotechmorning.com/news/jj-ottava-robotic-surgery-fda-authorization 2026-07-22T14:20:43.141Z never 0.8 https://biotechmorning.com/news/alzheimers-drug-escaped-waiting-room 2026-07-22T14:19:51.054Z never 0.8 https://biotechmorning.com/news/gsk-b7h3-adc-first-survival-win 2026-07-21T14:29:10.427Z never 0.8 https://biotechmorning.com/news/novartis-entresto-decline-q2-2026-earnings-beat 2026-07-21T14:28:11.263Z never 0.8 https://biotechmorning.com/news/dyne-duchenne-drug-fda-fast-lane 2026-07-21T14:27:18.821Z never 0.8 https://biotechmorning.com/news/stargardt-disease-first-treatment-tinlarebant 2026-07-21T14:26:27.705Z never 0.8 https://biotechmorning.com/news/glp1-giants-novo-nordisk-sues-eli-lilly-false-advertising 2026-07-21T14:25:32.814Z never 0.8 https://biotechmorning.com/news/tempus-ai-personalis-acquisition-oncology-data 2026-07-21T14:24:41.058Z never 0.8 https://biotechmorning.com/news/biotech-cmo-fugitive-fake-identity 2026-07-21T14:23:47.597Z never 0.8 https://biotechmorning.com/news/abbott-cyberattack-q2-earnings-july-2026 2026-07-21T14:22:56.208Z never 0.8 https://biotechmorning.com/news/two-minutes-wegovy-telehealth-safety 2026-07-21T14:22:00.089Z never 0.8 https://biotechmorning.com/news/ozempic-generic-semaglutide-canada-approval 2026-07-21T14:21:10.417Z never 0.8 https://biotechmorning.com/news/samsung-biologics-polypeptide-acquisition-glp1 2026-07-21T14:20:19.619Z never 0.8 https://biotechmorning.com/news/pentagon-flu-vaccine-mandate-reversal-texas-outbreak 2026-07-20T14:30:29.198Z never 0.8 https://biotechmorning.com/news/scribe-therapeutics-ipo-crispr-cholesterol 2026-07-20T14:29:39.782Z never 0.8 https://biotechmorning.com/news/mwyngil-therapeutics-obesity-beyond-glp1 2026-07-20T14:28:46.064Z never 0.8 https://biotechmorning.com/news/bms-nvidia-vera-rubin-ai-supercomputer-drug-discovery 2026-07-20T14:27:52.036Z never 0.8 https://biotechmorning.com/news/china-insurance-glp1-pfizer-innovent 2026-07-20T14:26:57.092Z never 0.8 https://biotechmorning.com/news/india-first-dengue-vaccine-qdenga-approved 2026-07-20T14:26:09.132Z never 0.8 https://biotechmorning.com/news/ollin-biosciences-330m-ophthalmology-bet 2026-07-20T14:25:10.438Z never 0.8 https://biotechmorning.com/news/senator-investigation-fda-rare-disease-rejections 2026-07-20T14:24:20.572Z never 0.8 https://biotechmorning.com/news/fda-liked-the-drug-hated-the-factory-lantheus 2026-07-20T14:23:30.464Z never 0.8 https://biotechmorning.com/news/new-drug-launch-prices-dropped-2025 2026-07-20T14:22:43.186Z never 0.8 https://biotechmorning.com/news/sonothera-ultrasound-gene-therapy-duchenne 2026-07-20T14:21:52.275Z never 0.8 https://biotechmorning.com/news/voquezna-nerd-approval-unlocks-millions 2026-07-19T14:21:58.238Z never 0.8 https://biotechmorning.com/news/parabilis-medicines-record-670-million-biotech-ipo 2026-07-19T14:21:02.502Z never 0.8 https://biotechmorning.com/news/adc-replaces-chemo-first-line-lung-cancer 2026-07-19T14:20:16.203Z never 0.8 https://biotechmorning.com/news/innocare-tyk2-vitiligo-new-challenger 2026-07-19T14:19:26.189Z never 0.8 https://biotechmorning.com/news/715-million-back-to-back-biotech-bets 2026-07-19T14:18:37.032Z never 0.8 https://biotechmorning.com/news/supreme-court-roundup-bayer-preemption-ruling 2026-07-19T14:17:48.954Z never 0.8 https://biotechmorning.com/news/hengrui-elevar-fda-third-manufacturing-rejection 2026-07-19T14:16:59.642Z never 0.8 https://biotechmorning.com/news/lilly-blood-test-rivals-pet-scan-alzheimers 2026-07-18T14:27:34.111Z never 0.8 https://biotechmorning.com/news/roche-exits-huntingtons-gene-silencing 2026-07-18T14:26:44.243Z never 0.8 https://biotechmorning.com/news/vertex-10-billion-crinetics-endocrinology-bet 2026-07-18T14:25:50.189Z never 0.8 https://biotechmorning.com/news/merck-kgaa-bio-techne-11-billion-acquisition 2026-07-18T14:24:55.649Z never 0.8 https://biotechmorning.com/news/hansoh-backdoor-wall-street-reverse-merger 2026-07-18T14:24:00.915Z never 0.8 https://biotechmorning.com/news/jasper-kira-merger-rescue-deal-flowchart 2026-07-18T14:23:03.977Z never 0.8 https://biotechmorning.com/news/wegovy-mash-liver-disease-india-approval 2026-07-18T14:22:02.034Z never 0.8 https://biotechmorning.com/news/ractigen-rag17-als-nature-medicine 2026-07-18T14:21:04.897Z never 0.8 https://biotechmorning.com/news/astrazeneca-chia-tai-tianqing-copd-deal 2026-07-18T14:20:10.669Z never 0.8 https://biotechmorning.com/news/takeda-zasocitinib-phase-3-psoriasis-results 2026-07-17T14:28:51.617Z never 0.8 https://biotechmorning.com/news/kardigan-myokardia-crew-400-million-ipo-2 2026-07-17T14:28:00.890Z never 0.8 https://biotechmorning.com/news/italy-state-backed-angelini-catalyst-rare-disease-deal 2026-07-17T14:27:05.257Z never 0.8 https://biotechmorning.com/news/lilly-atabeckley-psychedelics-acquisition 2026-07-17T14:26:10.097Z never 0.8 https://biotechmorning.com/news/merck-lipfendra-oral-pcsk9-cholesterol-pill 2026-07-17T14:25:19.363Z never 0.8 https://biotechmorning.com/news/fabhalta-traditional-approval-iga-nephropathy 2026-07-17T14:24:24.254Z never 0.8 https://biotechmorning.com/news/tepezza-loses-ted-monopoly-viridian-lumvoa-approved 2026-07-17T14:22:53.986Z never 0.8 https://biotechmorning.com/news/kalshi-biopharma-prediction-markets-fda 2026-07-17T14:21:57.680Z never 0.8 https://biotechmorning.com/news/doudna-ai-designed-crispr-enzymes 2026-07-17T14:21:01.236Z never 0.8 https://biotechmorning.com/news/fda-warning-letters-telehealth-compounded-glp1 2026-07-17T14:20:00.917Z never 0.8 https://biotechmorning.com/news/sanofi-eu-antitrust-flu-vaccine-marketing 2026-07-16T14:25:56.699Z never 0.8 https://biotechmorning.com/news/novartis-myricx-bio-adc-acquisition-2 2026-07-16T14:25:06.309Z never 0.8 https://biotechmorning.com/news/abbvie-apogee-therapeutics-acquisition 2026-07-16T14:24:13.770Z never 0.8 https://biotechmorning.com/news/sobi-gout-drug-fda-manufacturing-rejection 2026-07-16T14:23:17.347Z never 0.8 https://biotechmorning.com/news/pfizer-penicillin-recall-syphilis-pregnancy-crisis 2026-07-16T14:22:24.727Z never 0.8 https://biotechmorning.com/news/generic-ozempic-south-africa-sun-pharma 2026-07-16T14:21:33.137Z never 0.8 https://biotechmorning.com/news/eye-gene-therapy-easy-win-jnj 2026-07-16T14:20:43.000Z never 0.8 https://biotechmorning.com/news/fda-approves-first-treg-cell-therapy-tregzi 2026-07-16T14:19:41.623Z never 0.8 https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-duchenne-2 2026-07-16T14:18:53.437Z never 0.8 https://biotechmorning.com/news/oral-wegovy-pill-eu-approval-obesity 2026-07-16T14:17:54.450Z never 0.8 https://biotechmorning.com/news/ebola-pill-obeldesivir-trial-congo-outbreak 2026-07-15T14:27:16.832Z never 0.8 https://biotechmorning.com/news/insilico-bora-ai-drug-manufacturing-partnership 2026-07-15T14:26:21.188Z never 0.8 https://biotechmorning.com/news/biogen-diranersen-alzheimers-phase-2-tau-phase-3 2026-07-15T14:25:27.744Z never 0.8 https://biotechmorning.com/news/celcuity-gedatolisib-fda-approval-breast-cancer 2026-07-15T14:24:37.795Z never 0.8 https://biotechmorning.com/news/attovia-ipo-dupixent-challenger 2026-07-15T14:23:39.977Z never 0.8 https://biotechmorning.com/news/fda-distributed-manufacturing-biologics-framework 2026-07-15T14:22:47.006Z never 0.8 https://biotechmorning.com/news/fda-final-guidance-psychedelic-clinical-trials 2026-07-15T14:21:53.735Z never 0.8 https://biotechmorning.com/news/q32-bio-alopecia-stock-surge 2026-07-14T14:29:05.540Z never 0.8 https://biotechmorning.com/news/fda-silent-three-months-14-rejection-letters 2026-07-14T14:28:17.284Z never 0.8 https://biotechmorning.com/news/dostarlimab-rectal-cancer-tumors-vanish 2026-07-14T14:27:27.028Z never 0.8 https://biotechmorning.com/news/roche-divarasib-beats-sotorasib-adagrasib-kras-nsclc 2026-07-14T14:26:33.769Z never 0.8 https://biotechmorning.com/news/oxford-bundibugyo-ebola-vaccine-trial 2026-07-14T14:25:39.431Z never 0.8 https://biotechmorning.com/news/big-pharma-china-drug-licensing-110-billion-record 2026-07-14T14:24:39.331Z never 0.8 https://biotechmorning.com/news/leqembi-at-home-alzheimers-drug-fda-approval 2026-07-14T14:23:46.648Z never 0.8 https://biotechmorning.com/news/jnj-stelara-revenue-plummets-wall-street-cheers 2026-07-13T14:27:31.475Z never 0.8 https://biotechmorning.com/news/ai-picks-cancer-patients-who-survive 2026-07-13T14:26:39.105Z never 0.8 https://biotechmorning.com/news/crispr-first-cure-casgevy-unexpected-problem 2026-07-13T14:25:48.214Z never 0.8 https://biotechmorning.com/news/gene-therapy-sickle-cell-toddlers-fda-approval 2026-07-13T14:24:56.429Z never 0.8 https://biotechmorning.com/news/fda-overrules-experts-moderna-flu-vaccine 2026-07-13T14:24:07.227Z never 0.8 https://biotechmorning.com/news/fda-bespoke-gene-therapy-framework 2026-07-13T14:23:12.159Z never 0.8 https://biotechmorning.com/news/car-t-therapy-intercept-multiple-myeloma-before-it-starts 2026-07-13T14:22:21.643Z never 0.8 https://biotechmorning.com/news/bladder-cancer-chemo-monopoly-broken-keytruda-padcev 2026-07-13T14:21:32.347Z never 0.8 https://biotechmorning.com/news/astrazeneca-cspc-extrahepatic-sirna-deal 2026-07-12T14:22:16.679Z never 0.8 https://biotechmorning.com/news/bundibugyo-ebola-american-infected-no-vaccine 2026-07-12T14:21:21.393Z never 0.8 https://biotechmorning.com/news/arpa-h-160-million-custom-gene-editing-thrive 2026-07-12T14:20:26.190Z never 0.8 https://biotechmorning.com/news/vaccine-skeptic-nominee-emergency-health-role 2026-07-12T14:19:35.058Z never 0.8 https://biotechmorning.com/news/fda-slams-door-cheap-ozempic-knockoffs 2026-07-12T14:18:40.934Z never 0.8 https://biotechmorning.com/news/lilly-zepbound-cheaper-single-dose-vials 2026-07-12T14:17:51.708Z never 0.8 https://biotechmorning.com/news/novo-nordisk-wegovy-subscription-pricing 2026-07-12T14:16:55.615Z never 0.8 https://biotechmorning.com/news/ipsen-memo-therapeutics-bk-virus-deal 2026-07-12T14:15:56.170Z never 0.8 https://biotechmorning.com/news/eplontersen-attr-cm-phase-3-failure 2026-07-12T14:14:55.389Z never 0.8 https://biotechmorning.com/news/relacorilant-cortisol-ovarian-cancer-approval 2026-07-12T14:14:08.935Z never 0.8 https://biotechmorning.com/news/moderna-flu-covid-combo-vaccine-eu-approval-2 2026-07-11T14:21:05.752Z never 0.8 https://biotechmorning.com/news/arpa-h-160m-customizable-gene-therapy 2026-07-11T14:20:17.822Z never 0.8 https://biotechmorning.com/news/gsk-hansoh-adc-sclc-phase-3-win 2026-07-11T14:19:26.794Z never 0.8 https://biotechmorning.com/news/pharma-tariff-shakedown-16-companies-blink 2026-07-11T14:18:36.223Z never 0.8 https://biotechmorning.com/news/ema-progestin-contraceptive-meningioma-risk 2026-07-11T14:17:43.987Z never 0.8 https://biotechmorning.com/news/liver-cancer-drug-manufacturing-rejection-fda 2026-07-11T14:16:54.936Z never 0.8 https://biotechmorning.com/news/germany-tougher-drug-pricing-reform-2026 2026-07-11T14:16:04.595Z never 0.8 https://biotechmorning.com/news/bayer-apollo-contraceptives-equity-deal 2026-07-11T14:15:09.309Z never 0.8 https://biotechmorning.com/news/sanofi-subcutaneous-sarclisa-myeloma-convenience 2026-07-11T14:14:18.456Z never 0.8 https://biotechmorning.com/news/400m-bet-fixing-blindness-big-pharma-walked-away 2026-07-10T14:26:57.323Z never 0.8 https://biotechmorning.com/news/roche-kills-two-huntingtons-programs 2026-07-10T14:26:00.889Z never 0.8 https://biotechmorning.com/news/trump-100-percent-tariff-brand-name-drugs 2026-07-10T14:25:07.088Z never 0.8 https://biotechmorning.com/news/chikungunya-vaccine-ixchiq-pulled-us-market 2026-07-10T14:24:11.625Z never 0.8 https://biotechmorning.com/news/car-t-systemic-sclerosis-fate-therapeutics 2026-07-10T14:23:20.978Z never 0.8 https://biotechmorning.com/news/moderna-h5-bird-flu-vaccine-phase-3-trial 2026-07-10T14:22:28.690Z never 0.8 https://biotechmorning.com/news/moderna-combined-flu-covid-vaccine-eu-approval 2026-07-10T14:21:36.161Z never 0.8 https://biotechmorning.com/news/bms-krazati-chemo-colorectal-cancer-failure 2026-07-10T14:20:44.169Z never 0.8 https://biotechmorning.com/news/keytruda-biosimilar-samsung-bioepis-sb27-phase-3 2026-07-10T14:19:49.604Z never 0.8 https://biotechmorning.com/news/china-glp1-essential-medicines-semaglutide 2026-07-10T14:18:59.727Z never 0.8 https://biotechmorning.com/news/satellos-muscle-remodeling-adult-duchenne 2026-07-09T14:26:15.884Z never 0.8 https://biotechmorning.com/news/trump-tax-bill-biotech-giveth-taketh 2026-07-09T14:25:24.329Z never 0.8 https://biotechmorning.com/news/astrazeneca-sino-biopharma-copd-deal 2026-07-09T14:24:31.243Z never 0.8 https://biotechmorning.com/news/sino-biopharm-lanova-acquisition-bispecific-antibody 2026-07-09T14:23:38.295Z never 0.8 https://biotechmorning.com/news/ebola-jumps-new-province-no-weapons 2026-07-09T14:22:44.274Z never 0.8 https://biotechmorning.com/news/fda-commissioner-search-2026-white-house-contenders 2026-07-09T14:21:47.911Z never 0.8 https://biotechmorning.com/news/tavneos-nejm-retraction-advocate-trial 2026-07-09T14:20:56.487Z never 0.8 https://biotechmorning.com/news/gsk-alector-700-million-alzheimers-deal-dead 2026-07-09T14:20:06.870Z never 0.8 https://biotechmorning.com/news/prime-medicine-beam-patent-ruling-gene-editing 2026-07-09T14:19:10.260Z never 0.8 https://biotechmorning.com/news/penicillin-recall-syphilis-crisis 2026-07-08T14:25:33.912Z never 0.8 https://biotechmorning.com/news/astrazeneca-amyloidosis-drug-phase-3-failure 2026-07-08T14:24:46.049Z never 0.8 https://biotechmorning.com/news/novo-nordisk-hims-wegovy-ozempic-telehealth-deal 2026-07-08T14:23:56.300Z never 0.8 https://biotechmorning.com/news/intellia-crispr-trial-pause-safety-concern 2026-07-08T14:22:59.999Z never 0.8 https://biotechmorning.com/news/ionis-tryngolza-expanded-approval-blockbuster 2026-07-08T14:22:07.998Z never 0.8 https://biotechmorning.com/news/fda-cder-staff-exodus-drug-approvals-at-risk 2026-07-08T14:21:15.515Z never 0.8 https://biotechmorning.com/news/kailera-oral-obesity-pill-phase-3-china 2026-07-08T14:20:19.736Z never 0.8 https://biotechmorning.com/news/lilly-ajax-2-3b-jak2-inhibitor-deal 2026-07-08T14:19:27.242Z never 0.8 https://biotechmorning.com/news/vera-therapeutics-atacicept-trutakna-iga-nephropathy-fda-approval 2026-07-08T14:18:36.440Z never 0.8 https://biotechmorning.com/news/intrabio-first-drug-ataxia-telangiectasia 2026-07-07T14:29:57.932Z never 0.8 https://biotechmorning.com/news/doctors-sue-cdc-childhood-vaccine-schedule 2026-07-07T14:29:07.632Z never 0.8 https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-duchenne 2026-07-07T14:28:13.988Z never 0.8 https://biotechmorning.com/news/gilead-tubulis-5-billion-adc-acquisition-3 2026-07-07T14:27:20.072Z never 0.8 https://biotechmorning.com/news/vertex-10-billion-crinetics-endocrinology-deal 2026-07-07T14:26:27.207Z never 0.8 https://biotechmorning.com/news/jnj-shrugs-off-mfn-drug-pricing 2026-07-07T14:25:28.261Z never 0.8 https://biotechmorning.com/news/genentech-layoffs-breast-cancer-deal 2026-07-07T14:24:29.707Z never 0.8 https://biotechmorning.com/news/scribe-therapeutics-ipo-gene-editing-cholesterol 2026-07-07T14:23:33.495Z never 0.8 https://biotechmorning.com/news/novartis-myricx-bio-adc-acquisition 2026-07-07T14:22:37.298Z never 0.8 https://biotechmorning.com/news/40-year-drought-aatd-sanofi-wave 2026-07-06T14:25:44.277Z never 0.8 https://biotechmorning.com/news/big-pharma-trump-pricing-deals-tariff-relief 2026-07-06T14:24:55.849Z never 0.8 https://biotechmorning.com/news/regeneron-parabilis-2-3-billion-helicon-deal 2026-07-06T14:24:12.294Z never 0.8 https://biotechmorning.com/news/roche-divarasib-beats-amgen-bms-kras-lung-cancer 2026-07-06T14:23:26.129Z never 0.8 https://biotechmorning.com/news/immunovant-fcrn-inhibitor-eye-disease-failure 2026-07-06T14:22:40.640Z never 0.8 https://biotechmorning.com/news/lilly-engage-biologics-tethosome-non-viral-dna-delivery 2026-07-06T14:21:56.741Z never 0.8 https://biotechmorning.com/news/denmark-861m-bet-europes-biotech-capital 2026-07-06T14:21:11.943Z never 0.8 https://biotechmorning.com/news/biomarin-270m-inozyme-phase-3-failure 2026-07-06T14:20:37.167Z never 0.8 https://biotechmorning.com/news/regeneron-fianlimab-keytruda-melanoma-phase-3-failure 2026-07-06T14:19:54.821Z never 0.8 https://biotechmorning.com/news/biontech-selling-german-manufacturing-sites 2026-07-05T14:25:24.263Z never 0.8 https://biotechmorning.com/news/colorado-enbrel-price-cap-blocked-federal-court 2026-07-05T14:24:33.421Z never 0.8 https://biotechmorning.com/news/anthropic-claude-science-pharma-launch 2026-07-05T14:23:43.157Z never 0.8 https://biotechmorning.com/news/roche-axelios-sequencer-challenges-illumina 2026-07-05T14:22:39.748Z never 0.8 https://biotechmorning.com/news/car-t-hunts-tumors-and-bodyguards-gpnmb 2026-07-05T14:21:45.185Z never 0.8 https://biotechmorning.com/news/chikungunya-vaccine-ixchiq-us-withdrawal 2026-07-05T14:20:51.478Z never 0.8 https://biotechmorning.com/news/sandoz-generic-glp1-fda-review 2026-07-05T14:20:02.620Z never 0.8 https://biotechmorning.com/news/zymeworks-acquires-theravance-copd-drug 2026-07-05T14:19:14.299Z never 0.8 https://biotechmorning.com/news/tepezza-loses-thyroid-eye-disease-monopoly 2026-07-05T14:18:21.486Z never 0.8 https://biotechmorning.com/news/atacicept-iga-nephropathy-fda-decision 2026-07-03T14:25:50.614Z never 0.8 https://biotechmorning.com/news/fda-peptide-panel-conflicts-of-interest 2026-07-03T14:24:54.282Z never 0.8 https://biotechmorning.com/news/roche-divarasib-beats-lumakras-krazati-kras-g12c 2026-07-03T14:23:59.371Z never 0.8 https://biotechmorning.com/news/deaf-toddlers-hearing-gene-therapy-sensorion 2026-07-03T14:23:02.404Z never 0.8 https://biotechmorning.com/news/macrogenics-sells-factory-bora-pharmaceuticals 2026-07-03T14:22:14.205Z never 0.8 https://biotechmorning.com/news/united-therapeutics-thymmune-thymus-acquisition 2026-07-03T14:21:19.963Z never 0.8 https://biotechmorning.com/news/biotech-billion-dollar-shopping-spree-has-a-catch 2026-07-03T14:20:28.599Z never 0.8 https://biotechmorning.com/news/ipsen-two-acquisitions-one-week-memo-kartos 2026-07-03T14:19:32.564Z never 0.8 https://biotechmorning.com/news/bridgebio-billion-dollar-preferred-equity-sixth-street-kkr 2026-07-03T14:18:38.077Z never 0.8 https://biotechmorning.com/news/merck-alzheimers-trial-mk-1167-halted 2026-07-02T14:26:53.847Z never 0.8 https://biotechmorning.com/news/takeda-insilico-600m-ai-drug-discovery-deal 2026-07-02T14:26:00.349Z never 0.8 https://biotechmorning.com/news/orca-bio-tregzi-fda-approval-blood-cancer 2026-07-02T14:25:06.180Z never 0.8 https://biotechmorning.com/news/oral-carbapenem-utebzi-fda-approval 2026-07-02T14:24:13.462Z never 0.8 https://biotechmorning.com/news/medicare-glp1-weight-loss-pilot-50-copay 2026-07-02T14:23:18.754Z never 0.8 https://biotechmorning.com/news/celea-180m-ipf-deupirfenidone-financing 2026-07-02T14:22:30.059Z never 0.8 https://biotechmorning.com/news/fda-real-time-clinical-trial-data-streaming 2026-07-02T14:19:01.391Z never 0.8 https://biotechmorning.com/news/startup-2-2-billion-alzheimers-deal 2026-07-02T14:17:33.491Z never 0.8 https://biotechmorning.com/news/astrazeneca-cspc-kidney-disease-deal 2026-07-02T14:16:39.775Z never 0.8 https://biotechmorning.com/news/vertex-casgevy-gene-therapy-toddlers-sickle-cell 2026-07-02T14:15:44.271Z never 0.8 https://biotechmorning.com/news/cdc-covid-vaccine-study-blocked 2026-07-01T14:29:40.472Z never 0.8 https://biotechmorning.com/news/moderna-bird-flu-vaccine-phase-3-trial 2026-07-01T14:28:50.152Z never 0.8 https://biotechmorning.com/news/sobi-gout-drug-fda-rejection-manufacturing 2026-07-01T14:27:58.124Z never 0.8 https://biotechmorning.com/news/ema-revokes-amgen-tavneos-data-integrity 2026-07-01T14:27:04.880Z never 0.8 https://biotechmorning.com/news/china-first-solid-tumor-car-t-approval 2026-07-01T14:26:14.928Z never 0.8 https://biotechmorning.com/news/fda-gene-therapy-brain-drain-getting-worse 2026-07-01T14:25:22.700Z never 0.8 https://biotechmorning.com/news/biogen-850m-china-tj-biopharma-felzartamab-deal 2026-07-01T14:24:30.389Z never 0.8 https://biotechmorning.com/news/moderna-flu-covid-combo-vaccine-eu-approval 2026-07-01T14:23:36.649Z never 0.8 https://biotechmorning.com/news/fda-precheck-pilot-program-first-cohort 2026-07-01T14:22:41.349Z never 0.8 https://biotechmorning.com/news/fda-fired-3000-now-hiring-2200-back 2026-07-01T14:21:44.273Z never 0.8 https://biotechmorning.com/news/merck-abbvie-china-clinical-trials-national-security-probe 2026-07-01T14:20:56.725Z never 0.8 https://biotechmorning.com/news/ai-scientist-builds-biotech-companies 2026-06-30T14:26:41.512Z never 0.8 https://biotechmorning.com/news/biocryst-shuts-down-internal-discovery 2026-06-30T14:25:46.513Z never 0.8 https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-cell-therapy 2026-06-30T14:24:53.763Z never 0.8 https://biotechmorning.com/news/parabilis-medicines-record-biotech-ipo 2026-06-30T14:23:57.130Z never 0.8 https://biotechmorning.com/news/moderna-mrna-flu-vaccine-fda-panel-endorsement 2026-06-30T14:23:03.354Z never 0.8 https://biotechmorning.com/news/enspryng-thyroid-eye-disease-at-home-injection 2026-06-30T14:22:08.996Z never 0.8 https://biotechmorning.com/news/vistagen-anxiety-drug-phase-3-failures 2026-06-30T14:21:17.556Z never 0.8 https://biotechmorning.com/news/fda-running-on-fumes-biotech-paying-price 2026-06-30T14:20:19.552Z never 0.8 https://biotechmorning.com/news/fda-precheck-pilot-manufacturing-reviews 2026-06-30T14:19:26.343Z never 0.8 https://biotechmorning.com/news/boulevard-bio-1-6-billion-trispecific-tce-deal 2026-06-30T14:18:41.616Z never 0.8 https://biotechmorning.com/news/stealth-antibody-vir-astellas-prostate-cancer-deal 2026-06-29T14:27:45.289Z never 0.8 https://biotechmorning.com/news/novo-nordisk-cagrisema-loses-to-zepbound-3 2026-06-29T14:26:53.981Z never 0.8 https://biotechmorning.com/news/adhd-drug-centanafadine-anxiety-otsuka-phase-3b 2026-06-29T14:26:01.104Z never 0.8 https://biotechmorning.com/news/astrazeneca-strensiq-successor-mixed-phase-3-results 2026-06-29T14:25:02.913Z never 0.8 https://biotechmorning.com/news/novartis-qeq278-zero-responses-30-patients 2026-06-29T14:24:00.305Z never 0.8 https://biotechmorning.com/news/lilly-zepbound-vial-pricing-glp1-price-war 2026-06-29T14:23:11.486Z never 0.8 https://biotechmorning.com/news/sarepta-black-box-warning-layoffs-elevidys 2026-06-29T14:22:08.447Z never 0.8 https://biotechmorning.com/news/ipsen-kartos-myelofibrosis-deal 2026-06-29T14:21:16.154Z never 0.8 https://biotechmorning.com/news/alumis-250m-ipo-back-to-back-raises 2026-06-28T14:24:47.990Z never 0.8 https://biotechmorning.com/news/immunovant-39m-batoclimab-termination 2026-06-28T14:23:56.299Z never 0.8 https://biotechmorning.com/news/cipepofol-china-anesthetic-fda-approval 2026-06-28T14:23:13.681Z never 0.8 https://biotechmorning.com/news/incyte-120m-genesis-ai-drug-discovery-bet 2026-06-28T14:22:14.132Z never 0.8 https://biotechmorning.com/news/liminatus-innocsai-320m-all-stock-deal 2026-06-28T14:21:19.777Z never 0.8 https://biotechmorning.com/news/annexon-huntington-patient-dropouts-stock-crash 2026-06-28T14:20:26.242Z never 0.8 https://biotechmorning.com/news/lilly-202m-engage-dna-delivery-acquisition 2026-06-28T14:19:30.200Z never 0.8 https://biotechmorning.com/news/biogen-apellis-pipeline-gutted 2026-06-28T14:18:35.407Z never 0.8 https://biotechmorning.com/news/infex-therapeutics-resp-x-phase-2a-ncfb-insmed 2026-06-28T14:17:34.037Z never 0.8 https://biotechmorning.com/news/parabilis-670-million-ipo-no-phase-3 2026-06-27T14:23:04.037Z never 0.8 https://biotechmorning.com/news/needle-free-epipen-alternative-insurance-wont-cover 2026-06-27T14:22:09.501Z never 0.8 https://biotechmorning.com/news/bio-2026-china-biosecure-ai-drug-discovery 2026-06-27T14:21:11.885Z never 0.8 https://biotechmorning.com/news/ibio-ai-obesity-drug-clinical-trial 2026-06-27T14:20:16.155Z never 0.8 https://biotechmorning.com/news/first-muscle-gain-fshd-epicrispr-epi-321 2026-06-27T14:19:23.888Z never 0.8 https://biotechmorning.com/news/viridian-lumvoa-fda-approval-thyroid-eye-disease 2026-06-27T14:18:33.759Z never 0.8 https://biotechmorning.com/news/boehringer-immunai-t-cell-target-discovery 2026-06-27T14:17:41.284Z never 0.8 https://biotechmorning.com/news/pharma-ma-boom-2026-shopping-spree 2026-06-27T14:16:47.388Z never 0.8 https://biotechmorning.com/news/lantheus-lnth-2501-crl-manufacturing-delay 2026-06-27T14:15:52.356Z never 0.8 https://biotechmorning.com/news/biogen-apellis-acquisition-rd-cuts 2026-06-27T14:14:58.389Z never 0.8 https://biotechmorning.com/news/gilead-tubulis-5-billion-adc-acquisition-2 2026-06-26T14:26:31.726Z never 0.8 https://biotechmorning.com/news/pharma-pricing-deals-trump-tariffs 2026-06-26T14:25:40.071Z never 0.8 https://biotechmorning.com/news/daraxonrasib-doubles-survival-pancreatic-cancer 2026-06-26T14:24:42.972Z never 0.8 https://biotechmorning.com/news/crispr-base-editing-human-embryos-precision-ethics 2026-06-26T14:23:48.643Z never 0.8 https://biotechmorning.com/news/gilead-kymera-molecular-glue-degrader-deal 2026-06-26T14:22:59.296Z never 0.8 https://biotechmorning.com/news/novartis-antares-undruggable-cancer-deal 2026-06-26T14:21:59.918Z never 0.8 https://biotechmorning.com/news/moderna-in-vivo-car-t-autoimmune 2026-06-26T14:21:04.031Z never 0.8 https://biotechmorning.com/news/ucb-neurona-therapeutics-cell-therapy-epilepsy-deal 2026-06-26T14:20:09.049Z never 0.8 https://biotechmorning.com/news/ms-drug-does-what-no-drug-has-done-before 2026-06-26T14:19:13.108Z never 0.8 https://biotechmorning.com/news/ai-designed-lung-drug-rentosertib-ipf-phase-2a 2026-06-25T14:28:42.428Z never 0.8 https://biotechmorning.com/news/fda-ngs-genome-editing-off-target-guidance 2026-06-25T14:27:52.585Z never 0.8 https://biotechmorning.com/news/one-shot-to-silence-disease-forever-intellia-crispr 2026-06-25T14:26:59.430Z never 0.8 https://biotechmorning.com/news/merck-kgaa-bio-techne-acquisition-11-billion 2026-06-25T14:26:01.236Z never 0.8 https://biotechmorning.com/news/ibrance-hER2-positive-breast-cancer-maintenance-approval 2026-06-25T14:25:05.164Z never 0.8 https://biotechmorning.com/news/nipocalimab-waiha-first-approved-treatment 2026-06-25T14:24:13.981Z never 0.8 https://biotechmorning.com/news/biosecure-act-china-biotech-expansion 2026-06-25T14:23:25.976Z never 0.8 https://biotechmorning.com/news/alzpath-abbott-alzheimer-blood-test-deal 2026-06-25T14:22:29.974Z never 0.8 https://biotechmorning.com/news/pfizer-berobenatide-monthly-glp1-phase-2b 2026-06-25T14:21:42.476Z never 0.8 https://biotechmorning.com/news/trodelvy-first-line-tnbc-fda-approval 2026-06-25T14:20:43.430Z never 0.8 https://biotechmorning.com/news/pig-kidney-271-days-fda-expansion 2026-06-25T14:19:53.694Z never 0.8 https://biotechmorning.com/news/eli-lilly-cuts-off-hospitals-340b-discounts 2026-06-24T14:25:25.078Z never 0.8 https://biotechmorning.com/news/sangamo-gene-editing-pioneer-sold-for-parts 2026-06-24T14:24:37.621Z never 0.8 https://biotechmorning.com/news/biogen-apellis-acquisition-complement-platform 2026-06-24T14:23:50.396Z never 0.8 https://biotechmorning.com/news/china-car-t-solid-tumor-approval 2026-06-24T14:22:58.756Z never 0.8 https://biotechmorning.com/news/jnj-firefly-bio-billion-dollar-acquisition 2026-06-24T14:22:07.024Z never 0.8 https://biotechmorning.com/news/serapha-bio-230m-series-a-gene-editing-china 2026-06-24T14:21:14.459Z never 0.8 https://biotechmorning.com/news/ollin-330m-bet-dethrone-roche-eye-drug 2026-06-24T14:20:18.151Z never 0.8 https://biotechmorning.com/news/lilly-abbisko-1-9-billion-shanghai-collaboration 2026-06-24T14:19:20.196Z never 0.8 https://biotechmorning.com/news/servier-edgewise-muscular-dystrophy-deal 2026-06-24T14:18:29.322Z never 0.8 https://biotechmorning.com/news/eli-lilly-centessa-sleep-disorders-acquisition 2026-06-24T14:17:31.378Z never 0.8 https://biotechmorning.com/news/merck-6-7-billion-terns-pharmaceuticals-cml-2 2026-06-24T14:16:35.597Z never 0.8 https://biotechmorning.com/news/ai-designed-drug-crosses-human-brain 2026-06-23T14:27:02.041Z never 0.8 https://biotechmorning.com/news/cancer-treatment-on-body-injector-uk-approval 2026-06-23T14:26:17.473Z never 0.8 https://biotechmorning.com/news/merck-calderasib-keytruda-kras-lung-cancer-breakthrough 2026-06-23T14:25:29.254Z never 0.8 https://biotechmorning.com/news/pfizer-seagen-adc-lung-cancer-phase-3-failure 2026-06-23T14:24:42.126Z never 0.8 https://biotechmorning.com/news/first-disease-modifying-therapy-childhood-type-1-diabetes 2026-06-23T14:23:59.095Z never 0.8 https://biotechmorning.com/news/cemdisiran-quarterly-shot-myasthenia-gravis-fda-priority-review 2026-06-23T14:23:12.561Z never 0.8 https://biotechmorning.com/news/exelixis-zanzalintinib-colorectal-cancer-endpoint-miss 2026-06-23T14:22:22.014Z never 0.8 https://biotechmorning.com/news/fda-operation-trailblazer-phase-1-acceleration 2026-06-23T14:21:35.367Z never 0.8 https://biotechmorning.com/news/merck-tulisokibart-phase-3-ulcerative-colitis-results 2026-06-23T14:20:48.553Z never 0.8 https://biotechmorning.com/news/fda-real-time-clinical-trials-astrazeneca-amgen-2 2026-06-23T14:19:59.365Z never 0.8 https://biotechmorning.com/news/fda-moderna-white-house-pressure-reversal 2026-06-22T14:28:21.196Z never 0.8 https://biotechmorning.com/news/lsd-pill-crushes-depression-drugs-phase-3 2026-06-22T14:27:29.516Z never 0.8 https://biotechmorning.com/news/novo-nordisk-cagrisema-loses-head-to-head-lilly-tirzepatide 2026-06-22T14:26:38.200Z never 0.8 https://biotechmorning.com/news/bionyra-launches-165-million-inflammation-immunology 2026-06-22T14:25:45.411Z never 0.8 https://biotechmorning.com/news/lilly-alzcure-alzheimer-billion-dollar-deal 2026-06-22T14:24:51.975Z never 0.8 https://biotechmorning.com/news/big-pharma-106-billion-shopping-spree-2026 2026-06-22T14:23:52.258Z never 0.8 https://biotechmorning.com/news/pfizer-innovent-10-billion-oncology-deal 2026-06-22T14:22:49.816Z never 0.8 https://biotechmorning.com/news/insilico-sk-biopharmaceuticals-ai-neuroimmune-deal 2026-06-22T14:21:56.437Z never 0.8 https://biotechmorning.com/news/fda-real-time-clinical-trials-initiative-2 2026-06-22T14:20:59.600Z never 0.8 https://biotechmorning.com/news/abbvie-apogee-therapeutics-acquisition-10-billion 2026-06-22T14:20:04.273Z never 0.8 https://biotechmorning.com/news/otc-naloxone-rextovy-fda-approval 2026-06-21T14:18:47.587Z never 0.8 https://biotechmorning.com/news/sarepta-elevidys-gene-therapy-trial-failure-layoffs 2026-06-21T14:17:56.471Z never 0.8 https://biotechmorning.com/news/astellas-vir-biotechnology-masked-t-cell-engager-deal 2026-06-21T14:17:00.099Z never 0.8 https://biotechmorning.com/news/novo-nordisk-vect-horus-delivery-platform-deal 2026-06-21T14:16:06.119Z never 0.8 https://biotechmorning.com/news/gsk-billion-dollar-bet-hepatitis-b-functional-cure 2026-06-21T14:15:12.551Z never 0.8 https://biotechmorning.com/news/pfizer-obesity-pipeline-monthly-glp1-bet 2026-06-20T14:22:21.672Z never 0.8 https://biotechmorning.com/news/novo-nordisk-oral-wegovy-china-filing 2026-06-20T14:21:29.363Z never 0.8 https://biotechmorning.com/news/lilly-zepbound-vials-pricing-trick 2026-06-20T14:20:36.246Z never 0.8 https://biotechmorning.com/news/zepzelca-confirmatory-trial-failure 2026-06-20T14:19:45.247Z never 0.8 https://biotechmorning.com/news/novo-nordisk-cyberattack-fulcrumsec-ransom 2026-06-20T14:18:54.798Z never 0.8 https://biotechmorning.com/news/pharma-300-billion-us-manufacturing-tariff 2026-06-20T14:17:55.286Z never 0.8 https://biotechmorning.com/news/sanofi-riliprubart-cidp-trial-halted 2026-06-20T14:17:03.922Z never 0.8 https://biotechmorning.com/news/novartis-orionis-molecular-glue-degrader-deal 2026-06-20T14:16:13.413Z never 0.8 https://biotechmorning.com/news/soon-shiong-pancreatic-cancer-promises 2026-06-19T14:28:22.935Z never 0.8 https://biotechmorning.com/news/galleri-blood-test-finds-cancer-cant-prove-saves-lives 2026-06-19T14:27:22.901Z never 0.8 https://biotechmorning.com/news/moderna-mrna-flu-vaccine-fda-panel-approval 2026-06-19T14:26:28.559Z never 0.8 https://biotechmorning.com/news/personalized-mrna-cancer-vaccine-five-year-melanoma-results 2026-06-19T14:25:33.776Z never 0.8 https://biotechmorning.com/news/first-protac-drug-fda-approval-vepdegestrant-2 2026-06-19T14:24:40.555Z never 0.8 https://biotechmorning.com/news/merck-keytruda-welireg-adjuvant-kidney-cancer-fda-approval 2026-06-19T14:23:51.337Z never 0.8 https://biotechmorning.com/news/180m-to-fix-the-pill-that-makes-you-sick 2026-06-19T14:22:59.749Z never 0.8 https://biotechmorning.com/news/merck-capvaxive-pediatric-expansion-pfizer-prevnar 2026-06-19T14:22:05.103Z never 0.8 https://biotechmorning.com/news/lorlatinib-7-year-pfs-alk-lung-cancer 2026-06-19T14:21:15.771Z never 0.8 https://biotechmorning.com/news/one-shot-replace-lifetime-cholesterol-pills 2026-06-19T14:20:27.805Z never 0.8 https://biotechmorning.com/news/orexin-2-agonist-phase-2-milestone-narcolepsy 2026-06-18T14:23:57.867Z never 0.8 https://biotechmorning.com/news/gsk-nuvalent-11-billion-oncology-acquisition 2026-06-18T14:23:08.267Z never 0.8 https://biotechmorning.com/news/vc-opposes-us-china-biotech-investment-restrictions 2026-06-18T14:22:11.412Z never 0.8 https://biotechmorning.com/news/olorofim-antifungal-phase-3-results 2026-06-18T14:21:24.742Z never 0.8 https://biotechmorning.com/news/kardigan-myokardia-crew-400-million-ipo 2026-06-18T14:20:31.564Z never 0.8 https://biotechmorning.com/news/beam-therapeutics-base-editing-pku-gene-therapy 2026-06-18T14:19:39.348Z never 0.8 https://biotechmorning.com/news/jazz-abcellera-4-billion-tce-deal 2026-06-18T14:18:43.861Z never 0.8 https://biotechmorning.com/news/biogen-raythera-billion-dollar-immunology-bet 2026-06-18T14:17:41.638Z never 0.8 https://biotechmorning.com/news/lilly-acquires-4e-therapeutics-non-opioid-pain 2026-06-18T14:16:50.253Z never 0.8 https://biotechmorning.com/news/oral-carbapenem-tebipenem-fda-approval-uti 2026-06-18T14:15:57.094Z never 0.8 https://biotechmorning.com/news/fda-mixed-signals-moderna-mrna-flu-vaccine 2026-06-17T14:25:40.176Z never 0.8 https://biotechmorning.com/news/fda-gene-therapy-cheat-code-prior-knowledge 2026-06-17T14:24:47.099Z never 0.8 https://biotechmorning.com/news/medicare-glp1-obesity-coverage-hard-to-undo 2026-06-17T14:23:51.849Z never 0.8 https://biotechmorning.com/news/biontech-curevac-mRNA-acquisition 2026-06-17T14:22:55.977Z never 0.8 https://biotechmorning.com/news/fda-reversal-uniqure-huntington-gene-therapy 2026-06-17T14:22:05.954Z never 0.8 https://biotechmorning.com/news/altaris-simulations-plus-375m-acquisition 2026-06-17T14:21:07.162Z never 0.8 https://biotechmorning.com/news/failed-trial-ai-goldmine-verge-labs 2026-06-17T14:20:12.864Z never 0.8 https://biotechmorning.com/news/incyte-vega-therapeutics-von-willebrand-acquisition 2026-06-17T14:19:20.038Z never 0.8 https://biotechmorning.com/news/novo-nordisk-812m-deep-apple-non-incretin-obesity 2026-06-17T14:18:27.420Z never 0.8 https://biotechmorning.com/news/edgewise-hcm-drug-phase-2-data-competition 2026-06-17T14:17:30.781Z never 0.8 https://biotechmorning.com/news/colorado-fda-canada-drug-importation 2026-06-16T14:22:48.550Z never 0.8 https://biotechmorning.com/news/neumora-navacaprant-depression-phase-3-failure 2026-06-16T14:22:04.841Z never 0.8 https://biotechmorning.com/news/intellia-crispr-hae-one-shot-cure 2026-06-16T14:21:08.719Z never 0.8 https://biotechmorning.com/news/europe-clinical-trial-registry-transparency-problem 2026-06-16T14:20:13.701Z never 0.8 https://biotechmorning.com/news/spyre-spy002-phase-2-ulcerative-colitis-results 2026-06-16T14:19:17.582Z never 0.8 https://biotechmorning.com/news/adaptive-biotechnologies-splitting-diagnostics-drug-discovery 2026-06-16T14:18:24.118Z never 0.8 https://biotechmorning.com/news/medicare-subcutaneous-keytruda-opdivo-pricing-loophole 2026-06-16T14:17:28.995Z never 0.8 https://biotechmorning.com/news/chiesi-kalvista-oral-hae-treatment-acquisition 2026-06-16T14:16:36.696Z never 0.8 https://biotechmorning.com/news/ucb-candid-therapeutics-2-billion-acquisition-3 2026-06-16T14:15:37.432Z never 0.8 https://biotechmorning.com/news/lilly-jaypirca-cll-frontline-surprise 2026-06-15T14:28:16.646Z never 0.8 https://biotechmorning.com/news/merck-terns-pharmaceuticals-acquisition-6-7-billion 2026-06-15T14:27:24.299Z never 0.8 https://biotechmorning.com/news/allogene-off-the-shelf-car-t-breaks-wall-street 2026-06-15T14:26:30.116Z never 0.8 https://biotechmorning.com/news/pfizer-mrna-flu-vaccine-beats-standard-shot 2026-06-15T14:25:31.567Z never 0.8 https://biotechmorning.com/news/legend-biotech-in-vivo-car-t-proof-of-concept 2026-06-15T14:24:43.136Z never 0.8 https://biotechmorning.com/news/asundexian-fxia-stroke-prevention-phase-3 2026-06-15T14:23:43.269Z never 0.8 https://biotechmorning.com/news/revolution-medicines-pancreatic-cancer-survival-breakthrough 2026-06-15T14:22:51.410Z never 0.8 https://biotechmorning.com/news/biogen-apellis-acquisition-ophthalmology 2026-06-15T14:22:03.328Z never 0.8 https://biotechmorning.com/news/gilead-arcellx-7-8-billion-car-t-acquisition 2026-06-15T14:21:07.382Z never 0.8 https://biotechmorning.com/news/sun-pharma-organon-acquisition-indian-pharma 2026-06-15T14:20:11.317Z never 0.8 https://biotechmorning.com/news/jj-posdinemab-alzheimer-tau-failure 2026-06-15T14:19:12.168Z never 0.8 https://biotechmorning.com/news/illumina-shrinking-again-sequencing-industry-pressure 2026-06-14T14:22:32.317Z never 0.8 https://biotechmorning.com/news/jj-myeloma-talvey-darzalex-combo-eha-2026 2026-06-14T14:21:37.777Z never 0.8 https://biotechmorning.com/news/survodutide-visceral-liver-fat-obesity-drug 2026-06-14T14:20:42.160Z never 0.8 https://biotechmorning.com/news/obesity-drug-makes-surgery-look-like-warmup 2026-06-14T14:19:51.090Z never 0.8 https://biotechmorning.com/news/biotech-biggest-ipo-week-2026 2026-06-14T14:18:53.973Z never 0.8 https://biotechmorning.com/news/novartis-avidity-rna-muscular-dystrophy-data 2026-06-14T14:17:51.952Z never 0.8 https://biotechmorning.com/news/lilly-ajax-jak2-inhibitor-early-data 2026-06-14T14:16:59.485Z never 0.8 https://biotechmorning.com/news/prostate-cancer-pten-her2-moment-truqap 2026-06-14T14:16:09.991Z never 0.8 https://biotechmorning.com/news/incyte-genesis-ai-drug-discovery-expansion 2026-06-14T14:15:16.491Z never 0.8 https://biotechmorning.com/news/summit-therapeutics-500m-offering-canceled 2026-06-13T14:24:31.070Z never 0.8 https://biotechmorning.com/news/glp1-pregnancy-exposure-harvard-study 2026-06-13T14:23:42.764Z never 0.8 https://biotechmorning.com/news/whoop-fda-blood-pressure-fight 2026-06-13T14:22:53.242Z never 0.8 https://biotechmorning.com/news/amgen-tavneos-fda-withdrawal-duke-review 2026-06-13T14:21:59.544Z never 0.8 https://biotechmorning.com/news/wegovy-oral-pill-uk-mhra-approval 2026-06-13T14:21:09.459Z never 0.8 https://biotechmorning.com/news/cms-locks-in-medicare-drug-price-negotiations 2026-06-13T14:20:22.748Z never 0.8 https://biotechmorning.com/news/roche-nurix-btk-degrader-bexobrutideg-deal 2026-06-13T14:19:25.588Z never 0.8 https://biotechmorning.com/news/lilly-retatrutide-sleep-apnea-phase-3 2026-06-13T14:18:29.866Z never 0.8 https://biotechmorning.com/news/roche-enicepatide-obesity-weight-loss-trial 2026-06-13T14:17:41.467Z never 0.8 https://biotechmorning.com/news/fda-war-cheap-ozempic-knockoffs 2026-06-13T14:16:50.643Z never 0.8 https://biotechmorning.com/news/heartseed-catheter-ipsc-heart-failure-first-patient 2026-06-12T14:25:58.234Z never 0.8 https://biotechmorning.com/news/takeda-zasocitinib-beats-sotyktu-psoriasis-2 2026-06-12T14:25:01.341Z never 0.8 https://biotechmorning.com/news/novo-nordisk-cagrisema-loses-to-zepbound-2 2026-06-12T14:24:09.576Z never 0.8 https://biotechmorning.com/news/roche-tecentriq-colon-cancer-priority-review 2026-06-12T14:23:10.158Z never 0.8 https://biotechmorning.com/news/slate-medicines-130m-pacap-migraine-bet 2026-06-12T14:22:15.588Z never 0.8 https://biotechmorning.com/news/novo-nordisk-new-ceo-doustdar-comeback-plan 2026-06-12T14:21:18.846Z never 0.8 https://biotechmorning.com/news/ideaya-eye-cancer-combo-hits-endpoint 2026-06-12T14:20:17.970Z never 0.8 https://biotechmorning.com/news/fda-declared-war-on-cheap-ozempic 2026-06-12T14:19:25.334Z never 0.8 https://biotechmorning.com/news/genentech-fires-vishva-dixit-gred-restructuring 2026-06-12T14:18:32.235Z never 0.8 https://biotechmorning.com/news/caribou-biosciences-off-the-shelf-car-t-data 2026-06-11T14:25:02.844Z never 0.8 https://biotechmorning.com/news/ethyreal-bio-101m-tepezza-thyroid-eye-disease 2026-06-11T14:24:03.541Z never 0.8 https://biotechmorning.com/news/astrazeneca-oral-glp1-obesity-pill-phase-3 2026-06-11T14:23:08.168Z never 0.8 https://biotechmorning.com/news/parabilis-670m-record-biotech-ipo 2026-06-11T14:22:08.254Z never 0.8 https://biotechmorning.com/news/glp1-drugs-gut-microbe-depression 2026-06-11T14:21:13.503Z never 0.8 https://biotechmorning.com/news/enliven-therapeutics-cml-leukemia-data 2026-06-11T14:20:21.272Z never 0.8 https://biotechmorning.com/news/sonothera-125m-series-b-ultrasound-gene-therapy 2026-06-11T14:19:23.061Z never 0.8 https://biotechmorning.com/news/novo-nordisk-cagrisema-retatrutide-ada-2026 2026-06-11T14:18:27.130Z never 0.8 https://biotechmorning.com/news/sanofi-plan-b-lost-its-plan-b 2026-06-11T14:17:34.746Z never 0.8 https://biotechmorning.com/news/takeda-zasocitinib-beats-sotyktu-psoriasis 2026-06-11T14:16:37.869Z never 0.8 https://biotechmorning.com/news/glp1-drugs-cancer-risk-reduction-asco-2026 2026-06-10T14:27:45.218Z never 0.8 https://biotechmorning.com/news/gilead-trodelvy-nsclc-lung-cancer-failure 2026-06-10T14:26:54.780Z never 0.8 https://biotechmorning.com/news/daraxonrasib-ras-cancer-survival-breakthrough 2026-06-10T14:25:54.273Z never 0.8 https://biotechmorning.com/news/lilly-haisco-3-billion-china-deal 2026-06-10T14:25:03.649Z never 0.8 https://biotechmorning.com/news/fda-approves-bemotrizinol-first-new-sunscreen-ingredient-20-years 2026-06-10T14:24:06.633Z never 0.8 https://biotechmorning.com/news/japan-approves-telomelysin-cancer-killing-virus 2026-06-10T14:23:11.723Z never 0.8 https://biotechmorning.com/news/novartis-orionis-molecular-glue-deal 2026-06-10T14:22:20.234Z never 0.8 https://biotechmorning.com/news/fda-meeting-killed-fulcrum-therapeutics 2026-06-10T14:21:21.214Z never 0.8 https://biotechmorning.com/news/bepirovirsen-hepatitis-b-functional-cure-phase-3 2026-06-10T14:20:19.461Z never 0.8 https://biotechmorning.com/news/pentagon-blacklist-wuxi-apptec-biotech-supplier 2026-06-10T14:19:18.624Z never 0.8 https://biotechmorning.com/news/ivonescimab-beats-pd1-inhibitor-overall-survival-squamous-nsclc 2026-06-10T14:18:17.152Z never 0.8 https://biotechmorning.com/news/parabilis-medicines-ipo-800m-startup 2026-06-09T14:29:17.246Z never 0.8 https://biotechmorning.com/news/astrazeneca-oral-glp1-comeback 2026-06-09T14:28:28.867Z never 0.8 https://biotechmorning.com/news/jnj-billion-dollar-firefly-bio-dac-acquisition 2026-06-09T14:27:32.654Z never 0.8 https://biotechmorning.com/news/gsk-nuvalent-10-billion-oncology-acquisition 2026-06-09T14:26:41.471Z never 0.8 https://biotechmorning.com/news/hympavzi-fda-expansion-pediatric-hemophilia-inhibitors 2026-06-09T14:25:50.181Z never 0.8 https://biotechmorning.com/news/tango-therapeutics-pancreatic-cancer-breakthrough 2026-06-09T14:24:58.534Z never 0.8 https://biotechmorning.com/news/venglustat-brain-barrier-gaucher-type-3 2026-06-09T14:24:03.894Z never 0.8 https://biotechmorning.com/news/afrezza-inhaled-insulin-pediatric-approval 2026-06-09T14:23:12.570Z never 0.8 https://biotechmorning.com/news/hiv-pill-came-back-from-the-dead 2026-06-09T14:22:15.977Z never 0.8 https://biotechmorning.com/news/boehringer-survodutide-obesity-drug-ada-2026-competitive-concerns 2026-06-08T14:27:36.618Z never 0.8 https://biotechmorning.com/news/roche-nurix-btk-degrader-deal 2026-06-08T14:26:44.554Z never 0.8 https://biotechmorning.com/news/gsk-44-million-fibrosis-regression-engitix 2026-06-08T14:25:49.536Z never 0.8 https://biotechmorning.com/news/lilly-202m-engage-biologics-tethosome-no-drug 2026-06-08T14:24:58.643Z never 0.8 https://biotechmorning.com/news/car-t-liver-cancer-oricell-gpc3-hcc 2026-06-08T14:24:07.612Z never 0.8 https://biotechmorning.com/news/antag-therapeutics-gipr-antagonist-obesity 2026-06-08T14:23:09.996Z never 0.8 https://biotechmorning.com/news/incyte-2-billion-bet-von-willebrand-disease 2026-06-08T14:22:16.523Z never 0.8 https://biotechmorning.com/news/pfizer-berobenatide-monthly-obesity-shot-ada-2026 2026-06-07T14:21:23.648Z never 0.8 https://biotechmorning.com/news/sarepta-elevidys-black-box-warning-layoffs 2026-06-07T14:20:25.260Z never 0.8 https://biotechmorning.com/news/novo-nordisk-cagrisema-loses-to-zepbound 2026-06-07T14:19:32.625Z never 0.8 https://biotechmorning.com/news/gsk-elsie-biotechnologies-oligonucleotide-acquisition 2026-06-07T14:18:43.884Z never 0.8 https://biotechmorning.com/news/abivax-obefazimod-uc-efficacy-cancer-problem 2026-06-07T14:17:48.032Z never 0.8 https://biotechmorning.com/news/petrelintide-obesity-drug-tolerability-ada-2026 2026-06-07T14:16:57.385Z never 0.8 https://biotechmorning.com/news/fda-gene-therapy-prior-knowledge-guidance 2026-06-07T14:16:03.546Z never 0.8 https://biotechmorning.com/news/zepbound-cheaper-single-dose-vials 2026-06-07T14:15:13.599Z never 0.8 https://biotechmorning.com/news/lilly-retatrutide-triple-agonist-ada-2026 2026-06-07T14:14:17.148Z never 0.8 https://biotechmorning.com/news/uk-quarter-billion-life-sciences-site 2026-06-07T14:13:26.644Z never 0.8 https://biotechmorning.com/news/earendil-787m-multipolar-biotech-financing 2026-06-06T14:23:35.398Z never 0.8 https://biotechmorning.com/news/cancer-weapon-switched-sides-tce-autoimmune 2026-06-06T14:22:42.202Z never 0.8 https://biotechmorning.com/news/first-protac-protein-degrader-fda-approval-vepdegestrant 2026-06-06T14:21:50.645Z never 0.8 https://biotechmorning.com/news/roche-blackmail-us-drug-pricing 2026-06-06T14:20:58.360Z never 0.8 https://biotechmorning.com/news/takeda-amitiza-antitrust-verdict-loss 2026-06-06T14:20:06.729Z never 0.8 https://biotechmorning.com/news/4-dollar-semaglutide-india-alkem 2026-06-06T14:19:20.299Z never 0.8 https://biotechmorning.com/news/fda-mifepristone-safety-restudy-political-pressure 2026-06-06T14:18:30.973Z never 0.8 https://biotechmorning.com/news/fda-gene-therapy-platform-knowledge-sharing 2026-06-06T14:17:32.214Z never 0.8 https://biotechmorning.com/news/first-chinese-anesthetic-fda-approval-cipepofol 2026-06-06T14:16:43.286Z never 0.8 https://biotechmorning.com/news/moderna-merck-melanoma-vaccine-wont-stop-working 2026-06-06T14:15:51.097Z never 0.8 https://biotechmorning.com/news/axsome-sunosi-patent-settlement-2040-generic-block 2026-06-05T14:23:09.609Z never 0.8 https://biotechmorning.com/news/adc-drug-class-zynlonta-safety-deaths-reality-check 2026-06-05T14:22:15.714Z never 0.8 https://biotechmorning.com/news/supreme-court-skinny-label-ruling-hikma-generic-win 2026-06-05T14:21:22.320Z never 0.8 https://biotechmorning.com/news/ra-capital-china-clinical-expertise-in-a-box 2026-06-05T14:20:29.449Z never 0.8 https://biotechmorning.com/news/rallybio-avenzo-reverse-merger-oncology 2026-06-05T14:19:36.500Z never 0.8 https://biotechmorning.com/news/autobahn-thyroid-bipolar-depression-phase-2 2026-06-05T14:18:41.431Z never 0.8 https://biotechmorning.com/news/parabilis-medicines-ipo-filing-2026 2026-06-05T14:17:46.324Z never 0.8 https://biotechmorning.com/news/binsa-bill-biotech-investment-china-restrictions 2026-06-05T14:16:56.256Z never 0.8 https://biotechmorning.com/news/fda-real-time-clinical-trials-initiative 2026-06-05T14:16:06.195Z never 0.8 https://biotechmorning.com/news/asco-2026-china-biotech-coming-of-age 2026-06-04T14:17:28.282Z never 0.8 https://biotechmorning.com/news/regeneron-doubles-cytomx-probody-bet 2026-06-04T14:16:57.147Z never 0.8 https://biotechmorning.com/news/alnylam-inceptive-ai-rnai-deal 2026-06-04T14:16:01.080Z never 0.8 https://biotechmorning.com/news/autoimmune-car-t-durability-cabaletta-bio 2026-06-04T14:15:06.539Z never 0.8 https://biotechmorning.com/news/innovent-cldn18-2-adc-phase-3-win-takeda 2026-06-04T14:14:13.791Z never 0.8 https://biotechmorning.com/news/germany-loses-pharma-investment-healthcare-reform 2026-06-04T14:13:17.645Z never 0.8 https://biotechmorning.com/news/odyssey-therapeutics-304m-ipo-tpg-placement 2026-06-03T14:21:59.643Z never 0.8 https://biotechmorning.com/news/travere-billion-dollar-btk-inhibitor-deal 2026-06-03T14:21:08.956Z never 0.8 https://biotechmorning.com/news/bms-bispecific-adc-asco-trop2-threat 2026-06-03T14:20:15.237Z never 0.8 https://biotechmorning.com/news/lilly-ascidian-rna-exon-editing-kidney-disease-deal 2026-06-03T14:19:24.034Z never 0.8 https://biotechmorning.com/news/celcuity-10-billion-vision-one-drug 2026-06-03T14:18:25.360Z never 0.8 https://biotechmorning.com/news/cytokinetics-acacia-hcm-non-obstructive-readout 2026-06-03T14:17:31.985Z never 0.8 https://biotechmorning.com/news/newlimit-435m-cellular-rejuvenation-funding 2026-06-03T14:16:41.375Z never 0.8 https://biotechmorning.com/news/roche-giredestrant-first-line-breast-cancer-miss 2026-06-03T14:15:51.270Z never 0.8 https://biotechmorning.com/news/intellia-crispr-phase-3-hae-results 2026-06-03T14:14:55.447Z never 0.8 https://biotechmorning.com/news/legend-biotech-in-vivo-car-t-data 2026-06-03T14:14:00.460Z never 0.8 https://biotechmorning.com/news/telix-pluvicto-challenger-prostate-cancer 2026-06-02T14:23:11.191Z never 0.8 https://biotechmorning.com/news/servier-edgewise-muscular-dystrophy-pill-deal 2026-06-02T14:22:20.147Z never 0.8 https://biotechmorning.com/news/gsk-velzatinib-challenge-gleevec-gist 2026-06-02T14:21:31.442Z never 0.8 https://biotechmorning.com/news/abivax-efficacy-cancer-safety-stock-drop 2026-06-02T14:20:34.242Z never 0.8 https://biotechmorning.com/news/fda-kills-fulcrum-sickle-cell-drug 2026-06-02T14:19:39.105Z never 0.8 https://biotechmorning.com/news/ucb-candid-therapeutics-2-billion-acquisition-2 2026-06-02T14:18:46.841Z never 0.8 https://biotechmorning.com/news/daraxonrasib-doubles-pancreatic-cancer-survival 2026-06-01T14:21:57.595Z never 0.8 https://biotechmorning.com/news/ivonescimab-lung-cancer-os-data-asco-2026 2026-06-01T14:21:05.790Z never 0.8 https://biotechmorning.com/news/lilly-glp2-hanmi-short-bowel-syndrome-deal 2026-06-01T14:20:10.538Z never 0.8 https://biotechmorning.com/news/biontech-torched-pandemic-empire 2026-06-01T14:19:17.438Z never 0.8 https://biotechmorning.com/news/lilly-3-billion-haisco-china-deal 2026-06-01T14:18:21.828Z never 0.8 https://biotechmorning.com/news/merck-sac-tmt-endometrial-cancer-phase-3-win 2026-06-01T14:17:27.831Z never 0.8 https://biotechmorning.com/news/asco-2026-day-one-bms-pfizer 2026-06-01T14:16:36.207Z never 0.8 https://biotechmorning.com/news/pharma-billion-dollar-ai-drug-discovery-bet 2026-05-31T14:23:40.679Z never 0.8 https://biotechmorning.com/news/aacr-2026-lung-cancer-three-horse-race 2026-05-31T14:22:40.492Z never 0.8 https://biotechmorning.com/news/biontech-bms-pfizer-bispecific-nsclc-endpoint-split 2026-05-31T14:21:45.442Z never 0.8 https://biotechmorning.com/news/lilly-kelonia-in-vivo-car-t-asco-2026 2026-05-31T14:20:49.733Z never 0.8 https://biotechmorning.com/news/biotech-confidence-soaring-workforce-different-story 2026-05-31T14:19:54.157Z never 0.8 https://biotechmorning.com/news/biotech-funding-extensions-avoid-down-rounds 2026-05-31T14:18:56.340Z never 0.8 https://biotechmorning.com/news/fda-rare-disease-biotech-uncertainty 2026-05-31T14:18:05.207Z never 0.8 https://biotechmorning.com/news/first-pill-stops-covid-before-it-starts 2026-05-31T14:17:07.200Z never 0.8 https://biotechmorning.com/news/gilead-tubulis-asco-2026-ovarian-cancer-adc-data 2026-05-31T14:16:16.082Z never 0.8 https://biotechmorning.com/news/car-t-pioneer-wondercel-gene-editing-free 2026-05-30T14:19:08.873Z never 0.8 https://biotechmorning.com/news/biotech-ipo-window-hemab-seaport-556-million 2026-05-30T14:18:15.494Z never 0.8 https://biotechmorning.com/news/bms-hengrui-15-billion-deal-preclinical 2026-05-30T14:17:21.685Z never 0.8 https://biotechmorning.com/news/astrazeneca-approval-bid-after-phase-3-miss 2026-05-30T14:16:23.633Z never 0.8 https://biotechmorning.com/news/agios-tebapivat-phase-2-mds-failure 2026-05-30T14:15:32.047Z never 0.8 https://biotechmorning.com/news/zaynich-antibiotic-outgunned-last-line-of-defense 2026-05-30T14:14:40.902Z never 0.8 https://biotechmorning.com/news/bms-celmods-double-pfs-myeloma-asco-2026 2026-05-30T14:13:54.224Z never 0.8 https://biotechmorning.com/news/lilly-nectin-4-adc-padcev-challenger-asco-2026 2026-05-29T14:23:47.543Z never 0.8 https://biotechmorning.com/news/congress-coins-act-biotech-china-restrictions 2026-05-29T14:23:00.351Z never 0.8 https://biotechmorning.com/news/pancreatic-cancer-kras-inhibitor-daraxonrasib-survival-breakthrough 2026-05-29T14:22:07.302Z never 0.8 https://biotechmorning.com/news/pfizer-10-billion-innovent-biologics-deal 2026-05-29T14:21:17.287Z never 0.8 https://biotechmorning.com/news/dizal-egfr-lung-cancer-rival-from-shanghai 2026-05-29T14:20:25.549Z never 0.8 https://biotechmorning.com/news/icon-plc-revenue-overstatement-cro-trust 2026-05-29T14:19:37.217Z never 0.8 https://biotechmorning.com/news/gilead-mirobio-405-million-drug-scrapped 2026-05-29T14:18:47.459Z never 0.8 https://biotechmorning.com/news/big-pharma-292-billion-us-manufacturing-bet 2026-05-29T14:17:54.042Z never 0.8 https://biotechmorning.com/news/lantheus-curium-7-billion-radiopharmaceutical-deal 2026-05-29T14:16:58.659Z never 0.8 https://biotechmorning.com/news/bms-celmod-mezigdomide-phase-3-pfs-asco-2026 2026-05-29T14:16:01.980Z never 0.8 https://biotechmorning.com/news/kordata-ai-platform-cns-clinical-trials 2026-05-28T14:18:22.477Z never 0.8 https://biotechmorning.com/news/fda-one-day-inspection-pilot-ai-risk-analytics 2026-05-28T14:17:29.502Z never 0.8 https://biotechmorning.com/news/covid-vaccines-annual-strain-selection-2026-2027 2026-05-28T14:16:38.325Z never 0.8 https://biotechmorning.com/news/dd-pharmatech-mash-glp1-fibrosis-data 2026-05-28T14:15:48.188Z never 0.8 https://biotechmorning.com/news/gsk-hepatitis-b-functional-cure-bepirovirsen 2026-05-28T14:14:56.627Z never 0.8 https://biotechmorning.com/news/fda-approves-decnupaz-bpdcn-rare-blood-cancer 2026-05-28T14:14:00.115Z never 0.8 https://biotechmorning.com/news/astrazeneca-camizestrant-fda-delay-negative-adcomm-vote 2026-05-27T14:21:04.955Z never 0.8 https://biotechmorning.com/news/apogee-1-3-billion-royalty-deal-no-dilution 2026-05-27T14:20:12.326Z never 0.8 https://biotechmorning.com/news/fda-ipledge-rems-isotretinoin-overhaul 2026-05-27T14:19:20.387Z never 0.8 https://biotechmorning.com/news/olympus-bioprotect-270m-oncology-acquisition 2026-05-27T14:18:25.514Z never 0.8 https://biotechmorning.com/news/kardigan-myokardia-team-cardiovascular-ipo-2026 2026-05-27T14:17:31.067Z never 0.8 https://biotechmorning.com/news/coins-act-china-biotech-licensing-boom 2026-05-27T14:16:37.952Z never 0.8 https://biotechmorning.com/news/kura-oncology-kras-companion-drug 2026-05-27T14:15:47.769Z never 0.8 https://biotechmorning.com/news/brain-surgery-supply-chain-sponge-shortage 2026-05-26T14:21:54.436Z never 0.8 https://biotechmorning.com/news/zepbound-quiet-price-war-just-got-louder 2026-05-26T14:21:06.706Z never 0.8 https://biotechmorning.com/news/cellcentric-220m-series-d-european-biotech 2026-05-26T14:20:10.193Z never 0.8 https://biotechmorning.com/news/eli-lilly-three-vaccine-acquisitions 2026-05-26T14:19:20.755Z never 0.8 https://biotechmorning.com/news/fda-one-day-ai-inspections-pilot 2026-05-26T14:18:27.731Z never 0.8 https://biotechmorning.com/news/fda-ai-clinical-trial-pilot-rfi 2026-05-26T14:17:34.923Z never 0.8 https://biotechmorning.com/news/astellas-patent-cliff-ma-strategy 2026-05-26T14:16:44.799Z never 0.8 https://biotechmorning.com/news/fda-real-time-clinical-trials-astrazeneca-amgen 2026-05-26T14:15:48.178Z never 0.8 https://biotechmorning.com/news/first-protac-drug-fda-approval-vepdegestrant 2026-05-25T14:17:59.360Z never 0.8 https://biotechmorning.com/news/merck-6-7-billion-terns-pharmaceuticals-acquisition 2026-05-25T14:17:08.101Z never 0.8 https://biotechmorning.com/news/sun-pharma-organon-acquisition-biggest-indian-pharma-deal 2026-05-25T14:16:19.794Z never 0.8 https://biotechmorning.com/news/chiesi-kalvista-1-9-billion-rare-disease-deal 2026-05-25T14:15:21.784Z never 0.8 https://biotechmorning.com/news/roche-pathai-acquisition-ai-pathology 2026-05-25T14:14:30.595Z never 0.8 https://biotechmorning.com/news/one-shot-kill-cholesterol-forever 2026-05-25T14:13:38.136Z never 0.8 https://biotechmorning.com/news/gilead-acquires-ouro-medicines-2-billion 2026-05-25T14:12:45.363Z never 0.8 https://biotechmorning.com/news/lilly-kelonia-in-vivo-car-t-acquisition 2026-05-25T14:11:53.099Z never 0.8 https://biotechmorning.com/news/mentari-therapeutics-reverse-merger-migraine-pacap 2026-05-24T14:15:28.985Z never 0.8 https://biotechmorning.com/news/fda-streamlined-gene-therapy-rare-disease-pathway 2026-05-24T14:14:36.860Z never 0.8 https://biotechmorning.com/news/lilly-engage-bio-non-viral-gene-therapy 2026-05-24T14:13:34.474Z never 0.8 https://biotechmorning.com/news/regeneron-telix-radiopharmaceutical-deal-3 2026-05-24T14:12:40.148Z never 0.8 https://biotechmorning.com/news/fda-prv-authority-confusion 2026-05-24T14:11:45.494Z never 0.8 https://biotechmorning.com/news/novartis-t-charge-vs-in-vivo-car-t 2026-05-23T14:18:55.891Z never 0.8 https://biotechmorning.com/news/ema-approves-oral-wegovy-astrazeneca-etcamah 2026-05-23T14:18:01.291Z never 0.8 https://biotechmorning.com/news/sonrotoclax-fda-approval-mantle-cell-lymphoma 2026-05-23T14:17:08.683Z never 0.8 https://biotechmorning.com/news/baxfendy-baxdrostat-fda-approval-hypertension 2026-05-23T14:16:16.606Z never 0.8 https://biotechmorning.com/news/fda-brain-drain-biotech-talent-gold-rush 2026-05-23T14:15:26.805Z never 0.8 https://biotechmorning.com/news/abbvie-novartis-layoffs-restructuring-2026 2026-05-23T14:14:32.816Z never 0.8 https://biotechmorning.com/news/290m-says-migraine-drugs-not-good-enough 2026-05-23T14:13:42.016Z never 0.8 https://biotechmorning.com/news/ose-cancer-vaccine-ovarian-cancer-phase-2 2026-05-23T14:12:46.198Z never 0.8 https://biotechmorning.com/news/afrezza-needle-free-insulin-kids-fda-decision 2026-05-23T14:11:53.055Z never 0.8 https://biotechmorning.com/news/leqembi-subcutaneous-fda-delay-2 2026-05-22T14:24:51.879Z never 0.8 https://biotechmorning.com/news/merck-kelun-adc-keytruda-combo-asco-2026 2026-05-22T14:23:57.822Z never 0.8 https://biotechmorning.com/news/lilly-retatrutide-triple-agonist-weight-loss-phase-3 2026-05-22T14:23:05.219Z never 0.8 https://biotechmorning.com/news/prediction-markets-biotech-clinical-trials 2026-05-22T14:22:10.109Z never 0.8 https://biotechmorning.com/news/liminatus-innocsai-ai-car-t-acquisition 2026-05-22T14:21:15.596Z never 0.8 https://biotechmorning.com/news/lilly-engage-biologics-dna-delivery-acquisition 2026-05-22T14:20:22.533Z never 0.8 https://biotechmorning.com/news/blood-test-schizophrenia-bipolar-mRNA 2026-05-22T14:19:27.063Z never 0.8 https://biotechmorning.com/news/biogen-denali-parkinsons-lrrk2-failure 2026-05-22T14:18:29.928Z never 0.8 https://biotechmorning.com/news/isomorphic-labs-2-billion-series-b-ai-drug-discovery 2026-05-22T14:17:32.975Z never 0.8 https://biotechmorning.com/news/tennor-therapeutics-hong-kong-ipo-anti-infective 2026-05-22T14:16:46.903Z never 0.8 https://biotechmorning.com/news/novartis-profitable-firing-scientists 2026-05-21T14:24:07.730Z never 0.8 https://biotechmorning.com/news/pharma-290-billion-us-manufacturing-bet 2026-05-21T14:23:16.976Z never 0.8 https://biotechmorning.com/news/egenesis-pig-kidney-271-days 2026-05-21T14:22:21.469Z never 0.8 https://biotechmorning.com/news/personalized-mrna-cancer-vaccine-melanoma-phase-3 2026-05-21T14:21:20.842Z never 0.8 https://biotechmorning.com/news/faeth-therapeutics-piktor-starve-cancer-metabolic-therapy 2026-05-21T14:20:27.594Z never 0.8 https://biotechmorning.com/news/algorithm-shopping-cancer-drug-pathos-ai-deuteroncology 2026-05-21T14:19:34.017Z never 0.8 https://biotechmorning.com/news/bms-anthropic-claude-enterprise-ai-deployment 2026-05-21T14:18:37.637Z never 0.8 https://biotechmorning.com/news/esperion-archimed-take-private-billion-dollar-deal 2026-05-21T14:17:44.153Z never 0.8 https://biotechmorning.com/news/ucb-candid-therapeutics-2-billion-acquisition 2026-05-21T14:16:50.500Z never 0.8 https://biotechmorning.com/news/pfizer-pf-08634404-bispecific-keytruda-challenger 2026-05-21T14:15:55.665Z never 0.8 https://biotechmorning.com/news/ai-scaling-not-solving-clinical-trial-flaws 2026-05-20T14:29:20.389Z never 0.8 https://biotechmorning.com/news/parabilis-ipo-regeneron-adc-deal 2026-05-20T14:28:31.663Z never 0.8 https://biotechmorning.com/news/takeda-885m-pay-for-delay-verdict-pharma-risk 2026-05-20T14:27:39.707Z never 0.8 https://biotechmorning.com/news/pharma-loses-supreme-court-ira-drug-pricing 2026-05-20T14:26:41.976Z never 0.8 https://biotechmorning.com/news/biontech-mRNA-cancer-vaccine-melanoma-results 2026-05-20T14:25:47.581Z never 0.8 https://biotechmorning.com/news/immunovant-39-million-batoclimab-discontinuation 2026-05-20T14:24:56.769Z never 0.8 https://biotechmorning.com/news/first-protac-drug-nobody-wanted-to-sell 2026-05-20T14:24:05.479Z never 0.8 https://biotechmorning.com/news/one-blood-draw-fifty-cancers-cancerguard 2026-05-20T14:23:15.179Z never 0.8 https://biotechmorning.com/news/bimzelx-beats-skyrizi-psoriatic-arthritis 2026-05-20T14:22:20.146Z never 0.8 https://biotechmorning.com/news/pig-kidney-271-days-xenotransplantation-egenesis 2026-05-20T14:21:25.897Z never 0.8 https://biotechmorning.com/news/merck-keytruda-exelixis-combination-trial 2026-05-19T14:21:46.097Z never 0.8 https://biotechmorning.com/news/pi3k-inhibitor-relay-therapeutics-rare-disease-comeback 2026-05-19T14:20:55.952Z never 0.8 https://biotechmorning.com/news/biotech-civil-war-china-137-billion 2026-05-19T14:20:06.134Z never 0.8 https://biotechmorning.com/news/quince-therapeutics-reverse-merger-orphai 2026-05-19T14:19:11.908Z never 0.8 https://biotechmorning.com/news/china-homegrown-obesity-pill-vincentage-eli-lilly 2026-05-19T14:18:18.423Z never 0.8 https://biotechmorning.com/news/sanofi-wave-alpha-1-antitrypsin-race 2026-05-19T14:17:30.053Z never 0.8 https://biotechmorning.com/news/fda-biosimilar-guidance-streamlines-development 2026-05-18T14:22:42.909Z never 0.8 https://biotechmorning.com/news/moderna-flu-vaccine-fda-reversal 2026-05-18T14:21:46.460Z never 0.8 https://biotechmorning.com/news/regeneron-fianlimab-melanoma-phase-3-failure 2026-05-18T14:20:53.041Z never 0.8 https://biotechmorning.com/news/lilly-insilico-ai-drug-discovery-deal-2 2026-05-18T14:20:00.053Z never 0.8 https://biotechmorning.com/news/epicrispr-epi-321-fshd-epigenetic-crispr-trial 2026-05-18T14:19:10.920Z never 0.8 https://biotechmorning.com/news/seaport-therapeutics-255m-ipo-cns-bet 2026-05-18T14:18:13.507Z never 0.8 https://biotechmorning.com/news/ai-designed-drug-rentosertib-ipf-phase-2a-results 2026-05-18T14:17:15.776Z never 0.8 https://biotechmorning.com/news/bayer-perfuse-therapeutics-ophthalmology-deal 2026-05-18T14:16:29.389Z never 0.8 https://biotechmorning.com/news/angelini-pharma-catalyst-pharmaceuticals-acquisition 2026-05-18T14:15:35.977Z never 0.8 https://biotechmorning.com/news/regeneron-parabilis-adc-deal 2026-05-18T14:14:46.969Z never 0.8 https://biotechmorning.com/news/abbvie-haisco-pain-deal-china 2026-05-17T14:22:31.019Z never 0.8 https://biotechmorning.com/news/trump-100-percent-tariffs-pharmaceutical-drugs-abroad 2026-05-17T14:21:40.038Z never 0.8 https://biotechmorning.com/news/regeneron-telix-radiopharmaceutical-deal-2 2026-05-17T14:20:34.785Z never 0.8 https://biotechmorning.com/news/roche-tariff-shield-giant-hole 2026-05-17T14:19:41.201Z never 0.8 https://biotechmorning.com/news/biotech-rallies-behind-pazdur-fda-commissioner 2026-05-17T14:18:47.732Z never 0.8 https://biotechmorning.com/news/hemab-therapeutics-coag-ipo-301-million-rare-bleeding 2026-05-17T14:17:53.954Z never 0.8 https://biotechmorning.com/news/takeda-4500-layoffs-three-drug-bet 2026-05-17T14:16:55.532Z never 0.8 https://biotechmorning.com/news/pfizer-china-glp1-obesity-approval 2026-05-17T14:15:58.939Z never 0.8 https://biotechmorning.com/news/white-house-psychedelic-therapies-federal-priority-2026 2026-05-17T14:15:07.706Z never 0.8 https://biotechmorning.com/news/fda-lilly-foundayo-15-year-monitoring 2026-05-17T14:14:10.277Z never 0.8 https://biotechmorning.com/news/merck-gardasil-factory-shutdown-durham 2026-05-15T14:26:26.625Z never 0.8 https://biotechmorning.com/news/revolution-medicines-pancreatic-cancer-asco-2026 2026-05-15T14:25:38.035Z never 0.8 https://biotechmorning.com/news/fda-new-boss-never-approved-drug 2026-05-15T14:24:41.769Z never 0.8 https://biotechmorning.com/news/100-percent-tariff-branded-drugs-domestic-manufacturing 2026-05-15T14:23:51.991Z never 0.8 https://biotechmorning.com/news/ac-immune-ceo-departure-alzheimer-pipeline 2026-05-15T14:22:58.520Z never 0.8 https://biotechmorning.com/news/aardvark-fda-hold-prader-willi-phase-3 2026-05-15T14:22:00.076Z never 0.8 https://biotechmorning.com/news/create-medicines-122m-in-vivo-car-t 2026-05-15T14:21:10.238Z never 0.8 https://biotechmorning.com/news/regenxbio-dmd-gene-therapy-beats-elevidys 2026-05-15T14:20:17.588Z never 0.8 https://biotechmorning.com/news/servier-acquires-day-one-biopharmaceuticals-pediatric-oncology 2026-05-15T14:19:21.895Z never 0.8 https://biotechmorning.com/news/gene-therapy-tumor-aav-safety-alarm 2026-05-15T14:18:25.782Z never 0.8 https://biotechmorning.com/news/icon-san-antonio-clinical-research-unit-expansion 2026-05-14T14:16:07.658Z never 0.8 https://biotechmorning.com/news/lexicon-ceo-200m-pipeline-expansion 2026-05-14T14:15:17.721Z never 0.8 https://biotechmorning.com/news/beqalzi-sonrotoclax-fda-approval-mantle-cell-lymphoma 2026-05-14T14:14:25.502Z never 0.8 https://biotechmorning.com/news/fosun-60m-aribio-alzheimers-option-deal 2026-05-14T14:13:36.142Z never 0.8 https://biotechmorning.com/news/takeda-nausea-vomiting-0-for-4 2026-05-14T14:12:42.366Z never 0.8 https://biotechmorning.com/news/assertio-bidding-war-sweetened-acquisition 2026-05-14T14:11:54.478Z never 0.8 https://biotechmorning.com/news/biogen-alzheimers-tau-drug-phase-3-despite-miss 2026-05-14T14:11:05.235Z never 0.8 https://biotechmorning.com/news/us-biotechs-moving-trials-overseas-fda-upheaval 2026-05-14T14:10:11.315Z never 0.8 https://biotechmorning.com/news/valneva-layoffs-travel-vaccine-market-weakens 2026-05-13T14:15:59.470Z never 0.8 https://biotechmorning.com/news/boehringer-immunitas-407m-inflammation-deal 2026-05-13T14:15:17.086Z never 0.8 https://biotechmorning.com/news/isomorphic-labs-2-1-billion-series-b 2026-05-13T14:14:26.978Z never 0.8 https://biotechmorning.com/news/pfizer-hympavzi-eu-approval-hemophilia-inhibitors 2026-05-13T14:13:46.316Z never 0.8 https://biotechmorning.com/news/mbx-4291-once-monthly-obesity-shot 2026-05-13T14:13:03.789Z never 0.8 https://biotechmorning.com/news/lilly-299-bet-obesity-drug-price-war 2026-05-13T14:12:20.072Z never 0.8 https://biotechmorning.com/news/car-t-autoimmune-first-fda-submission 2026-05-13T14:11:31.881Z never 0.8 https://biotechmorning.com/news/china-biopharma-out-licensing-explosion 2026-05-13T14:10:46.328Z never 0.8 https://biotechmorning.com/news/us-biotechs-moving-trials-abroad-fda-upheaval 2026-05-13T14:09:55.972Z never 0.8 https://biotechmorning.com/news/bms-hengrui-15-billion-china-pharma-deal 2026-05-12T14:11:21.013Z never 0.8 https://biotechmorning.com/news/first-protac-drug-destroys-cancer-protein-fda-approval 2026-05-12T14:10:36.729Z never 0.8 https://biotechmorning.com/news/enterprise-therapeutics-enac-blocker-cf-breakthrough 2026-05-12T14:09:55.719Z never 0.8 https://biotechmorning.com/news/pfizer-deal-european-pharma-stocks-surge 2026-05-12T14:09:18.622Z never 0.8 https://biotechmorning.com/news/parkinsons-therapy-came-back-from-dead 2026-05-12T14:08:41.546Z never 0.8 https://biotechmorning.com/news/astellas-xlmtm-gene-therapy-second-chance 2026-05-11T14:11:06.268Z never 0.8 https://biotechmorning.com/news/fda-commissioner-makary-ouster-biotech-impact 2026-05-11T14:10:22.903Z never 0.8 https://biotechmorning.com/news/cellcentric-220m-series-d-oral-myeloma-drug 2026-05-11T14:09:33.153Z never 0.8 https://biotechmorning.com/news/amgen-quantinuum-quantum-computing-ipo 2026-05-11T14:08:45.472Z never 0.8 https://biotechmorning.com/news/vyvgart-first-treatment-all-myasthenia-gravis-serotypes 2026-05-11T14:07:58.292Z never 0.8 https://biotechmorning.com/news/banyan-bioinnovations-100m-launch-icon-partnership 2026-05-10T14:06:13.214Z never 0.8 https://biotechmorning.com/news/biotech-556m-double-ipo-hemab-seaport 2026-05-09T14:12:41.617Z never 0.8 https://biotechmorning.com/news/roche-pathai-billion-dollar-ai-pathology-deal 2026-05-09T14:11:59.477Z never 0.8 https://biotechmorning.com/news/leqembi-subcutaneous-fda-delay 2026-05-09T14:11:20.103Z never 0.8 https://biotechmorning.com/news/engene-80-percent-crash-bladder-cancer 2026-05-09T14:10:40.568Z never 0.8 https://biotechmorning.com/news/liver-gene-therapy-alzheimers-amyloid 2026-05-09T14:09:54.547Z never 0.8 https://biotechmorning.com/news/fda-loses-third-commissioner-three-years 2026-05-09T14:09:17.007Z never 0.8 https://biotechmorning.com/news/roche-pathai-acquisition-billion-dollar-ai-pathology 2026-05-08T14:14:05.678Z never 0.8 https://biotechmorning.com/news/blackstone-250m-anagram-cystic-fibrosis 2026-05-08T14:13:24.639Z never 0.8 https://biotechmorning.com/news/ascendis-kills-promising-il2-cancer-drug 2026-05-08T14:12:41.230Z never 0.8 https://biotechmorning.com/news/odyssey-therapeutics-ipo-comeback 2026-05-08T14:12:00.760Z never 0.8 https://biotechmorning.com/news/angelini-acquires-catalyst-pharmaceuticals 2026-05-08T14:11:23.482Z never 0.8 https://biotechmorning.com/news/five-biotech-buyouts-one-week-ma-frenzy 2026-05-08T14:10:39.041Z never 0.8 https://biotechmorning.com/news/ipsen-albireo-liver-disease-candidates-terminated 2026-05-07T14:14:17.391Z never 0.8 https://biotechmorning.com/news/sanofi-fda-voucher-program-withdrawal 2026-05-07T14:13:38.958Z never 0.8 https://biotechmorning.com/news/one-bad-day-killed-this-70m-biotech 2026-05-07T14:13:02.965Z never 0.8 https://biotechmorning.com/news/avalo-phase-2-hs-results-abbvie-competition 2026-05-07T14:12:24.068Z never 0.8 https://biotechmorning.com/news/fda-blinked-rare-cancer-drug-reversal 2026-05-07T14:11:39.587Z never 0.8 https://biotechmorning.com/news/ucb-acquires-candid-therapeutics-2-billion-2 2026-05-07T14:11:00.411Z never 0.8 https://biotechmorning.com/news/fda-real-time-clinical-trial-data-pilot 2026-05-07T14:10:17.199Z never 0.8 https://biotechmorning.com/news/primate-act-ban-monkey-imports-drug-development 2026-05-07T14:09:42.474Z never 0.8 https://biotechmorning.com/news/cytospire-83m-gamma-delta-t-cell-engager 2026-05-07T14:09:01.492Z never 0.8 https://biotechmorning.com/news/china-supply-chain-regulations-biopharma-threat 2026-05-06T14:16:46.050Z never 0.8 https://biotechmorning.com/news/bayer-perfuse-acquisition-ophthalmology-implant 2026-05-06T14:16:06.748Z never 0.8 https://biotechmorning.com/news/cellcentric-220m-epigenetics-multiple-myeloma 2026-05-06T14:15:20.346Z never 0.8 https://biotechmorning.com/news/novo-nordisk-cagrisema-device-decision 2026-05-06T14:14:36.934Z never 0.8 https://biotechmorning.com/news/biontech-restructuring-1860-jobs-oncology-pivot 2026-05-06T14:13:58.109Z never 0.8 https://biotechmorning.com/news/gsk-siranbio-obesity-oligonucleotide-deal 2026-05-06T14:13:15.472Z never 0.8 https://biotechmorning.com/news/madrigal-billion-dollar-bet-silencing-genes 2026-05-06T14:12:31.435Z never 0.8 https://biotechmorning.com/news/fda-real-time-clinical-trial-data-sharing-pilot 2026-05-06T14:11:51.176Z never 0.8 https://biotechmorning.com/news/latus-bio-97m-low-dose-gene-therapy-huntingtons 2026-05-05T14:13:00.603Z never 0.8 https://biotechmorning.com/news/cytokinetics-aficamten-data-challenges-camzyos 2026-05-05T14:12:18.628Z never 0.8 https://biotechmorning.com/news/amgen-tepezza-monopoly-viridian-phase-3-win 2026-05-05T14:11:38.032Z never 0.8 https://biotechmorning.com/news/passage-bio-layoffs-fda-gene-therapy 2026-05-05T14:10:59.944Z never 0.8 https://biotechmorning.com/news/biotech-avengers-abia-trade-group-launch 2026-05-05T14:10:14.410Z never 0.8 https://biotechmorning.com/news/odyssey-therapeutics-ipo-filing-2026 2026-05-05T14:09:33.575Z never 0.8 https://biotechmorning.com/news/celcuity-gedatolisib-breast-cancer-pik3ca-mutant-wild-type 2026-05-05T14:08:50.560Z never 0.8 https://biotechmorning.com/news/trump-administration-psychedelics-fda-vouchers 2026-05-04T14:07:15.519Z never 0.8 https://biotechmorning.com/news/intellia-one-shot-crispr-gene-editing-hae 2026-05-04T14:06:36.003Z never 0.8 https://biotechmorning.com/news/ucb-acquires-candid-therapeutics-2-billion 2026-05-04T14:05:53.213Z never 0.8 https://biotechmorning.com/news/celcuity-gedatolisib-beats-novartis-piqray-breast-cancer 2026-05-04T14:05:12.040Z never 0.8 https://biotechmorning.com/news/esperion-goes-private-archimed-deal 2026-05-03T14:07:20.953Z never 0.8 https://biotechmorning.com/news/gilead-walks-away-arcus-oncology-alliance 2026-05-03T14:06:46.063Z never 0.8 https://biotechmorning.com/news/merck-billion-dollar-google-cloud-ai-deal-2 2026-05-03T14:06:02.149Z never 0.8 https://biotechmorning.com/news/fomat-topography-health-largest-embedded-research-organization 2026-05-02T14:12:07.194Z never 0.8 https://biotechmorning.com/news/hemab-ipo-doubled-day-one-blood-disease-bet 2026-05-02T14:11:31.267Z never 0.8 https://biotechmorning.com/news/seaport-therapeutics-ipo-neuropsychiatry-bet 2026-05-02T14:10:50.297Z never 0.8 https://biotechmorning.com/news/viking-obesity-drug-ligand-legal-dispute 2026-05-02T14:10:12.836Z never 0.8 https://biotechmorning.com/news/summit-therapeutics-ivonescimab-trial-miss 2026-05-02T14:09:35.778Z never 0.8 https://biotechmorning.com/news/fda-cber-prasad-exits-again 2026-05-02T14:08:54.198Z never 0.8 https://biotechmorning.com/news/first-protac-fda-approval-vepdegestrant-breast-cancer 2026-05-02T14:08:14.162Z never 0.8 https://biotechmorning.com/news/genomics-greywolf-autoimmune-gene-targets 2026-05-02T14:07:34.291Z never 0.8 https://biotechmorning.com/news/fda-slams-door-cheap-liraglutide-compounding 2026-05-02T14:06:55.767Z never 0.8 https://biotechmorning.com/news/hiv-drug-came-back-from-dead-idvynso 2026-05-01T14:13:04.133Z never 0.8 https://biotechmorning.com/news/bms-terminates-zymeworks-bispecific-collaboration 2026-05-01T14:12:23.241Z never 0.8 https://biotechmorning.com/news/astrazeneca-camizestrant-fda-panel-rejection 2026-05-01T14:11:43.744Z never 0.8 https://biotechmorning.com/news/jnj-cancels-car-t-program 2026-05-01T14:10:56.678Z never 0.8 https://biotechmorning.com/news/indivior-phase-2-failure-rd-layoffs 2026-05-01T14:10:09.469Z never 0.8 https://biotechmorning.com/news/leo-pharma-replay-gene-therapy-skin 2026-05-01T14:09:32.430Z never 0.8 https://biotechmorning.com/news/glp1-revolution-ditched-the-needle 2026-05-01T14:08:51.340Z never 0.8 https://biotechmorning.com/news/amgen-kills-two-programs-phase-2-failures 2026-05-01T14:08:11.498Z never 0.8 https://biotechmorning.com/news/astrazeneca-pinetree-egfr-degrader-deal 2026-04-30T14:11:42.543Z never 0.8 https://biotechmorning.com/news/astrazeneca-camizestrant-truqap-odac-meeting-fda-concerns 2026-04-30T14:11:02.608Z never 0.8 https://biotechmorning.com/news/teva-700m-emalex-tourette-syndrome-bet 2026-04-30T14:10:17.561Z never 0.8 https://biotechmorning.com/news/avalyn-pharma-300m-ipo-inhaled-pulmonary-fibrosis 2026-04-30T14:09:39.194Z never 0.8 https://biotechmorning.com/news/2-billion-bet-preclinical-trispecific-antibody 2026-04-30T14:08:55.107Z never 0.8 https://biotechmorning.com/news/fda-clinical-hold-newron-schizophrenia-trial 2026-04-30T14:08:12.617Z never 0.8 https://biotechmorning.com/news/gsk-alector-alzheimers-second-failure 2026-04-30T14:07:32.867Z never 0.8 https://biotechmorning.com/news/chiesi-kalvista-oral-hae-acquisition 2026-04-30T14:06:50.916Z never 0.8 https://biotechmorning.com/news/flap-inhibitor-asthma-failure-astrazeneca 2026-04-29T14:13:02.522Z never 0.8 https://biotechmorning.com/news/teva-emalex-tourette-syndrome-deal 2026-04-29T14:12:21.980Z never 0.8 https://biotechmorning.com/news/fda-real-time-clinical-trial-review 2026-04-29T14:11:38.909Z never 0.8 https://biotechmorning.com/news/gsk-oncology-gamble-future 2026-04-29T14:10:59.733Z never 0.8 https://biotechmorning.com/news/coultreon-galapagos-drug-125m-series-a 2026-04-29T14:10:23.844Z never 0.8 https://biotechmorning.com/news/incyte-opzelura-vitiligo-rinvoq-competition 2026-04-29T14:09:42.929Z never 0.8 https://biotechmorning.com/news/erasca-home-run-stock-drops 2026-04-29T14:08:52.547Z never 0.8 https://biotechmorning.com/news/astrazeneca-fda-concerns-camizestrant-truqap 2026-04-29T14:08:05.823Z never 0.8 https://biotechmorning.com/news/compass-therapeutics-trial-crossover-problem 2026-04-28T14:13:28.669Z never 0.8 https://biotechmorning.com/news/oruka-psoriasis-data-vs-skyrizi 2026-04-28T14:12:38.952Z never 0.8 https://biotechmorning.com/news/sun-pharma-organon-acquisition-12-billion 2026-04-28T14:11:51.311Z never 0.8 https://biotechmorning.com/news/survodutide-obesity-drug-wasnt-supposed-to-work 2026-04-28T14:11:08.851Z never 0.8 https://biotechmorning.com/news/coultreon-biopharma-125m-galapagos-rescued-assets 2026-04-28T14:10:23.576Z never 0.8 https://biotechmorning.com/news/astellas-gene-therapy-plan-b 2026-04-28T14:09:40.279Z never 0.8 https://biotechmorning.com/news/two-biotechs-ipo-same-day-biotech-window 2026-04-28T14:09:05.056Z never 0.8 https://biotechmorning.com/news/janux-kills-solid-tumor-t-cell-engager 2026-04-28T14:08:21.642Z never 0.8 https://biotechmorning.com/news/novartis-in-vivo-car-t-evaluation 2026-04-28T14:07:35.789Z never 0.8 https://biotechmorning.com/news/lilly-profluent-ai-gene-editing-deal 2026-04-28T14:06:52.641Z never 0.8 https://biotechmorning.com/news/intellia-first-in-vivo-crispr-fda-filing 2026-04-27T14:14:15.183Z never 0.8 https://biotechmorning.com/news/lilly-ajax-therapeutics-jak-inhibitor-deal 2026-04-27T14:13:27.213Z never 0.8 https://biotechmorning.com/news/oricell-110m-car-t-solid-tumors 2026-04-27T14:12:44.344Z never 0.8 https://biotechmorning.com/news/gilead-tubulis-5-billion-adc-acquisition 2026-04-27T14:12:02.395Z never 0.8 https://biotechmorning.com/news/neurocrine-soleno-prader-willi-acquisition-2 2026-04-27T14:11:19.448Z never 0.8 https://biotechmorning.com/news/ucb-neurona-cell-therapy-epilepsy-deal 2026-04-27T14:10:39.022Z never 0.8 https://biotechmorning.com/news/kidney-drug-filspari-fsgs-fda-approval 2026-04-27T14:09:54.445Z never 0.8 https://biotechmorning.com/news/lilly-foundayo-slow-launch-wall-street-panic 2026-04-27T14:09:14.532Z never 0.8 https://biotechmorning.com/news/uk-biotech-cash-no-ipos 2026-04-27T14:08:25.683Z never 0.8 https://biotechmorning.com/news/akt-pathway-108m-bet-terremoto 2026-04-27T14:07:45.418Z never 0.8 https://biotechmorning.com/news/generate-biomedicines-ipo-ai-drug-design 2026-04-26T14:11:42.460Z never 0.8 https://biotechmorning.com/news/roche-oral-ms-pill-fenebrutinib 2026-04-26T14:11:00.100Z never 0.8 https://biotechmorning.com/news/fda-cms-rapid-pathway-breakthrough-devices 2026-04-26T14:10:09.912Z never 0.8 https://biotechmorning.com/news/fda-peptide-reclassification-compounding-pharmacies 2026-04-26T14:09:32.398Z never 0.8 https://biotechmorning.com/news/avalyn-pharma-200m-ipo-inhaled-lung-therapy 2026-04-26T14:08:51.618Z never 0.8 https://biotechmorning.com/news/revolution-medicines-kras-undruggable-aacr-2026 2026-04-26T14:08:04.368Z never 0.8 https://biotechmorning.com/news/roche-nvidia-ai-factory-pharma 2026-04-26T14:07:15.623Z never 0.8 https://biotechmorning.com/news/alamar-biosciences-ipo-oversubscribed 2026-04-25T14:09:15.651Z never 0.8 https://biotechmorning.com/news/white-house-fda-fast-track-psychedelics 2026-04-25T14:08:32.930Z never 0.8 https://biotechmorning.com/news/kailera-therapeutics-ipo-breaks-nasdaq-record 2026-04-25T14:07:51.913Z never 0.8 https://biotechmorning.com/news/wcg-acquires-contract-network-clinical-trials 2026-04-25T14:07:12.640Z never 0.8 https://biotechmorning.com/news/amneal-kashiv-biosimilar-manufacturing-deal 2026-04-25T14:06:33.300Z never 0.8 https://biotechmorning.com/news/fda-fast-tracked-psychedelics-priority-review 2026-04-25T14:05:50.054Z never 0.8 https://biotechmorning.com/news/helus-pharma-ceo-exit-two-months 2026-04-24T14:09:50.103Z never 0.8 https://biotechmorning.com/news/regeneron-first-gene-therapy-approval-hearing-loss 2026-04-24T14:09:08.109Z never 0.8 https://biotechmorning.com/news/pfizer-cancer-campaign-fernando-mendoza 2026-04-24T14:08:26.720Z never 0.8 https://biotechmorning.com/news/avalyn-pharma-ipo-inhaled-lung-drugs 2026-04-24T14:07:43.525Z never 0.8 https://biotechmorning.com/news/regeneron-last-holdout-white-house-drug-pricing-deal 2026-04-24T14:06:57.128Z never 0.8 https://biotechmorning.com/news/lilly-ghosted-rigel-ripk1-deal 2026-04-23T14:13:18.405Z never 0.8 https://biotechmorning.com/news/merck-billion-dollar-google-cloud-ai-deal 2026-04-23T14:12:32.008Z never 0.8 https://biotechmorning.com/news/daraxonrasib-pancreatic-cancer-first-line-results 2026-04-23T14:11:49.120Z never 0.8 https://biotechmorning.com/news/137m-bet-cancer-smart-bombs-sidewinder 2026-04-23T14:11:08.868Z never 0.8 https://biotechmorning.com/news/gene-therapy-deaf-hear-whispers 2026-04-23T14:10:26.881Z never 0.8 https://biotechmorning.com/news/novartis-abelacimab-anticoagulant-retreat 2026-04-23T14:09:48.037Z never 0.8 https://biotechmorning.com/news/lilly-300m-crossbridge-bio-dual-payload-adc 2026-04-23T14:09:04.056Z never 0.8 https://biotechmorning.com/news/ray-therapeutics-125m-series-b-vision-restoration 2026-04-22T14:10:48.773Z never 0.8 https://biotechmorning.com/news/undruggable-kras-g12d-zoldonrasib-lung-cancer 2026-04-22T14:10:07.920Z never 0.8 https://biotechmorning.com/news/pbm-drug-price-transparency-fight 2026-04-22T14:09:25.208Z never 0.8 https://biotechmorning.com/news/flagship-serif-biomedicines-modified-dna-launch-2 2026-04-22T14:08:43.760Z never 0.8 https://biotechmorning.com/news/tortugas-neuroscience-106m-cns-launch 2026-04-22T14:07:52.441Z never 0.8 https://biotechmorning.com/news/idvynso-two-drug-hiv-pill-fda-approval 2026-04-22T14:07:09.080Z never 0.8 https://biotechmorning.com/news/gilead-arcus-tigit-failure-partnership-unravels 2026-04-21T14:10:03.321Z never 0.8 https://biotechmorning.com/news/lilly-kelonia-7-billion-in-vivo-car-t 2026-04-21T14:09:13.777Z never 0.8 https://biotechmorning.com/news/replimune-oncolytic-virus-layoffs-fda-rejection 2026-04-21T14:08:20.784Z never 0.8 https://biotechmorning.com/news/flagship-serif-biomedicines-modified-dna-launch 2026-04-21T14:07:37.061Z never 0.8 https://biotechmorning.com/news/biogen-850m-tj-biopharma-felzartamab-china-deal 2026-04-21T14:06:49.827Z never 0.8 https://biotechmorning.com/news/odyssey-therapeutics-second-ipo-attempt 2026-04-20T14:07:40.639Z never 0.8 https://biotechmorning.com/news/astrazeneca-il33-tozorakimab-phase-3-copd-win 2026-04-20T14:07:04.833Z never 0.8 https://biotechmorning.com/news/novo-nordisk-sickle-cell-disease-etavopivat-phase-3 2026-04-20T14:06:23.243Z never 0.8 https://biotechmorning.com/news/fda-rejects-replimune-melanoma-drug-twice-2 2026-04-19T14:06:45.145Z never 0.8 https://biotechmorning.com/news/foundayo-oral-obesity-pill-launch-prescriptions 2026-04-19T14:06:02.299Z never 0.8 https://biotechmorning.com/news/fda-reclassifies-banned-peptides-compounding-pharmacies 2026-04-19T14:05:16.824Z never 0.8 https://biotechmorning.com/news/janux-double-masked-t-cell-engager 2026-04-18T14:08:57.191Z never 0.8 https://biotechmorning.com/news/ucb-neurona-epilepsy-cell-therapy-acquisition 2026-04-18T14:08:13.557Z never 0.8 https://biotechmorning.com/news/cerebras-2-billion-ipo-bet-against-nvidia 2026-04-18T14:07:27.377Z never 0.8 https://biotechmorning.com/news/roivant-ceo-china-biotech-red-herring 2026-04-18T14:06:47.986Z never 0.8 https://biotechmorning.com/news/merck-secret-weapon-life-after-keytruda 2026-04-18T14:06:10.714Z never 0.8 https://biotechmorning.com/news/openai-gpt-rosalind-biotech-drug-discovery 2026-04-18T14:05:27.589Z never 0.8 https://biotechmorning.com/news/fda-bone-growth-stimulator-reclassification 2026-04-17T14:13:55.272Z never 0.8 https://biotechmorning.com/news/aligos-amoytop-china-hbv-deal 2026-04-17T14:13:13.091Z never 0.8 https://biotechmorning.com/news/terremoto-akt-inhibitor-358m-bet 2026-04-17T14:12:28.595Z never 0.8 https://biotechmorning.com/news/kailera-therapeutics-biggest-biotech-ipo-obesity 2026-04-17T14:11:46.388Z never 0.8 https://biotechmorning.com/news/pancreatic-cancer-finally-blinked 2026-04-17T14:11:01.079Z never 0.8 https://biotechmorning.com/news/alzheimers-anti-amyloid-drugs-trivial-benefits-report 2026-04-17T14:10:21.686Z never 0.8 https://biotechmorning.com/news/beeline-medicines-300m-launch-bms-autoimmune 2026-04-17T14:09:36.186Z never 0.8 https://biotechmorning.com/news/meiragtx-reacquires-eye-gene-therapy-jj 2026-04-17T14:08:48.314Z never 0.8 https://biotechmorning.com/news/storm-therapeutics-series-c-epitranscriptomics-sarcoma 2026-04-17T14:08:03.448Z never 0.8 https://biotechmorning.com/news/first-fsgs-drug-filspari-approved 2026-04-17T14:07:18.545Z never 0.8 https://biotechmorning.com/news/beeline-medicines-bain-bms-launch 2026-04-16T14:12:40.847Z never 0.8 https://biotechmorning.com/news/novartis-ceo-narasimhan-joins-anthropic-board 2026-04-16T14:11:52.227Z never 0.8 https://biotechmorning.com/news/lilly-foundayo-obesity-pill-fda-liver-safety 2026-04-16T14:11:00.407Z never 0.8 https://biotechmorning.com/news/pill-rewriting-pancreatic-cancer-death-sentence 2026-04-16T14:10:17.453Z never 0.8 https://biotechmorning.com/news/spain-200m-biotech-fund-boston 2026-04-16T14:09:31.751Z never 0.8 https://biotechmorning.com/news/biotech-early-stage-funding-slump-2026 2026-04-16T14:08:47.673Z never 0.8 https://biotechmorning.com/news/fda-rejects-six-peptides-compounding 2026-04-16T14:08:03.455Z never 0.8 https://biotechmorning.com/news/novo-nordisk-openai-partnership 2026-04-16T14:07:20.020Z never 0.8 https://biotechmorning.com/news/ocugen-gene-therapy-commercial-scalability 2026-04-16T14:06:33.776Z never 0.8 https://biotechmorning.com/news/astellas-stem-cell-seattle-closure 2026-04-15T14:07:38.958Z never 0.8 https://biotechmorning.com/news/click-therapeutics-layoffs-digital-therapeutics 2026-04-15T14:06:56.696Z never 0.8 https://biotechmorning.com/news/fda-clinical-trial-reporting-crackdown-2026 2026-04-15T14:06:14.675Z never 0.8 https://biotechmorning.com/news/senator-sasse-pancreatic-cancer-revolution-medicines-trial 2026-04-15T14:05:30.919Z never 0.8 https://biotechmorning.com/news/neomorph-100m-molecular-glue-degrader 2026-04-14T14:13:46.875Z never 0.8 https://biotechmorning.com/news/kailera-therapeutics-ipo-obesity-drugs 2026-04-14T14:13:05.406Z never 0.8 https://biotechmorning.com/news/big-pharma-immunology-spring-cleaning-2 2026-04-14T14:12:20.806Z never 0.8 https://biotechmorning.com/news/alamar-biosciences-ipo-billion-dollar-valuation 2026-04-14T14:11:35.666Z never 0.8 https://biotechmorning.com/news/abbvie-745m-haisco-pain-deal 2026-04-14T14:10:50.119Z never 0.8 https://biotechmorning.com/news/lilly-300m-crossbridge-bio-adc-acquisition 2026-04-14T14:10:05.057Z never 0.8 https://biotechmorning.com/news/gsk-adc-phase-3-gynecologic-cancer 2026-04-13T14:15:08.758Z never 0.8 https://biotechmorning.com/news/big-pharma-immunology-spring-cleaning 2026-04-13T14:14:23.300Z never 0.8 https://biotechmorning.com/news/regeneron-telix-radiopharmaceutical-deal 2026-04-13T14:13:44.037Z never 0.8 https://biotechmorning.com/news/sclc-ifinatamab-deruxtecan-priority-review 2026-04-13T14:12:56.154Z never 0.8 https://biotechmorning.com/news/allogene-off-the-shelf-car-t-lymphoma-results 2026-04-13T14:12:07.005Z never 0.8 https://biotechmorning.com/news/eye-cancer-uveal-melanoma-ideaya-darovasertib-fda 2026-04-13T14:11:14.474Z never 0.8 https://biotechmorning.com/news/seaport-hemab-ipo-filings-same-day 2026-04-13T14:10:31.528Z never 0.8 https://biotechmorning.com/news/ras-undruggable-target-revolution-medicines-phase-3-win 2026-04-13T14:09:42.450Z never 0.8 https://biotechmorning.com/news/gilead-13-billion-six-weeks-acquisition-spree 2026-04-12T14:12:57.510Z never 0.8 https://biotechmorning.com/news/big-pharma-china-biopharma-out-licensing-surge-2026 2026-04-12T14:12:11.241Z never 0.8 https://biotechmorning.com/news/avalyn-pharma-ipo-lung-disease-bet 2026-04-12T14:11:25.851Z never 0.8 https://biotechmorning.com/news/oricell-110m-car-t-solid-tumors-ipo 2026-04-12T14:10:42.491Z never 0.8 https://biotechmorning.com/news/fda-rejects-replimune-rp1-melanoma-second-time 2026-04-12T14:10:03.125Z never 0.8 https://biotechmorning.com/news/glp1-pill-foundayo-oral-obesity-drug-fda-approval 2026-04-12T14:09:22.453Z never 0.8 https://biotechmorning.com/news/neurocrine-soleno-acquisition-prader-willi 2026-04-12T14:08:37.660Z never 0.8 https://biotechmorning.com/news/biotech-ipo-drought-over-q1-2026 2026-04-12T14:07:58.532Z never 0.8 https://biotechmorning.com/news/fda-rejects-replimune-melanoma-drug-twice 2026-04-11T14:12:46.330Z never 0.8 https://biotechmorning.com/news/treefrog-ceo-joins-orano-med-alpha-therapy 2026-04-11T14:12:02.188Z never 0.8 https://biotechmorning.com/news/medicine-cabinet-strait-of-hormuz-problem 2026-04-11T14:11:15.690Z never 0.8 https://biotechmorning.com/news/rna-biggest-problem-54m-bet 2026-04-11T14:10:32.882Z never 0.8 https://biotechmorning.com/news/biotech-velvet-rope-q1-2026-ipo-party 2026-04-11T14:09:50.822Z never 0.8 https://biotechmorning.com/news/takeover-tuesday-lilly-biogen-biotech-ma-surge 2026-04-11T14:09:08.033Z never 0.8 https://biotechmorning.com/news/oral-glp1-pill-foundayo-obesity-approval 2026-04-11T14:08:26.351Z never 0.8 https://biotechmorning.com/news/fda-delay-killed-kezar-life-sciences 2026-04-11T14:07:37.590Z never 0.8 https://biotechmorning.com/news/biotech-vcs-identity-crisis 2026-04-10T14:14:27.562Z never 0.8 https://biotechmorning.com/news/car-t-three-autoimmune-diseases-remission 2026-04-10T14:13:39.823Z never 0.8 https://biotechmorning.com/news/rfk-jr-peptides-vaccines-contradiction 2026-04-10T14:12:54.759Z never 0.8 https://biotechmorning.com/news/avalyn-pharma-ipo-inhaled-lung-therapy 2026-04-10T14:12:12.315Z never 0.8 https://biotechmorning.com/news/why-pharma-still-cant-crack-menopause 2026-04-10T14:11:29.630Z never 0.8 https://biotechmorning.com/news/oricell-110m-car-t-liver-cancer-ipo 2026-04-10T14:10:40.648Z never 0.8 https://biotechmorning.com/news/biotech-next-gold-rush-lpa-inhibitors 2026-04-10T14:09:58.411Z never 0.8 https://biotechmorning.com/news/gut-bacteria-sugars-als-brain-damage 2026-04-10T14:09:09.572Z never 0.8 https://biotechmorning.com/news/life-biosciences-80m-epigenetic-reprogramming-glaucoma 2026-04-09T14:14:04.790Z never 0.8 https://biotechmorning.com/news/vivtex-novo-nordisk-2-billion-deal 2026-04-09T14:13:19.743Z never 0.8 https://biotechmorning.com/news/roche-biggest-gpu-pharma-supercomputer 2026-04-09T14:12:33.725Z never 0.8 https://biotechmorning.com/news/avalyn-pharma-ipo-inhaled-lung-therapies 2026-04-09T14:11:55.595Z never 0.8 https://biotechmorning.com/news/akari-wuxi-adc-deal-geopolitical-risk 2026-04-09T14:11:09.439Z never 0.8 https://biotechmorning.com/news/shionogi-barda-us-antibiotic-manufacturing 2026-04-09T14:10:23.397Z never 0.8 https://biotechmorning.com/news/roche-c4t-protein-degradation-deal 2026-04-09T14:09:34.083Z never 0.8 https://biotechmorning.com/news/gilead-45m-kymera-protein-degrader-deal 2026-04-09T14:08:50.072Z never 0.8 https://biotechmorning.com/news/novo-wegovy-price-war-obesity 2026-04-09T14:08:05.861Z never 0.8 https://biotechmorning.com/news/anthropic-claude-banned-federal-healthcare 2026-04-08T14:10:16.812Z never 0.8 https://biotechmorning.com/news/biogen-alloy-anticlastic-aso-partnership 2026-04-08T14:09:39.953Z never 0.8 https://biotechmorning.com/news/sidewinder-therapeutics-137m-series-b-adc 2026-04-08T14:08:55.017Z never 0.8 https://biotechmorning.com/news/jeito-capital-1-2-billion-european-biopharma-fund 2026-04-08T14:08:08.348Z never 0.8 https://biotechmorning.com/news/triglyceride-aneurysm-causal-link-first-drug-lead 2026-04-08T14:07:25.809Z never 0.8 https://biotechmorning.com/news/anthropic-coefficient-bio-acquisition 2026-04-07T14:15:33.206Z never 0.8 https://biotechmorning.com/news/neurocrine-soleno-prader-willi-acquisition 2026-04-07T14:14:52.384Z never 0.8 https://biotechmorning.com/news/gilead-tubulis-adc-acquisition-3-billion 2026-04-07T14:14:09.859Z never 0.8 https://biotechmorning.com/news/replimune-rp1-fda-identity-crisis 2026-04-07T14:13:22.851Z never 0.8 https://biotechmorning.com/news/biogen-alloy-aso-delivery-deal 2026-04-07T14:12:37.387Z never 0.8 https://biotechmorning.com/news/ai-designed-opioid-addiction-drug 2026-04-07T14:11:55.022Z never 0.8 https://biotechmorning.com/news/sanofi-lunsekimig-mixed-phase-2-results 2026-04-07T14:11:10.459Z never 0.8 https://biotechmorning.com/news/takeda-ghosted-denali-brain-drug-deal 2026-04-07T14:10:24.214Z never 0.8 https://biotechmorning.com/news/fda-ghosted-kezar-life-sciences 2026-04-07T14:09:41.460Z never 0.8 https://biotechmorning.com/news/big-pharma-tariff-offer-cant-refuse 2026-04-06T14:08:02.865Z never 0.8 https://biotechmorning.com/news/big-pharma-march-2026-ma-shopping-spree 2026-04-06T14:07:15.997Z never 0.8 https://biotechmorning.com/news/ftl1-protein-brain-aging-off-switch 2026-04-06T14:06:30.530Z never 0.8 https://biotechmorning.com/news/stipple-bio-100m-launch-precision-oncology 2026-04-06T14:05:52.056Z never 0.8 https://biotechmorning.com/news/boehringer-adc-tce-shopping-list 2026-04-06T14:05:09.100Z never 0.8 https://biotechmorning.com/news/denali-avlayah-hunter-syndrome-fda-approval 2026-04-05T14:09:42.263Z never 0.8 https://biotechmorning.com/news/fda-makary-faster-drug-approvals-catch 2026-04-05T14:09:00.568Z never 0.8 https://biotechmorning.com/news/gsk-poached-sanofi-vaccine-guru 2026-04-05T14:08:13.075Z never 0.8 https://biotechmorning.com/news/mit-boltz-2-ai-drug-screening 2026-04-05T14:07:31.573Z never 0.8 https://biotechmorning.com/news/tecartus-first-car-t-full-fda-approval-mcl 2026-04-04T14:09:01.986Z never 0.8 https://biotechmorning.com/news/syneron-bio-250m-four-months-series-b 2026-04-04T14:08:20.614Z never 0.8 https://biotechmorning.com/news/gilead-weekly-hiv-pill-terminated-safety 2026-04-04T14:07:35.012Z never 0.8 https://biotechmorning.com/news/400-billion-bluff-pharma-tariff-escape-hatch 2026-04-04T14:06:57.227Z never 0.8 https://biotechmorning.com/news/white-house-hhs-budget-cut-fy2027-biotech 2026-04-04T14:06:16.401Z never 0.8 https://biotechmorning.com/news/biopharma-pipeline-shrinks-first-time-30-years 2026-04-04T14:05:31.561Z never 0.8 https://biotechmorning.com/news/syneron-bio-150m-peptide-platform 2026-04-03T14:23:19.592Z never 0.8 https://biotechmorning.com/news/beam-base-editing-sickle-cell-nejm 2026-04-03T14:22:37.143Z never 0.8 https://biotechmorning.com/news/lilly-oral-obesity-pill-fda-approval 2026-04-03T14:19:56.945Z never 0.8 https://biotechmorning.com/news/spinraza-high-dose-biogen-sma-fda-approval 2026-04-03T14:15:13.429Z never 0.8 https://biotechmorning.com/news/uk-us-pharma-tariff-deal 2026-04-03T14:11:10.020Z never 0.8 https://biotechmorning.com/news/100-percent-tariff-pharma-imports 2026-04-03T14:10:24.366Z never 0.8 https://biotechmorning.com/news/paradox-mutation-cancer-drug-combination 2026-04-02T14:15:32.482Z never 0.8 https://biotechmorning.com/news/alto-neuroscience-pde4-inhibitor-schizophrenia-failure 2026-04-02T14:14:51.528Z never 0.8 https://biotechmorning.com/news/merck-infinimmune-838-million-antibody-deal 2026-04-02T14:14:04.999Z never 0.8 https://biotechmorning.com/news/gilead-hiv-weekly-pill-trial-canceled 2026-04-02T14:13:18.556Z never 0.8 https://biotechmorning.com/news/fda-delays-orca-bio-decision 2026-04-02T14:12:39.049Z never 0.8 https://biotechmorning.com/news/korsana-cyclerion-reverse-merger-alzheimers 2026-04-02T14:12:00.864Z never 0.8 https://biotechmorning.com/news/middle-east-conflict-clinical-trial-disruptions 2026-04-02T14:11:12.856Z never 0.8 https://biotechmorning.com/news/ambrosia-100m-oral-glp1-obesity 2026-04-02T14:10:29.214Z never 0.8 https://biotechmorning.com/news/tyvaso-aces-ipf-trial 2026-04-02T14:09:45.187Z never 0.8 https://biotechmorning.com/news/immunovant-batoclimab-ted-phase-3-failure 2026-04-02T14:08:36.476Z never 0.8 https://biotechmorning.com/news/us-vcs-china-biotech-pre-publication-deals 2026-04-01T14:29:36.616Z never 0.8 https://biotechmorning.com/news/tRNA-therapy-first-clinical-trial 2026-04-01T14:26:04.082Z never 0.8 https://biotechmorning.com/news/lilly-centessa-acquisition-7-8-billion 2026-04-01T14:25:18.494Z never 0.8 https://biotechmorning.com/news/nih-bhattacharya-endless-frontier-cpac-backlash 2026-04-01T14:24:27.684Z never 0.8 https://biotechmorning.com/news/takeda-634-job-cuts-billion-savings 2026-04-01T14:23:37.493Z never 0.8 https://biotechmorning.com/news/novo-nordisk-kbp-biosciences-fraud-dispute 2026-04-01T14:20:48.140Z never 0.8 https://biotechmorning.com/news/oric-pharmaceuticals-phase-3-prostate-cancer 2026-04-01T14:20:05.017Z never 0.8 https://biotechmorning.com/news/enveda-env-294-dupixent-rival-atopic-dermatitis 2026-04-01T14:19:19.557Z never 0.8 https://biotechmorning.com/news/io-biotech-bankruptcy-cancer-vaccine 2026-04-01T14:18:12.878Z never 0.8 https://biotechmorning.com/news/biogen-apellis-acquisition-complement-disease 2026-04-01T14:17:29.207Z never 0.8 https://biotechmorning.com/news/bicycle-therapeutics-padcev-challenger-layoffs 2026-03-31T14:14:27.831Z never 0.8 https://biotechmorning.com/news/takeda-634-us-job-cuts-restructuring 2026-03-31T14:13:43.822Z never 0.8 https://biotechmorning.com/news/blackstone-6-billion-life-sciences-fund 2026-03-31T14:12:55.117Z never 0.8 https://biotechmorning.com/news/merck-terns-pharmaceuticals-acquisition 2026-03-31T14:12:16.980Z never 0.8 https://biotechmorning.com/news/merck-oral-pcsk9-inhibitor-pill-vs-needle 2026-03-31T14:11:33.921Z never 0.8 https://biotechmorning.com/news/denali-avlayah-blood-brain-barrier-hunter-syndrome 2026-03-31T14:10:50.565Z never 0.8 https://biotechmorning.com/news/astellas-kills-sting-inhibitor-sjogrens 2026-03-31T14:10:06.101Z never 0.8 https://biotechmorning.com/news/kailera-therapeutics-ipo-obesity-drug 2026-03-31T14:09:15.187Z never 0.8 https://biotechmorning.com/news/jj-impella-heart-pump-trials-fail 2026-03-31T14:08:34.011Z never 0.8 https://biotechmorning.com/news/lilly-insilico-ai-drug-discovery-deal 2026-03-30T14:15:29.722Z never 0.8 https://biotechmorning.com/news/kardigan-hypertension-drug-worked-too-well-one-dose 2026-03-30T14:12:09.565Z never 0.8 https://biotechmorning.com/news/biogen-litifilimab-lupus-trial-results 2026-03-30T14:11:20.185Z never 0.8 https://biotechmorning.com/news/pig-semen-eye-drops-cancer-treatment 2026-03-29T14:04:54.782Z never 0.8 https://biotechmorning.com/news/wave-life-sciences-stock-crash-obesity-drug 2026-03-29T14:04:12.742Z never 0.8 https://biotechmorning.com/news/mfn-drug-pricing-bill-pharma-first-look 2026-03-28T14:12:17.282Z never 0.8 https://biotechmorning.com/news/novocure-ttfields-pancreatic-cancer-data 2026-03-28T14:11:27.689Z never 0.8 https://biotechmorning.com/news/weekly-insulin-novo-nordisk-fda-approval 2026-03-28T14:10:46.200Z never 0.8 https://biotechmorning.com/news/otsuka-biggest-psychedelics-bet-transcend 2026-03-28T14:09:59.078Z never 0.8 https://biotechmorning.com/news/copd-antibody-drug-class-revival 2026-03-28T14:09:19.766Z never 0.8 https://biotechmorning.com/news/vertex-kidney-drug-gamble-paid-off 2026-03-27T14:14:00.219Z never 0.8 https://biotechmorning.com/news/cytomx-masked-adc-colorectal-cancer 2026-03-27T14:13:14.858Z never 0.8 https://biotechmorning.com/news/pinnacle-medicines-89m-oral-peptide-bet 2026-03-27T14:12:32.419Z never 0.8 https://biotechmorning.com/news/pfizer-lyme-vaccine-works-trial-technically-failed 2026-03-27T14:11:44.743Z never 0.8 https://biotechmorning.com/news/35-insulin-cap-drug-pricing-precedent 2026-03-27T14:10:51.437Z never 0.8 https://biotechmorning.com/news/novartis-2b-excellergy-xolair-successor 2026-03-27T14:10:07.685Z never 0.8 https://biotechmorning.com/news/gene-therapy-fda-rejected-twice-approved 2026-03-27T14:09:17.307Z never 0.8 https://biotechmorning.com/news/cmr-surgical-us-launch-challenges-intuitive 2026-03-27T14:08:36.043Z never 0.8 https://biotechmorning.com/news/lifyorli-relacorilant-ovarian-cancer-fda-approval 2026-03-27T14:07:52.933Z never 0.8 https://biotechmorning.com/news/sarepta-elevidys-liver-safety-fix 2026-03-27T14:07:05.078Z never 0.8 https://biotechmorning.com/news/gilgamesh-pharma-60m-series-a-psychedelic-biotech 2026-03-26T14:13:21.726Z never 0.8 https://biotechmorning.com/news/endogenex-zap-gut-treat-diabetes 2026-03-26T14:12:38.519Z never 0.8 https://biotechmorning.com/news/innate-pharma-kills-nk-cell-engager-program 2026-03-26T14:12:00.693Z never 0.8 https://biotechmorning.com/news/insmed-arikayce-mac-lung-disease-encore-trial 2026-03-26T14:11:22.980Z never 0.8 https://biotechmorning.com/news/maze-therapeutics-stock-drop-best-in-class-phase-2 2026-03-26T14:10:41.524Z never 0.8 https://biotechmorning.com/news/merck-6-7-billion-terns-pharmaceuticals-cml 2026-03-26T14:09:50.944Z never 0.8 https://biotechmorning.com/news/denali-avlayah-brain-penetrating-hunter-syndrome 2026-03-26T14:08:40.664Z never 0.8 https://biotechmorning.com/news/immutrin-87m-series-a-stealth-biotech 2026-03-26T14:07:58.630Z never 0.8 https://biotechmorning.com/news/parkinsons-drug-vitamin-b6-seizure-risk 2026-03-25T14:10:13.177Z never 0.8 https://biotechmorning.com/news/sarepta-arrowhead-sirna-early-data 2026-03-25T14:09:32.965Z never 0.8 https://biotechmorning.com/news/genmab-profoundbio-acquisition-pipeline-attrition 2026-03-25T14:08:46.324Z never 0.8 https://biotechmorning.com/news/gilead-ouro-medicines-autoimmune-tcell-engager 2026-03-25T14:08:05.869Z never 0.8 https://biotechmorning.com/news/merck-terns-pharma-acquisition-oncology 2026-03-25T14:07:19.354Z never 0.8 https://biotechmorning.com/news/merck-quotient-ibd-deal 2026-03-24T14:09:54.697Z never 0.8 https://biotechmorning.com/news/glyconex-nippon-kayaku-stealth-adc-partnership 2026-03-24T14:09:05.158Z never 0.8 https://biotechmorning.com/news/innovent-eye-drug-matched-eylea-phase-3 2026-03-24T14:08:24.718Z never 0.8 https://biotechmorning.com/news/helium-shortage-mri-crisis-iran-conflict 2026-03-24T14:07:38.950Z never 0.8 https://biotechmorning.com/news/aardvark-obesity-trials-halted 2026-03-24T14:06:50.126Z never 0.8 https://biotechmorning.com/news/oryon-regrow-parkinsons-neurons 2026-03-23T14:07:40.926Z never 0.8 https://biotechmorning.com/news/rocket-pharma-kresladi-fda-second-chance 2026-03-23T14:06:56.342Z never 0.8 https://biotechmorning.com/news/abbott-acquires-exact-sciences-cancer-screening 2026-03-23T14:06:13.243Z never 0.8 https://biotechmorning.com/news/gsk-sold-linerixibat-before-fda-approval 2026-03-22T14:09:46.441Z never 0.8 https://biotechmorning.com/news/xenon-epilepsy-drug-broke-wall-street 2026-03-22T14:09:07.661Z never 0.8 https://biotechmorning.com/news/rapport-tenacia-rap-219-epilepsy-deal 2026-03-22T14:08:27.390Z never 0.8 https://biotechmorning.com/news/novartis-2-billion-breast-cancer-drug-no-data 2026-03-22T14:07:33.373Z never 0.8 https://biotechmorning.com/news/gilead-drops-assembly-bio-hbv-drug 2026-03-22T14:06:51.489Z never 0.8 https://biotechmorning.com/news/pfizer-trispecific-antibody-dupixent-atopic-dermatitis 2026-03-22T14:06:10.827Z never 0.8 https://biotechmorning.com/news/gilead-passes-on-assembly-biosciences-hbv-drug 2026-03-21T14:08:35.002Z never 0.8 https://biotechmorning.com/news/myostatin-inhibition-emugrobart-failure 2026-03-21T14:07:50.643Z never 0.8 https://biotechmorning.com/news/novartis-2-billion-pi3k-breast-cancer-bet 2026-03-21T14:07:10.403Z never 0.8 https://biotechmorning.com/news/eric-topol-joins-flagship-pioneering 2026-03-21T14:06:25.243Z never 0.8 https://biotechmorning.com/news/intuitive-surgical-stapler-recall-patient-death 2026-03-21T14:05:40.876Z never 0.8 https://biotechmorning.com/news/america-invented-car-t-losing-race-to-china 2026-03-20T14:06:31.525Z never 0.8 https://biotechmorning.com/news/minimed-flex-screen-free-insulin-pump-fda-clearance 2026-03-20T14:05:47.859Z never 0.8 https://biotechmorning.com/news/embecta-owen-mumford-acquisition-auto-injector 2026-03-20T14:05:05.238Z never 0.8 https://biotechmorning.com/news/fda-vinay-prasad-departure 2026-03-19T14:13:40.629Z never 0.8 https://biotechmorning.com/news/immutep-phase-3-failure-stock-crash 2026-03-19T14:12:59.905Z never 0.8 https://biotechmorning.com/news/jenavalve-first-fda-approval-aortic-regurgitation 2026-03-19T14:12:03.156Z never 0.8 https://biotechmorning.com/news/oral-peptide-icotyde-psoriasis-fda-approval 2026-03-19T14:11:21.630Z never 0.8 https://biotechmorning.com/news/crossbow-therapeutics-77m-series-b 2026-03-19T14:10:36.444Z never 0.8 https://biotechmorning.com/news/r1-therapeutics-series-a-kidney-disease 2026-03-19T14:09:50.135Z never 0.8 https://biotechmorning.com/news/bicycle-therapeutics-shelves-lead-program-cuts-staff 2026-03-19T14:09:00.875Z never 0.8 https://biotechmorning.com/news/gossamer-bio-seralutinib-failure-layoffs 2026-03-19T14:08:17.887Z never 0.8 https://biotechmorning.com/news/first-drug-cholestatic-pruritus-pbc-lynavoy-fda-approval 2026-03-19T14:07:36.156Z never 0.8 https://biotechmorning.com/news/prism-biolab-receptor-ai-drug-discovery-partnership 2026-03-18T14:10:58.654Z never 0.8 https://biotechmorning.com/news/fda-lost-4000-staff-now-what 2026-03-18T14:10:16.038Z never 0.8 https://biotechmorning.com/news/jj-jlabs-new-york-closure 2026-03-18T14:09:32.269Z never 0.8 https://biotechmorning.com/news/gsk-flovent-inhaler-authorized-generic-senator-scrutiny 2026-03-18T14:08:51.799Z never 0.8 https://biotechmorning.com/news/bicycle-therapeutics-restructuring-lead-drug-shelved 2026-03-18T14:08:12.761Z never 0.8 https://biotechmorning.com/news/aldeyra-reproxalap-third-fda-rejection 2026-03-18T14:07:27.675Z never 0.8 https://biotechmorning.com/news/pill-that-wants-to-kill-needle-psoriasis 2026-03-18T14:06:44.240Z never 0.8 https://biotechmorning.com/news/big-pharma-obsessed-south-korea 2026-03-17T14:14:18.618Z never 0.8 https://biotechmorning.com/news/cytomx-masked-adc-colorectal-cancer-stock-surge 2026-03-17T14:13:36.539Z never 0.8 https://biotechmorning.com/news/vertex-iga-nephropathy-bla-filing 2026-03-17T14:12:49.415Z never 0.8 https://biotechmorning.com/news/bayer-kerendia-kidney-drug-five-phase-iii-wins 2026-03-17T14:12:02.445Z never 0.8 https://biotechmorning.com/news/r1-therapeutics-78m-kidney-disease-bet 2026-03-17T14:11:21.492Z never 0.8 https://biotechmorning.com/news/idorsia-ceo-departure-founder-returns 2026-03-17T14:10:38.465Z never 0.8 https://biotechmorning.com/news/sarepta-elevidys-liver-safety-regimen 2026-03-17T14:09:52.704Z never 0.8 https://biotechmorning.com/news/pfizer-cdk4-inhibitor-replace-ibrance 2026-03-17T14:09:04.771Z never 0.8 https://biotechmorning.com/news/amplifon-gn-hearing-acquisition-medtech 2026-03-17T14:08:23.361Z never 0.8 https://biotechmorning.com/news/fda-biosimilar-cost-cut-guidance 2026-03-17T14:07:34.373Z never 0.8 https://biotechmorning.com/news/sana-biotech-islet-cell-therapy-14-month-data 2026-03-16T14:18:51.215Z never 0.8 https://biotechmorning.com/news/akeso-trispecific-antibody-ak150-cold-tumors 2026-03-16T14:18:07.928Z never 0.8 https://biotechmorning.com/news/bysanti-milsaperidone-fda-approval-antipsychotic-remix 2026-03-16T14:17:25.613Z never 0.8 https://biotechmorning.com/news/first-drug-arginase-1-deficiency-loargys-fda-approval 2026-03-16T14:16:34.788Z never 0.8 https://biotechmorning.com/news/eikon-therapeutics-381m-ipo-bet-on-watching-proteins-move 2026-03-16T14:15:51.248Z never 0.8 https://biotechmorning.com/news/fda-biosimilar-pk-guidance-non-us-comparators 2026-03-16T14:15:09.121Z never 0.8 https://biotechmorning.com/news/jj-nipocalimab-sle-fda-fast-track 2026-03-16T14:14:26.718Z never 0.8 https://biotechmorning.com/news/generate-biomedicines-400m-ipo-ai-drug-discovery 2026-03-16T14:13:44.425Z never 0.8 https://biotechmorning.com/news/vistagen-phase-3-failure-palisade-4-bet 2026-03-15T14:09:08.650Z never 0.8 https://biotechmorning.com/news/pfizer-3sbio-ssgj-707-phase-3-speed 2026-03-15T14:08:22.082Z never 0.8 https://biotechmorning.com/news/inovio-112-employees-one-drug-zero-room-for-error 2026-03-15T14:07:36.875Z never 0.8 https://biotechmorning.com/news/immutep-stock-crash-phase-3-failure 2026-03-14T14:10:58.387Z never 0.8 https://biotechmorning.com/news/vertex-povetacicept-igan-phase-3-results 2026-03-14T14:10:19.008Z never 0.8 https://biotechmorning.com/news/fda-prasad-departure-gene-therapy-stocks-rally 2026-03-14T14:09:29.853Z never 0.8 https://biotechmorning.com/news/insulet-omnipod-5-recall-insulin-leakage 2026-03-14T14:08:43.526Z never 0.8 https://biotechmorning.com/news/inovio-layoffs-ino-3107-fda-accelerated-approval 2026-03-14T14:07:56.631Z never 0.8 https://biotechmorning.com/news/biogen-salanersen-sma-once-a-year-shot 2026-03-14T14:07:12.592Z never 0.8 https://biotechmorning.com/news/china-beats-neuralink-bci-approval 2026-03-14T14:06:22.704Z never 0.8 https://biotechmorning.com/news/biotech-turns-50-next-50-look-different 2026-03-13T14:09:55.156Z never 0.8 https://biotechmorning.com/news/ultragenyx-gene-therapy-urea-cycle-disorder-phase-3 2026-03-13T14:09:06.815Z never 0.8 https://biotechmorning.com/news/vistagen-layoffs-phase-3-anxiety-gamble 2026-03-13T14:06:46.192Z never 0.8 https://biotechmorning.com/news/diabetes-device-land-grab-type-2 2026-03-13T14:05:34.305Z never 0.8 https://biotechmorning.com/news/novo-nordisk-fda-warning-glp1-deaths 2026-03-12T14:20:12.954Z never 0.8 https://biotechmorning.com/news/im-biologics-ipo-839-to-1-demand 2026-03-12T14:19:25.124Z never 0.8 https://biotechmorning.com/news/amgen-horizon-therapeutics-layoffs-evotec-restructuring 2026-03-12T14:18:39.907Z never 0.8 https://biotechmorning.com/news/salspera-ipo-bacteria-pancreatic-cancer 2026-03-12T14:16:36.897Z never 0.8 https://biotechmorning.com/news/iran-hacked-stryker-medical-devices 2026-03-12T14:15:45.627Z never 0.8 https://biotechmorning.com/news/install-gene-editing-tool-large-scale 2026-03-12T14:12:14.476Z never 0.8 https://biotechmorning.com/news/fda-second-chance-capricor-duchenne-cell-therapy 2026-03-11T14:14:41.310Z never 0.8 https://biotechmorning.com/news/biontech-founders-leaving-new-mrna-venture 2026-03-11T14:13:59.602Z never 0.8 https://biotechmorning.com/news/f5-therapeutics-molecular-glue-shutdown 2026-03-11T14:12:43.539Z never 0.8 https://biotechmorning.com/news/abbvie-regeneron-obesity-drug-data 2026-03-11T14:11:10.735Z never 0.8 https://biotechmorning.com/news/arpa-h-delphi-wearable-biosensor-program 2026-03-11T14:10:19.288Z never 0.8 https://biotechmorning.com/news/big-pharma-abandoning-antibiotics 2026-03-11T14:09:21.635Z never 0.8 https://biotechmorning.com/news/takeda-zasocitinib-psoriasis-phase-3-results 2026-03-10T14:11:06.884Z never 0.8 https://biotechmorning.com/news/bms-celmod-mezigdomide-myeloma-phase-3 2026-03-10T14:10:20.333Z never 0.8 https://biotechmorning.com/news/gsk-sells-itch-drug-before-fda-decision 2026-03-10T14:09:35.781Z never 0.8 https://biotechmorning.com/news/xenon-epilepsy-drug-breaks-expectations 2026-03-10T14:08:55.815Z never 0.8 https://biotechmorning.com/news/vertex-kidney-disease-povetacicept-phase-3-results 2026-03-10T14:08:14.179Z never 0.8 https://biotechmorning.com/news/yuviwel-achondroplasia-fda-approval 2026-03-09T14:08:35.505Z never 0.8 https://biotechmorning.com/news/candid-therapeutics-rallybio-reverse-merger-505m 2026-03-09T14:07:55.967Z never 0.8 https://biotechmorning.com/news/gsk-alfasigma-690m-itch-drug-fda-decision 2026-03-09T14:07:13.666Z never 0.8 https://biotechmorning.com/news/roche-giredestrant-persevera-phase-3-failure 2026-03-09T14:06:21.230Z never 0.8 https://biotechmorning.com/news/gilead-arcellx-deal-ftc-scrutiny 2026-03-08T14:05:27.271Z never 0.8 https://biotechmorning.com/news/bavarian-nordic-ceo-exits-failed-takeover 2026-03-07T14:14:52.297Z never 0.8 https://biotechmorning.com/news/gsk-950-million-35pharma-pulmonary-hypertension 2026-03-07T14:14:02.675Z never 0.8 https://biotechmorning.com/news/servier-day-one-acquisition-pediatric-oncology 2026-03-07T14:13:14.827Z never 0.8 https://biotechmorning.com/news/vertex-cuts-20-jobs-whats-really-going-on 2026-03-07T14:12:22.709Z never 0.8 https://biotechmorning.com/news/alltrna-ceo-departure-layoffs-trna-platform 2026-03-07T14:11:37.408Z never 0.8 https://biotechmorning.com/news/iqvia-charles-river-discovery-services-acquisition 2026-03-07T14:10:48.751Z never 0.8 https://biotechmorning.com/news/fda-cber-director-prasad-quits-again 2026-03-07T14:10:01.358Z never 0.8 https://biotechmorning.com/news/science-corp-230m-series-c-vision-implant 2026-03-06T14:06:29.005Z never 0.8 https://biotechmorning.com/news/alnylam-tenaya-cardiovascular-rnai-deal 2026-03-06T14:05:48.520Z never 0.8 https://biotechmorning.com/news/flagship-trna-bet-alltrna-layoffs 2026-03-06T14:05:08.118Z never 0.8 https://biotechmorning.com/news/fda-warning-letters-compounded-glp1-sellers 2026-03-05T14:09:39.732Z never 0.8 https://biotechmorning.com/news/sanofi-sino-biopharmaceutical-rovadicitinib-deal 2026-03-05T14:08:58.322Z never 0.8 https://biotechmorning.com/news/roche-half-billion-south-korea-clinical-trials 2026-03-05T14:08:17.022Z never 0.8 https://biotechmorning.com/news/fda-3-year-exclusivity-draft-guidance 2026-03-05T14:07:34.980Z never 0.8 https://biotechmorning.com/news/lonza-octane-personalized-medicine-deal 2026-03-05T14:06:50.956Z never 0.8 https://biotechmorning.com/news/oral-obesity-pill-orforglipron-lilly-2026 2026-03-05T14:06:06.611Z never 0.8 https://biotechmorning.com/news/vial-health-bispecific-antibody-asthma 2026-03-04T10:09:24.450Z never 0.8 https://biotechmorning.com/news/prolium-t-cell-engager-autoimmune-disease 2026-03-04T10:08:37.460Z never 0.8 https://biotechmorning.com/news/teva-blackstone-royalty-deal-ibd 2026-03-04T10:07:46.245Z never 0.8 https://biotechmorning.com/news/eczema-drug-killed-by-cancer-signal 2026-03-04T10:06:56.368Z never 0.8 https://biotechmorning.com/news/first-hepatitis-b-functional-cure-bepirovirsen 2026-03-04T10:06:13.032Z never 0.8 https://biotechmorning.com/news/ql-biopharm-series-c-monthly-glp1 2026-03-03T18:13:20.103Z never 0.8 https://biotechmorning.com/news/mash-claims-another-victim-boehringer-ose 2026-03-03T18:12:41.586Z never 0.8 https://biotechmorning.com/news/abbvie-skyrizi-crohns-hard-to-treat 2026-03-03T18:12:30.980Z never 0.8 https://biotechmorning.com/news/fda-sham-surgery-huntington-gene-therapy 2026-03-03T18:11:48.756Z never 0.8 https://biotechmorning.com/news/crispr-armed-phage-therapy-first-safety-trial 2026-03-03T18:10:56.696Z never 0.8 https://biotechmorning.com/news/bms-sotyktu-psoriatic-arthritis-fda-decision 2026-03-03T18:09:53.791Z never 0.8 https://biotechmorning.com/news/biohaven-reverses-rd-cuts-molecular-degraders 2026-03-03T18:09:09.544Z never 0.8 https://biotechmorning.com/news/theravance-bet-everything-one-drug-lost 2026-03-03T18:08:20.179Z never 0.8 https://biotechmorning.com/news/oncolytic-virus-colorectal-cancer-trial 2026-03-02T16:30:46.788Z never 0.8 https://biotechmorning.com/news/lynk-zemprocitinib-eczema-phase-3-results 2026-03-02T16:30:00.796Z never 0.8 https://biotechmorning.com/news/generate-biomedicines-ipo-face-plant 2026-03-02T16:29:18.004Z never 0.8 https://biotechmorning.com/news/roche-fenebrutinib-ms-phase-3-sweep 2026-03-02T16:28:30.163Z never 0.8 https://biotechmorning.com/news/matricelf-innovation-award-spinal-cord-injury 2026-03-02T16:27:36.030Z never 0.8 https://biotechmorning.com/news/septerna-sep-631-mrgprx2-urticaria-phase-1 2026-03-02T16:26:45.795Z never 0.8 https://biotechmorning.com/news/merck-keytruda-patent-cliff-reorganization 2026-03-02T00:01:25.449Z never 0.8 https://biotechmorning.com/news/biomarin-roctavian-gene-therapy-withdrawal 2026-03-02T00:00:33.111Z never 0.8 https://biotechmorning.com/news/viruses-found-weak-spot-superbugs-antibiotic-target 2026-03-01T23:59:46.542Z never 0.8 https://biotechmorning.com/news/rna-nanostars-programmable-organelles-bacteria 2026-03-01T23:59:03.102Z never 0.8 https://biotechmorning.com/news/slate-medicines-pacap-migraine-launch 2026-03-01T23:58:20.320Z never 0.8 https://biotechmorning.com/news/dupixent-ninth-fda-approval-afrs 2026-03-01T23:57:37.691Z never 0.8 https://biotechmorning.com/news/bms-china-adc-breast-cancer-phase-3-results 2026-03-01T23:56:48.969Z never 0.8 https://biotechmorning.com/news/senate-hearing-fda-rare-disease-roadblock 2026-02-27T21:54:17.246Z never 0.8 https://biotechmorning.com/news/psychedelics-without-the-trip 2026-02-27T21:24:52.656Z never 0.8 https://biotechmorning.com/news/abbvie-650m-remegen-bispecific-antibody 2026-02-27T21:24:49.146Z never 0.8 https://biotechmorning.com/news/novo-triple-g-obesity-drug-results 2026-02-27T21:24:43.366Z never 0.8 https://biotechmorning.com/news/885m-bet-adc-linker-technology-earendil-wuxi-xdc 2026-02-27T21:15:52.614Z never 0.8 https://biotechmorning.com/news/gilead-arcellx-7-8-billion-car-t-deal 2026-02-27T21:15:40.552Z never 0.8 https://biotechmorning.com/news/atrium-therapeutics-avidity-spinoff-270m 2026-02-27T21:15:37.521Z never 0.8 https://biotechmorning.com/news/sarepta-ceo-doug-ingram-retirement 2026-02-26T21:18:00.547Z never 0.8 https://biotechmorning.com/news/gsk-950m-35pharma-pulmonary-hypertension 2026-02-26T21:18:00.261Z never 0.8 https://biotechmorning.com/news/viatris-layoffs-biotech-2026-wave 2026-02-26T21:17:48.932Z never 0.8 https://biotechmorning.com/news/bms-adc-tnbc-phase-3-win 2026-02-26T21:17:45.274Z never 0.8 https://biotechmorning.com/news/novo-nordisk-vivtex-oral-obesity-pill-deal 2026-02-26T21:17:44.321Z never 0.8 https://biotechmorning.com/news/asahi-kasei-920m-aicuris-antiviral-acquisition 2026-02-26T21:17:43.772Z never 0.8 https://biotechmorning.com/news/boehringer-sitryx-500m-oral-autoimmune-deal 2026-02-26T21:17:43.438Z never 0.8 https://biotechmorning.com/news/accent-dhx9-inhibitor-clinical-hold-safety 2026-02-26T21:17:40.934Z never 0.8 https://biotechmorning.com/news/fda-one-patient-approval-plausible-mechanism 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/zero-treatments-friedreichs-ataxia-larimar-breakthrough 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/til-therapy-sarcoma-lifileucel-iovance 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/fda-approves-smartphone-app-migraine-treatment 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/novo-ubt251-weight-loss-competitive-gap 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/250-patients-changed-fda-playbook 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/130m-bet-migraine-patients-nobody-can-help 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/masked-t-cell-engager-astellas-vir-deal 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/protara-tara-002-bladder-cancer-response-rate-durability-collapse 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/gsk-250m-bora-pharmaceuticals-north-america-supply-chain 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/fda-gene-therapy-startups-skip-gmp-phase2 2026-02-24T12:00:00.000Z never 0.8 https://biotechmorning.com/news/gossamer-bio-seralutinib-missed-endpoint-fda-filing 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/gilead-arcellx-7-8b-car-t-acquisition 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/moderna-rare-disease-garage-sale 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/sanofi-fires-ceo-hudson-garijo-replacement 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/pfizer-monthly-weight-loss-shot-pf-3944 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/biomarin-rival-benched-three-months 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/fda-approval-skipped-phase-3-vanda-bysanti 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/ultragenyx-dtx401-gene-therapy-glycogen-storage-disease 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/moonlake-90-percent-crash-fifth-positive-indication 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/fortress-biotech-205m-priority-review-voucher-no-drug-sales 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/nih-funding-cuts-wrecking-ball-clinical-trials 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/lilly-repertoire-immune-tolerance-deal 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/novo-nordisk-cagrisema-loses-head-to-head-zepbound 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/rare-disease-biotech-hunger-problem 2026-02-23T12:00:00.000Z never 0.8 https://biotechmorning.com/news/oxygen-gel-every-treated-mouse-survived 2026-02-22T12:00:00.000Z never 0.8 https://biotechmorning.com/news/axsome-therapeutics-9b-market-cap-16b-cns-portfolio 2026-02-22T12:00:00.000Z never 0.8 https://biotechmorning.com/news/india-30-billion-generic-drug-machine 2026-02-22T12:00:00.000Z never 0.8 https://biotechmorning.com/news/daiichi-sankyo-poached-novartis-drug-approval-machine 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/galleri-blood-test-found-cancer-stock-tanked 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/revlimid-successor-iberdomide-fda-priority-review 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/tremfya-ulcerative-colitis-three-year-remission 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/ionis-one-patient-alzheimers-down-syndrome-trial 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/scotus-killed-ieepa-tariffs-pharma-not-off-hook 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/crohns-pill-works-before-biologic-wakes-up 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/one-brain-tumor-freezes-two-gene-therapies 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/recursion-cfo-stock-sale-earnings 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/virus-kills-prostate-cancer-100m-backer 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/novartis-nkg2d-qeq278-zero-responses-solid-tumors 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/news/roche-giredestrant-breast-cancer-pill-secret-weapon 2026-02-21T12:00:00.000Z never 0.8 https://biotechmorning.com/issues/2026-10-20 2026-10-20T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-19 2026-10-19T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-18 2026-10-18T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-17 2026-10-17T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-16 2026-10-16T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-15 2026-10-15T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-14 2026-10-14T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-13 2026-10-13T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-12 2026-10-12T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-11 2026-10-11T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-10 2026-10-10T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-09 2026-10-09T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-08 2026-10-08T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-07 2026-10-07T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-06 2026-10-06T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-05 2026-10-05T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-04 2026-10-04T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-03 2026-10-03T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-02 2026-10-02T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-10-01 2026-10-01T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-30 2026-09-30T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-29 2026-09-29T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-28 2026-09-28T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-27 2026-09-27T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-26 2026-09-26T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-25 2026-09-25T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-24 2026-09-24T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-23 2026-09-23T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-22 2026-09-22T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-21 2026-09-21T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-20 2026-09-20T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-19 2026-09-19T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-18 2026-09-18T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-17 2026-09-17T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-16 2026-09-16T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-15 2026-09-15T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-14 2026-09-14T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-13 2026-09-13T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-12 2026-09-12T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-11 2026-09-11T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-10 2026-09-10T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-09 2026-09-09T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-08 2026-09-08T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-07 2026-09-07T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-06 2026-09-06T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-05 2026-09-05T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-04 2026-09-04T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-03 2026-09-03T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-02 2026-09-02T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-09-01 2026-09-01T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-31 2026-08-31T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-30 2026-08-30T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-29 2026-08-29T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-28 2026-08-28T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-26 2026-08-26T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-25 2026-08-25T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-24 2026-08-24T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-23 2026-08-23T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-22 2026-08-22T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-21 2026-08-21T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-20 2026-08-20T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-19 2026-08-19T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-18 2026-08-18T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-17 2026-08-17T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-16 2026-08-16T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-15 2026-08-15T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-14 2026-08-14T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-13 2026-08-13T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-12 2026-08-12T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-10 2026-08-10T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-09 2026-08-09T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-08 2026-08-08T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-07 2026-08-07T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-06 2026-08-06T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-05 2026-08-05T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-04 2026-08-04T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-03 2026-08-03T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-02 2026-08-02T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-08-01 2026-08-01T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-31 2026-07-31T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-30 2026-07-30T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-29 2026-07-29T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-28 2026-07-28T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-27 2026-07-27T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-26 2026-07-26T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-25 2026-07-25T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-24 2026-07-24T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-23 2026-07-23T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-22 2026-07-22T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-21 2026-07-21T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-20 2026-07-20T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-19 2026-07-19T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-18 2026-07-18T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-17 2026-07-17T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-16 2026-07-16T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-15 2026-07-15T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-14 2026-07-14T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-13 2026-07-13T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-12 2026-07-12T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-11 2026-07-11T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-10 2026-07-10T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-09 2026-07-09T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-08 2026-07-08T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-07 2026-07-07T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-06 2026-07-06T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-05 2026-07-05T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-03 2026-07-03T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-02 2026-07-02T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-07-01 2026-07-01T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-30 2026-06-30T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-29 2026-06-29T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-28 2026-06-28T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-27 2026-06-27T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-26 2026-06-26T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-25 2026-06-25T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-24 2026-06-24T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-23 2026-06-23T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-22 2026-06-22T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-21 2026-06-21T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-20 2026-06-20T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-19 2026-06-19T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-18 2026-06-18T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-17 2026-06-17T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-16 2026-06-16T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-15 2026-06-15T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-14 2026-06-14T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-13 2026-06-13T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-12 2026-06-12T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-11 2026-06-11T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-10 2026-06-10T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-09 2026-06-09T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-08 2026-06-08T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-07 2026-06-07T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-06 2026-06-06T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-05 2026-06-05T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-04 2026-06-04T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-03 2026-06-03T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-02 2026-06-02T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-06-01 2026-06-01T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-31 2026-05-31T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-30 2026-05-30T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-29 2026-05-29T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-28 2026-05-28T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-27 2026-05-27T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-26 2026-05-26T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-25 2026-05-25T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-24 2026-05-24T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-23 2026-05-23T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-22 2026-05-22T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-21 2026-05-21T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-20 2026-05-20T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-19 2026-05-19T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-18 2026-05-18T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-17 2026-05-17T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-14 2026-05-14T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-13 2026-05-13T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-12 2026-05-12T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-11 2026-05-11T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-09 2026-05-09T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-08 2026-05-08T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-07 2026-05-07T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-06 2026-05-06T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-05 2026-05-05T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-04 2026-05-04T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-03 2026-05-03T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-02 2026-05-02T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-05-01 2026-05-01T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-30 2026-04-30T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-29 2026-04-29T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-28 2026-04-28T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-27 2026-04-27T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-26 2026-04-26T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-25 2026-04-25T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-24 2026-04-24T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-23 2026-04-23T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-22 2026-04-22T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-21 2026-04-21T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-20 2026-04-20T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-19 2026-04-19T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-18 2026-04-18T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-17 2026-04-17T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-16 2026-04-16T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-15 2026-04-15T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-14 2026-04-14T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-13 2026-04-13T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-12 2026-04-12T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-11 2026-04-11T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-10 2026-04-10T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-09 2026-04-09T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-08 2026-04-08T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-07 2026-04-07T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-06 2026-04-06T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-05 2026-04-05T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-04 2026-04-04T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-03 2026-04-03T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-02 2026-04-02T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-04-01 2026-04-01T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-31 2026-03-31T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-30 2026-03-30T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-29 2026-03-29T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-28 2026-03-28T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-27 2026-03-27T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-26 2026-03-26T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-25 2026-03-25T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-24 2026-03-24T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-23 2026-03-23T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-22 2026-03-22T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-21 2026-03-21T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-20 2026-03-20T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-19 2026-03-19T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-18 2026-03-18T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-17 2026-03-17T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-16 2026-03-16T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-15 2026-03-15T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-14 2026-03-14T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-13 2026-03-13T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-12 2026-03-12T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-11 2026-03-11T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-10 2026-03-10T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-09 2026-03-09T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-07 2026-03-07T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-06 2026-03-06T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-05 2026-03-05T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-04 2026-03-04T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-03 2026-03-03T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-03-01 2026-03-01T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-02-27 2026-02-27T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-02-26 2026-02-26T12:00:00.000Z never 0.7 https://biotechmorning.com/issues/2026-02-25 2026-02-25T14:00:48.752Z never 0.7 https://biotechmorning.com/issues/2026-02-24 2026-02-24T14:00:20.018Z never 0.7 https://biotechmorning.com/issues/2026-02-23 2026-02-23T14:00:17.082Z never 0.7 https://biotechmorning.com/issues/2026-02-22 2026-02-22T14:00:24.908Z never 0.7 https://biotechmorning.com/issues/2026-02-21 2026-02-21T14:00:24.872Z never 0.7